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Humans are subject to infection with a wide range of commensal and pathogenic organisms. 
Each pathogen requires an appropriate immune response to eliminate or control the invading 
organism and minimise pathology. Many pathogens have evolved strategies to subvert or 
manipulate the immune response and establish on-going infections. Similarly acute respiratory 
infection with virulent strains of influenza A virus are often poorly controlled by the immune 
system and can cause severe immunopathology and even fatality as a result of an inappropriate 
and excessive inflammatory response called a ‘cytokine storm’.  
Morbidity due to influenza infection and exacerbation by the immune response can vary greatly 
between individuals. The effect of underlying infection on the immune system could contribute 
to the variation in response. The aim of this project was therefore to determine if co-infection 
with two pathogens that establish on-going infections could alter the immune response to 
influenza A and impact the outcome of infection. 
Persistent infections with filarial helminths can cause debilitating disease and significantly 
impact the immune response toward a skewed TH2 or regulatory phenotype in order to control 
pathology. In contrast, infection with gammaherpesviruses in an immunocompetent host causes 
an initial inflammatory ‘anti-viral’ response before becoming an asymptomatic, latent infection. 
In an immunocompromised host, gammaherpesviruses can reactivate and lead to clinical 
presentation of disease. This suggests that these viruses require an on-going immune response to 
control all stages of infection. Both filarial helminths and gammaherpesviruses are common 
infections in human populations and therefore mouse models of these infections provide 
relevant systems to study their potential role in influenza virus infections.   
In a BALB/c murine co-infection model, latent infection with the rodent gammaherpesvirus 
MHV-68 led to significantly decreased weight loss and clinical signs following high dose 
infection with A/WSN/33, (a H1N1 influenza A virus). This was coupled with decreased 
immunopathology in the lung and fewer infiltrating lymphocytes in the alveolar spaces and 
around larger airways, although  infectious virus titres were not significantly reduced. This 
response was coupled with a decreased production of inflammatory cytokines and chemokines 
in co-infected mice 6 days post infection which correlated with the amelioration of pathogenesis 
in these animals.  
 A repeat of the study in 129Sv/Ev IFNγR knock out mice showed the same protective effect in 
the co-infected mice, suggesting IFNγ is not critical for the protective phenotype. Mice infected 




the lung and alveolar macrophages had a significantly increased production of suppressor of 
cytokine signalling (SOCS-1) suggesting latent MHV-68 infection may impact the phenotype of 
macrophages in the lung, modulating the response to influenza co-infection.  
A co-infection model with a persistent rodent filarial helminth, Litomosoides sigmodontis and 
A/WSN/33 was also established in BALB/c mice. The L4 developmental stage of L. 
sigmodontis infection had no impact on co-infection with A/WSN/33. Adult stage worms, 
however, appeared to have a protective effect against A/WSN/33 pathogenesis. Co-infected 





T cells in the lung draining lymph nodes had significantly reduced TH1 and TH2 
phenotypes (measured by cytokine production) compared with singly infected controls. IFNγ 
secreting CD4
+
 T cells in the lungs of co-infected mice also secreted increased levels of IL-10, 
suggesting an increase in regulation of the inflammatory response to A/WSN/33.  
At the full patent stage of L. sigmodontis infection, co-infection with A/WSN/33 led to 




 T cells in the 
lung draining lymph nodes were inflammatory in L. sigmodontis infected mice alone as well as 
co-infected mice and there were no differences in the percentage of CD4
+
 T cells in the lung 
secreting IL-10 and IFNγ between co-infected and influenza infected mice. A loss in regulatory 
responses during the patent stage of L. sigmodontis infection may therefore contribute to the 
loss of protection against A/WSN/33 at this time point within the co-infection model. 
Understanding the impact of an underlying infection on the immune system could provide 
immune mechanisms that could be exploited to increase vaccine efficacy against influenza and 
similarly help to provide better treatment for individuals infected with influenza A. These 
results may also help predict the outcome of influenza A infection in individuals already 
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Gareth Hardisty Introduction 1 
Chapter 1 -  Introduction 
1.1 The human host 
Humans are subject to continual infection by commensal and pathogenic organisms. The site of 
these infections is often the epithelial barriers, including the lung and intestine (Murphy 2011). 
The human immune response is therefore persistently activated in response to multiple harmful 
and innocuous antigens and must mount targeted and appropriate responses in order to maintain 
homeostasis with commensals, eliminate harmful pathogens and dampen excessive responses to 
harmless allergens. While the immune response has evolved the capability to elicit highly 
specific, polarised responses to a range of infectious agents, many pathogens utilise evasive 
mechanisms in order to establish long-term and persistent infections with deleterious effects on 
the host. Evidence of this can be seen in cancer associated herpesvirus infections or persistent, 
debilitating nematode infections and their associated pathologies. 
1.2 Modelling infection 
Animal models of infection are often employed by researchers in order to better understand such 
host-pathogen relationships. This is of particular importance to identify dysfunction in the host 
immune system that could be targeted or improved with therapeutics to enhance resistance to 
acute and persistent pathogens. In recent years models of infection usually utilise in-bred, 
pathogen free, laboratory strain animals in order to encourage consistency within responses. 
Mathematical modelling is also commonplace and applies similar principles to depict direct 
interactions between individual proteins / cells or pathogens in a defined host. 
In reality, genetics, environmental factors, pre-existing conditions, malignancies and lifestyle 
choices all contribute to the outcome of human infection. This explains the variation in response 
between individuals infected with the same pathogen. Therefore models of infection using 
outbred animals (Masuzawa, Beppu et al. 1992) and models that incorporate a second 
pathologe, confounding factor or pre-disposition are re-emerging and becoming more common 
(Zaccone, Raine et al. 2004; Pawlowski, Jansson et al. 2012; Castro Sanchez, Aerts et al. 2013) 
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1.3 Latent and persistent infections 
On-going immune responses required to control one infection have been shown to limit, 
counteract or in some cases heighten the immune response to a second, unrelated pathogen. Co-
infecting pathogens can directly interact or indirectly alter clinical presentation or transmission 
and kinetics of other infections. This can complicate treatment and hinder vaccination strategies 
(Griffiths, Pedersen et al. 2011). In many communities chronic,  latent and persistent infections 
occur at a very young age and are then maintained throughout the life of the host, obfuscating 
responses to new infections (Enders, Biber et al. 1990; Petney and Andrews 1998). 
Understanding the impact of on-going infection on the host is therefore important to understand 
the potential effect on the response to co-infection. Studies of this type, which observe the 
interaction between multiple pathogens and the immune response are rare.  
1.4 Polarisation of the immune response by latent and persistent infection 
The immune response has evolved the capability to produce polarised, pathogen type specific 
responses to infection. Lytic viruses, large parasitic multicellular organisms, opportunistic 
bacterial infections, fungi, pollutants and allergens all trigger distinct responses that aim to clear 
pathogens with minimal immunopathology and collateral damage to host tissues. The response 
for example, to clear a lytic viral infection is different to the response required to clear a 
helminth infection. A host already responding to a persistent helminth infection may respond 
differently to infection with a virus compared with an uninfected individual.  
At the site of infection, recognition of pathogen associated molecular patterns (PAMPs) by 
antigen presenting cells, or mechanical damage to barrier tissues caused by infection releases 
damage associated molecular patterns (DAMPs) and induces the production of cytokines, 
chemokines and immunomodulatory molecules (Kourilsky and Truffa-Bachi 2001). This 
systematically activates appropriate adaptive immune responses, such as TH0 differentiation (to 
TH1 / TH2 / TH17 etc) or class switched antibody production by B cells and ultimately 
neutralises the infection (Zhu and Paul 2008; Walsh and Mills 2013). Innate immune cells 
resident at the site of infection continue to propagate responses, and recruit other immune cells 
as necessary resulting in changes to the homeostatic balance at the site of infection to a 
phenotype that is suitably anti-viral / anti-helminthic etc. depending on the causative agent 
(Walsh and Mills 2013). 
During an acute infection this is rapidly followed by resolution and return to homeostasis. In 
chronic, latent or persistent infection, the pathogen is not cleared and an on-going immune 
response is required to control the pathogen. The host immune system is therefore skewed 
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towards a particular phenotype at the site of infection. This can impact responses to 
heterologous pathogen.  
 This project aims to identify how such changes caused by ongoing infection can impact the 
response to an unrelated acute, inflammatory viral infection with influenza A. As the immune 
response can be skewed towards significantly different phenotypes depending on the pathogen, 
two models of on-going infection will be considered; latent infection with an inflammatory 
gammaherpesvirus and persistent infection with an immunosuppressive lymphatic filarial 
nematode. 
1.5 Immune modulation by latent infection: herpesviruses 
1.5.1 Introduction to herpesviruses 
Herpesviruses are a highly disseminated order of double stranded DNA viruses identified in 
most vertebrates and some bi-valve molluscs.  The family may be subdivided into 3 sub-
families alpha α, beta β, and gamma γ, containing 17 genera and 90 species (Davison 2010). 
Each species is usually found to naturally infect a single host species and is therefore thought to 
have co-evolved during speciation of the host (McGeoch, Rixon et al. 2006). Herpesviruses are 
defined by four biological properties, represented in table 1.1 below. 
Table 1.1 Biological properties of herpesviruses 
1. They specify a large array of enzymes involved in nucleic acid metabolism (e.g., 
thymidine kinase, thymidylate synthetase, dUTPase, ribonucleotide reductase), DNA 
synthesis (e.g., DNA polymerase, helicase, primase), and processing of proteins (e.g., 
protein kinases), although the exact array of enzymes may vary from one herpesvirus 
to another. 
2. Virus gene transcription, synthesis of viral DNA, and nucleocapsid assembly occur in 
the nucleus. Most virions acquire at least part of their tegument and are enveloped in 
the cytoplasm. 
3. Production of infectious progeny virus (lytic infection) is generally accompanied by the 
destruction of the infected cell. 
4. The herpesviruses examined to date employ cellular latency as a mechanism for 
lifelong persistence in their hosts. 
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 Gammaherpesviruses 
The gammaherpesviruses are found extensively within mammalian populations. These viruses 
have high affinity for a single host and are restricted to transmission within the host family or 
order (Pellet 2001). The gammaherpesvirus sub-family may be further subdivided into two main 
genera, the Lymphcryptoviridae including Epstein Barr virus (HHV-4) which are exclusive to 
primates and humans and Rhadinoviridae, containing Kaposi-sarcoma associated virus (KSHV 
or HHV-8).  MHV-68 (MuHV-4) is a murine model of gammaherpesvirus infection. 
1.5.2 Lytic, latent and persistent infection of gammaherpesviruses 
Gammaherpesviruses initially cause a lytic acute infection in the upper respiratory tract. The 
virus then enters a latent state, predominantly in B and T lymphocytes and macrophages where 
viral replication is halted. Latency differs from chronic or persistent infection as progeny virus 
is not produced. Latency is distinguished from abortive infection by the ability of the virus to 
reactivate and produce infectious progeny virus.(Pellet 2001) 
EBV is relatively ubiquitous throughout human populations, predominantly infecting B 
lymphocytes but may also be found in T lymphocytes and natural killer (NK) cells as well as 
epithelial cells (Borza and Hutt-Fletcher 2002; Isobe, Sugimoto et al. 2004; Martin 2007). 
KSHV also has the ability to establish latent infection in B lymphocytes; cells that are 
maintained for the life of the host. KSHV is less widespread and prevalence varies between 
populations. These viruses often lie dormant, to evade detection by the host however 
reactivation events are required intermittently in order to produce progeny virus, spread from 
cell to cell and transmit from host to host.  
Gammaherpesviruses have also been shown to maintain persistent infections in the lung 
epithelium (Egan, Stewart et al. 1995; Stewart, Usherwood et al. 1998). As a result they can 
produce lytic, latent and persistent infections at any point during on-going infection. Sporadic 
reactivation applies an inflammatory selective pressure to the host immune system, which must 
continually mount appropriate responses to each stage of the gammaherpesvirus life cycle. 
The requirement for continual control of these infections is evident in immunocompromised 
hosts. Gammaherpesviruses can cause lymphoproliferative disease and tumour formation if host 
immunity is impaired (Cesarman and Knowles 1999; Carbone, Gloghini et al. 2008). EBV  is 
associated with a number of malignancies including Burkitt’s lymphoma, Hodgkin’s disease 
and Nasopharyngeal carcinoma (Fields, Knipe et al. 2007) and KSHV is commonly associated 
with Kaposi Sarcoma, a cancer commonly occurring in immunodeficient AIDS patients 
(Greene, Kuhne et al. 2007). 
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Latent herpesvirus infections therefore require continual immune responses to avoid disease. 
Murine gammaherpesvirus MHV-68 is present in the lung, at the site of influenza A infection. 
Understanding the immune response to latent herpesvirus infection could give insight into the 
potential interactions between concurrent infection with herpesvirus and influenza A.  
1.1.1 Innate immune responses to herpesviruses 
Viral infections are generally met with inflammatory ‘type 1’ immune responses during acute 
infection.  Infections by herpesviruses in the lung continue to induce inflammation and 
interferon production in an attempt to limit replication after acute infection (Christensen, Cardin 
et al. 1999).  
 Changes to cytokine environment in latent infection 
IFNγ is a key surveillance cytokine during gammaherpesvirus latency. IFNγ is known to be 
disposable during the lytic stage of infection with murine MHV-68 (a model of human 
gammaherpesviruses), resulting in only marginally increased viral titres at day 12 and mildly 
delayed clearance from the lung around day 15 (Sarawar, Cardin et al. 1997). Early innate 
immune cells including NK cells and macrophages are key contributors to IFNγ production 
during acute infection. During latent infection, reactivation of gammaherpesviruses was more 
prevalent in those with reduced IFNγ levels. A single polymorphism in the IFNγ gene, resulting 
in reduced production of the cytokine has been identified as contributing to increased incidence 
of EBV associated post-transplant lymphoproliferative disorder (PTLD) in an 
immunocompromised mouse model (Dierksheide, Baiocchi et al. 2005) and in human renal 
transplant patients (VanBuskirk, Malik et al. 2001). Herpes simplex virus infection is also 
controlled by persistent IFNγ production in the trigeminal ganglia by virus specific CD8
+
 T cells 
(Shimeld, Whiteland et al. 1997; Decman, Kinchington et al. 2005). CD8
+
 T cells or IFNγ alone 
can block reactivation of HSV-1 ex vivo from latently infected neurons by decreasing 
expression of the viral ICP0 gene required for lytic replication (Liu, Khanna et al. 2000; 
Decman, Kinchington et al. 2005). 
As the interferon system is a critical component of anti-viral immunity, disruption during 
gammaherpesvirus co-infection can interfere with subsequent viral infections. Nguyen et al 
2008, showed that latent MHV-68 infection caused increased CCL2 and CCL5 chemokine 
levels in the lungs as a result of increased IFNγ expression. Expression of IFNβ, IL-4 and 
CXCL1 was unaltered, as were chemokine levels in the spleen. When coinfection with mouse 
adenovirus type 1 (MAV-1), further increased CCL5 levels in the lung that lead to increased 
mononuclear infiltrates in the airways compared to MAV-1 infected mice. While lung MAV-1 
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titres remained unaltered by the co-infection, the levels of MAV-1 detectable in the spleen were 
reduced (Nguyen et al 2008).  
Transcriptomic analysis of spleens from mice infected with MHV-68 also demonstrated 
increased inflammatory IFNγ and IL-18 receptor as well as type 1 interferon inducible gene 
expression and SOCS-3 (White, Suzanne Beard et al. 2012). These cytokines may therefore also 
have an important role in the lung during persistent infection. 
The overall immune environment is fundamentally altered to an ‘anti-viral phenotype’ with 
increased production of IFNγ in response to latent herpesvirus infection, at both the site of 
persistent replication and during latency.   
 Changes to antigen presenting cells in the lung 
Latent gammaherpesvirus infection can modulate immune responses to secondary bacterial 
infections by modulating the function of antigen presenting cells. C57BL/6J mice latently 
infected with MHV-68 (for 4 and 12 weeks) were resistant to lethal doses of either gram 
positive Listeria monocytogenes or gram negative Yersinia pestis and showed decreased 
bacterial burdens in the spleen and lung respectively due to activation of bactericidal 
macrophages (Barton, White et al. 2007). Significant protection was also seen in mice infected 
with MCMV but not HSV, (perhaps due to restricted anatomical location) however protection 
by the latent herpesviruses was not universal. Mice challenged with West Nile virus succumb to 
infection with similarity to uninfected mice (Barton, White et al. 2007).  Latent infection caused 
increased serum levels of pro-inflammatory cytokines TNFα and IFNγ. This was not observed 
following infection with an ORF73 stop mutant incapable of establishing latent infection and 




 T cells were dispensable for protection when 
depleted before challenge with the bacterial pathogens suggesting a broadly acting innate cross-




 T cells along 
with bactericidal macrophages may all be elicited by bystander activation of inflammatory 
cytokines (Barton, White et al. 2007). Macrophages may therefore be a critical component 
during co-infection, as primary infection can significantly alter their phenotype prior to 
infection with a secondary pathogen. 
1.1.2 Adaptive immune responses to herpesviruses 
During asymptomatic HCMV infection (a betaherpesvirus with 60-100% prevalence within the 




 T cells HCMV 
antigen specific (Sylwester, Mitchell et al. 2005). Similar proportions of CD8
+
 T cells of 
asymptomatic individuals, seropositive for EBV were EBV antigen specific (Tan, Gudgeon et 
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al. 1999). These cells rapidly reactivated to viral antigens and did not show functional 
exhaustion, as is the case with other long term infections such as HIV, HCV and LCMV (Kim 
and Ahmed 2010).   
 Changes to CD8+ T cells  
Despite efforts of the virus to avoid detection the continual presence of virus antigens leads to 
an increasing population of herpesvirus specific CD8
+
 cells. These cells can also have an 
unexpected impact on a second infection. In a cohort of 20 patients infected with hepatitis B 
virus (HBV), CD8
+
 T cells were analysed for activation (CD38 and HLA-DR) and proliferation 
markers (Ki-67/Bcl-2low). The hepatitis infected patients showed 25% of CD8
+
 T cells with 
elevated activation and proliferation markers.  When tested for antigen specificity with MCMV, 
EBV and influenza MHC-pentamers, 12.5% of activated cells were HCMV specific and 30% 
EBV specific. There were no influenza specific CD8
+
 T cells identified. Cross reactivity may 
therefore be herpesvirus specific. The appearance and decrease of these herpesvirus specific 
cells mimicked the kinetics of the total activated CD8
+
 T cell population during the course of 
HBV infection (Sandalova, Laccabue et al. 2010).  When repeated in patients with dengue fever, 
influenza or adenovirus infection, similar herpesvirus responsive cells were identified despite 
fewer overall CD8
+
 T cells as a result of these viral infections. The effect may be associated 
with IL-15 production which in vitro was capable of HCMV/EBV specific reactivation of CD8
+
 
T cells. (Sandalova, Laccabue et al. 2010) Whilst it is plausible, due to the size of the 
herpesvirus genome and large number of antigens encoded by herpesviruses that these cells 
were activated by cross reactivity of antigens, it also remains possible that secondary infection 
is capable of reactivating herpesviruses by disruption of latent infection. Reactivation from 
latency would provide a source of antigen to stimulate EBV or HCMV specific T cells during 
heterologous infection that would not be available in the case of influenza infection. This would 
perhaps explain the source of herpes specific CD8
+
 T cells (White, Suzanne Beard et al. 2012) 
and contribute to the concept that incidence of antigen exposure increases proportions of 
herpesvirus specific lymphocytes  with age (Torti and Oxenius 2012). 
 Changes to CD4+ T cells 
CD4
+ 
T cells have multiple functions during herpesvirus latency. Fundamentally, CD4
+
 T cells 
are required during latent infection to maintain the function of CD8
+
 T cells. Presentation of 
CD40L to DCs encourages long term activation of CD8
+
 T cells (Ridge, Di Rosa et al. 1998). In 
I-A
-/- 
mice infected with MHV-68, inhibitory markers PD-1 and NKG2A are up regulated on 
CD8
+
 T cells, (Dias, Giannoni et al. 2010) however the cells retain cytolytic function and 
capacity to release IFNγ (Giannoni, Shea et al. 2008). This is unlike infection with the persistent 
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virus LCMV where CD4
+
 helper T cell depletion resulted in functional exhaustion of CD8
+
 T 
cells that also increased in expression of PD-1 (Freeman, Wherry et al. 2006), suggesting a 
difference in response due to the latent infection caused by MHV-68.  In MHV-68 infection the 
CD4
+
 T cells maintain CD8
+
 T cell hierarchy, with depletion resulting in changes in responses 
to specific viral epitopes. The CD8
+
 T cell response to one epitope in particular, ORF8604K
b
 




) infection (Freeman, Roberts et al. 2014).  
CD4
+
 T cells have direct cytolytic function during both lytic and persistent gammaherpesvirus 
infection. Up to 80% killing coupled with IFNγ production was observed when CD4
+
 T cells 
specific for an EBV lytic antigen BHRF-1 were co-cultured with EBV-transformed B-
lymphoblastoid cell lines (B-LCLs). This was also seen for EBNA-1 latency protein in blood 
samples from Burkitt’s lymphoma sufferers where 0.5% of all peripheral blood CD4
+
 T cells 
were EBNA-1 specific. These cells were capable of recognising Burkitt’s lymphoma cell lines, 
demonstrating a mechanism of adaptive immunity against the virus independent of MHC-I 
antigen presentation (Paludan, Bickham et al. 2002). Adoptive transfer of OVA specific CD4
+
 T 
cells prolonged survival of RAG mice (deficient in VDJ recombination gene / no mature T and 
B cells) infected with an OVA expressing MHV-68. This suggests a direct role for CD4
+
 T cells 
in viral regulation, independent of classical helper T cell and B cell class switching functions.  
Establishment of latency was impaired in these mice despite the absence of B and CD8
+
 T cell 
function (Sparks-Thissen, Braaten et al. 2004). Latently infected BALB/c mice had increased 
CD27, a marker for cytolytic function and CD107a/b, a marker for degranulation on virus 
specific CD4
+
 T cells in both the spleen and lung. These cells can kill viral antigen expressing 
cells in vivo (Stuller and Flano 2009).  
These cells were IFNγ independent and represent a functionally different phenotype to the IFNγ 
secreting CD4
+
 population which did not require antigenic stimulation to release the pro-
inflammatory cytokines. Total CD4
+
 T cells isolated from MHV-68 infected mice were capable 
of inhibiting reactivation from latency in vitro (Stuller, Cush et al. 2010) and had direct 
cytotoxicity against MHV-68 immortalised B cells preventing tumour formation (Liang, 
Crepeau et al. 2013). Removal of CD4
+
 T cells in vivo resulted in persistent replication of lytic 
virus, development of disease and increased numbers of latently infected splenocytes when 
coupled with depletion of IFNγ (Christensen and Doherty 1999) suggesting CD4
+
 derived IFNγ 
actively represses reactivation. CD4
+
 T cells have other non-cytolytic epigenetic functions 
through production of IFNγ, which is capable of directly repressing the ORF50 viral 
transcription factor required for lytic replication during MHV-68 infection (Goodwin, Canny et 
al. 2010).   
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CD4
+
 T cells have a role in modulation of adaptive immunity and polarisation of innate cells in 
the lung. Cytokine production during latent infection is a key component of the ability of 
gammaherpesviruses to modulate concurrent infection.  
1.5.3 Herpesvirus and respiratory co-infections 
Reports from human infections with herpesviruses that have led to hospitalisation show 
increased incidence of co-infection. Patients with suspected infectious mononucleosis showed a 
higher incidence (63.6%) of EBV and HCMV co-infection, along with respiratory infections 
(Wang, Yang et al. 2010). In a study of patients with non-typical bacteria induced pneumonia, 
the incidence of herpesvirus co-infection was higher than uninfected controls, particularly in the 
case of HCMV (Zhou, Lin et al. 2013). Interaction between two such infections can increase 
disease severity. These studies point to the lung as a potentially key site of co-infection with 
herpesviruses despite uncertainty about the presence of human gammaherpesviruses in the 
healthy lung.  
1.5.4 Herpesvirus infection and autoimmunity 
Changes in adaptive responses caused by herpesvirus infection can be protective against 
autoimmunity. Infection with acute MHV-68 increased the incidence of autoantibodies in lupus 
prone B6.sle123 mice whilst latent infection protected from development of autoimmunity by 
suppression of lymphocyte activation and vastly reduced production of autoantibodies. Infection 
with MHV-68 was also protective in mice that had already developed signs of disease, notably 4 
weeks post infection when latency had established. Latent infection in 6-8 week old mice 






 T cells, 
follicular and marginal zone B220
+
 B cells, which was suggested to inhibit the lymphoid 
expansion caused by autoimmunity (Nguyen et al 2008). Herpesviruses are not universally 
protective against autoimmunity however. Latent infection of C57BL/6 with MHV-68 led to 
exacerbated EAE clinical signs due to CD4
+
 and virus-specific CD8
+
 infiltrations in the brain 
and spinal cord. Increased levels of pro-inflammatory IFNγ, TNFα cytokines and CXCL9 and 
CCL5 chemokines and decreased IL-17a were detected in the serum of infected mice along with 
a decreased anti-MOG (EAE inducing antigen) IgG1 vs IgG2a antibody ratio (Casiraghi, 
Shanina et al. 2012). Production of inflammatory mediators during latent infection with MHV-
68 can therefore reduce IL-17a and IgG1 antibodies specific to EAE induction.  In an IL-10
-/-
 
model of inflammatory bowel disease, co-infection with MHV-68 exacerbated colonic disease 
scores, increased splenomegaly and showed reduced survival. MHV-68 titre was unaffected 
between IL-10
-/-
 and WT C57BL/6 control mice. 
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1.5.5 Herpesvirus infection and type 2 immunity 
A number of studies discussed above have reported the effect of herpesvirus latency on 
inflammatory processes of subsequent infections, providing cross protection or exacerbating 
symptoms. Herpesvirus infections have also been shown to modulate type 2 immunity. EBV 
infection has been demonstrated to have an inverse correlation with asthma sensitisation during 
the early years of development, suggesting that herpesviruses play a role in suppressing allergic 
responses during development (Nilsson, Linde et al. 2005). Challenge of MHV-68 latently 
infected mice with Heligmosomoides polygyrus or Schistosoma mansoni eggs however leads to 
reactivation of the virus into lytic replication due to STAT6 activation and IL-4 production, 
(discussed in 1.6.8). In atopic patients and those prone to allergic responses, atypical 
presentation of herpesvirus infection and more frequent reactivation events have been observed. 
While herpesviruses may reduce inflammatory immune responses, latency is dependent on IFNγ 
and inflammatory cytokine signalling to control reactivation. A skew towards type 2 immunity 
can reactivate herpesvirus infection. Interaction between immune responses during co-infection 
may therefore be dependent on the type of pathogen involved and how systemically polarised 
the immune response is as a result. 
1.6 Immune modulation by persistent infection: filarial nematodes 
Helminths are large, multicellular organisms transmitted by direct contact, through 
contaminated water and food sources or through an insect vector. Helminth infection can result 
in debilitating disease and huge financial burdens for developing countries where such 
infections are endemic (Wynd 2007). Lymphatic filarial parasites are found within the lymph 
vessels and body cavities and can significantly alter or subdue the host immune response. As 
with latent herpesvirus infection they are highly prevalent in human populations, particularly in 
the tropics. Lymphatic filarial parasites Wuchereria bancrofti, Brugia malayi and Brugia timori 
cause repeat and persistent infections. Multi-parasitic infection is therefore common. The 
impact of these infections on unrelated pathogens requires better understanding. 
1.6.1 Changes to host immunity by filarial helminth infections 
Helminths are capable of producing long lived, persistent or repeat infections as a result of 
successful immune evasion strategies or manipulation of host immune mediated attack. Co-
evolution of parasite and host immune response as well as the multicellular nature of these 
parasites means that helminths have driven diversification within the immune system and 
generated distinct immune mechanisms compared to that of microbial infections (Anthony, 
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Rutitzky et al. 2007). Immunity to many helminth infections is therefore governed by the type 2 
cytokines IL-4, IL-5, IL-9, IL-10 and IL-13 and production of robust immunoglobulin E (IgE), 
eosinophil, basophil, alternatively activated macrophages (aaMΦ) and mast cell responses 
(MacDonald, Araujo et al. 2002). These responses combine to strengthen barrier defences, 
expel, inactivate and destroy large invading parasites, restrict growth and repair mechanical 
damage (Palm, Rosenstein et al. 2012). While herpesviruses influence host immunity by long 
term production of inflammatory cytokines, helminths polarise the immunes system with 
suppressive and type 2 responses.  
The centre point of type 2 responses during helminth infection is the IL-4 receptor and 
subsequent activation of CD4
+
 TH2 cells. T cells are critical components in the immune 
response to filarial nematodes. Studies in nude mice lacking T cells (Suswillo, Owen et al. 
1980) and SCID and RAG mice lacking both T and B cells (Nelson, Greiner et al. 1991; Babu, 
Shultz et al. 1999) have shown the requirement of T cell responses for elimination of Brugia 
helminths. The canonical helminth response is a TH2 phenotype in T helper cells. Polarisation of 
the immune response in helminth infection to the TH2 phenotype requires the production of IL-
4. Therefore absence of IL-4, IL4R or STAT6 increases susceptibility to Brugia parasites. 
(Babu, Ganley et al. 2000; Spencer, Shultz et al. 2001) Filarial parasite infection can involve 
developmental stages during infection of the host. In L. sigmodontis infection, infection occurs 
with L3 stage larvae that progress to L4 and adult developmental stages in the host. Absence of 
IL-4 results in increased L4 parasite burden two weeks post infection with L3 larvae, with 
similarity to SCID mice. Additionally these mice were microfilaraemic by 10 weeks post 
infection. (Babu, Ganley et al. 2000)   
The inflammatory cytokine IFNγ (usually considered the polar opposite of IL-4) has a role in 
susceptibility to filarial infection. IFNγ
-/- 
mice mount stronger IL-4 governed TH2 responses and 
eliminate the infection at an earlier stage and so do not reach patent infection. (Babu, Ganley et 
al. 2000) IFNγ is produced by splenic lymphocytes in response to L. sigmodontis parasite 
antigens during the first 24 days post infection and from the point of patency at day 50 onwards 
in susceptible BALB/c mice (Taubert and Zahner 2001). In resistant C57BL/6 mice, high levels 
of IL-4, IL-5 and IFNγ are all increased between 10 and 30 days post infection compared to 
BALB/c mice. C57BL/6 had very low antibody titres whilst the high levels of IgG2a at day 10 
in BALB/c suggests a TH1 polarisation at early stage of infection (Babayan, Ungeheuer et al. 
2003). A subdued TH2 response at early stage of infection and in particular low levels of IL-5 
(associated with larval growth (Babayan, Ungeheuer et al. 2003)) suggests susceptibility to 
filarial parasites is highly dependent on polarisation of the CD4
+
 T cell environment. The 
combination of TH1 and TH2 is central to protective immunity in filarial infection. 
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 Heterologous immunity with helminths 
A number or studies have begun to demonstrate heterologous immunity afforded by helminth 
infection on concurrent infections (reviewed in 2014)). The pathology of a single helminth 
infection in humans is difficult to study, as it is more often the case that poly-parasitic infections 
are present (Raso, Luginbuhl et al. 2004). This is further complicated by interactions of the 
immune system with the natural microbiome and virome of the host as well as differences in 
susceptibility to each parasite between individuals as a result of genetic and environmental 
factors (Quinnell 2003; Walk, Blum et al. 2010). The encompassing factor between the majority 
of helminth infections is the polarisation towards TH2 and TREG immunity. Therefore 
information from different co-infection models allows insight into the extent of heterologous 
immunity afforded by parasitic infection.  
 Helminths and the hygiene hypothesis 
The ability of helminth infections to imprint selective pressure on the host immune response is 
seen in the hygiene hypothesis. There is strong evidence for an inverse relationship between 
helminthic infection and immunological diseases in the developed world. Common infectious 
agents that have co-evolved with the immune system for millennia have been eliminated as a 
result of better healthcare, medical treatment and hygiene practices. The hygiene hypothesis or 
microbial deprivation hypothesis suggests that removal of these selective pressures on a 
developing immune system can result in reduced immune tolerance and increased allergic and 
autoimmune disorders (Bloomfield, Stanwell-Smith et al. 2006; Okada, Kuhn et al. 2010).   
1.6.2 Helminths and autoimmunity 
Interaction of immune responses between helminth infections and autoimmune disorders has 
been observed. In the absence of TH2 immunity (IL-4
-/-
), the intestinal helminth, 




 T cell IL-10 production which 
was capable of limiting diabetes progression in non-obese diabetic (NOD) mice (Mishra, Patel 
et al. 2013). In the same NOD mice, Schistosoma mansoni soluble egg antigen (SEA) induced 
up-regulation of IL-2, IL-10 and C-type lectins on dendritic cells which then encouraged 
production of protective, disease limiting Foxp3
+
 TREGS and other TGFβ producing CD4
+
 T cells 
(Zaccone, Burton et al. 2009). Similarly in a Piroxicam induced inflammatory bowel disease 
model in IL-10
-/-
 mice, Heligmosomoides polygyrus infection altered IL-13 production at 
mucosal sites and limited pro-inflammatory IL-12 in the lamina propria thereby suppressing 
colitis pathology (Elliott, Setiawan et al. 2004). Helminth therapy has already been trialled in 
humans with Crohn’s disease by infection with Trichuris suis ova. 79% of patients treated 
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displayed reduced Crohn’s disease activity indexes after 24 weeks of treatment (Summers, 
Elliott et al. 2005).  In a cohort of multiple sclerosis (MS) patients, infection with intestinal 
worms resulted in increased eosinophilia, increased production of regulatory cytokines IL-10 
and TGFβ by PBMC and decreased secretion of inflammatory cytokines IFNγ and IL-12. This 
was coupled with alleviated MS symptoms (Correale and Farez 2007).  Inflammatory 
dysregulation may also be connected to the hygiene hypothesis. This suggests psychiatric 
diseases, (Rook, Lowry et al. 2013) depression (Raison, Lowry et al. 2010) and cancer (Rook 
and Dalgleish 2011) incidences in the western world may be higher due to the elimination of 
certain infections although a direct role for helminths in such diseases has yet to be fully 
explored.  
1.6.3 Helminths and allergy 
Infection of ovalbumin (OVA) sensitised BALB/c mice with the intestinal nematode 
Heligmosomoides polygyrus suppressed TH2 immunity and pathogenesis of asthma when these  
mice were challenged with OVA antigen compared with uninfected mice.  Reduced eosinophilia 
and increased production of IL-10 was exhibited in parasite infected/OVA sensitised mice 
challenged with OVA antigen after adoptive transfer of CD4
+
 T cells from Heligmosomoides 
polygyrus infected mice suggesting a role for TREGS in the protective effect (Kitagaki, Businga et 
al. 2006). Similarly in human Schistosoma haematobium infection a role for IL-10 production 
was identified in association with protection from atopy (van den Biggelaar, van Ree et al. 
2000).  
1.6.4 Effect of helminth infection on concurrent infection 
The National Institute of Allergy and Infectious Diseases (NIAID, 2014) in the USA has formed 
the international collaborative network for the study of human helminth co-infections to better 
understand interactions between endemic parasitic infection and their outcome on disease, 
treatment and vaccine strategy in areas where co-infection is common (NIAID, 2014). Helminth 
co-infections are thought to occur in 800 million people worldwide (Hotez, Molyneux et al. 
2007). Infection of humans by parasitic worms has been a longstanding relationship, as 
evidenced in whipworm (Trichuris trichiura) infection in Neolithic archaeological remains 
(Dickson, Oeggl et al. 2000). Helminths have therefore been an enduring selective pressure on 
the human immune system. The ubiquitous nature of helminthic infection around the tropics and 
sub tropics means that co-infection is frequently a confounding factor during the immune 
response to other infections. The nutritional and developmental impact of multiple parasitic 
infections is only recently being considered as a premeditator in outcome of subsequent 
infection (Pullan and Brooker 2008). The highly TH2 and regulatory responses often induced by 
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chronic helminth infection has the potential to alter outcome or pathogenesis of heterologous 
infection (Cox 2001). This is a key area of research in pro-inflammatory type 1 infections, 
particularly those that share regions of transmission with helminths, such as HIV, TB and 
Malaria. See Figure 1.1 below.   
 Figure 1.1 Co-infection with helminths 
 
Figure 1.1 World map showing the geographic distribution of co-infection with helminths together with 
tuberculosis, malaria and/or HIV infection of adults. (Salgame, Yap et al. 2013) 
1.6.5 Helminth-parasite co-infections 
Antagonism between helminths and the intestinal protozoan Giardia lamblia in a Bolivian 
cohort of patients has been demonstrated with Giardia less likely in helminth infected 
individuals, however it increases on anti-helminthic treatment (Blackwell, Martin et al. 2013). 
Persistent Schistosoma haematobium infection in Senegalese children has been shown to protect 
from the incidence of Plasmodium falciparum infection (Lemaitre, Watier et al. 2014).  
In filarial helminth infection, the stage of development is critical to the influence on co-
infection. Malaria co-infection is aggravated and results in severe weight loss in BALB/c mice 
co-infected with pre-patent L. sigmodontis.  This weight loss was associated with a significant 
increase in IFNγ production by splenocytes in amicrofilaremic mice at this time point (Graham, 
Lamb et al. 2005). If co-infection with malaria occurs during patent L. sigmodontis infection 
however malarial infection is alleviated. In a computational model of infection, co-infection 
resulted in decreased prevalence of lymphatic filarial worm burden and simultaneously led to 
extended disease as a result of malaria infection (Slater, Gambhir et al. 2013). In vivo co-
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infection of BALB/c mice with Plasmodium chabaudi and L. sigmodontis led to greatly 
decreased L. sigmodontis worm burden and unaltered plasmodium parasitaemia. Co-infection 
with Plasmodium yoelii and L. sigmodontis resulted in decreases in both parasite burdens across 
the first 30 days of both infections (Karadjian, Berrebi et al. 2014). Species specific differences 
therefore have a large impact on disease and can determine the outcome of co-infection.  
1.6.6 Helminth-bacterial co-infections 
Helminth infections increase susceptibility to and enhance pathogenicity of bacterial infections. 
Schistosoma haematobium infection of the urogenital tract in BALB/c mice induces production 
of IL-4 which can impair invariant NKT cell function, leaving previously resistant mice 
susceptible to urinary tract infection by Escherichia coli (UPEC) strain UTI89 (Hsieh, Fu et al. 
2014). Equally, 100% of BALB/c mice infected with Taenia crassiceps or Heligmosomoides 
polygyrus for 6 weeks succumb to Streptococcus pneumoniae rapidly after infection, an effect 
that can be reversed by anti-helminthic treatment (Apiwattanakul, Thomas et al. 2014). An In 
vivo model of Heligmosomoides polygyrus co-infection with Bordetella bronchiseptica results 
in exacerbated disease for both pathogens, increased faecal egg counts and higher, potentially 
lethal bacterial loads (Lass, Hudson et al. 2013). H. polygyrus infection greatly exacerbates 
experimental colitis with Citrobacter rhodentium. Interestingly, this is a result of AAMΦs 
becoming more susceptible to infection with C. rhodentium, increasing bacterial burden and 
production of TNFα (Weng, Huntley et al. 2007). This study actively demonstrates how 
helminth infection can impair macrophage responses to subsequent, unrelated pathogens 
although filarial infection appears to have limited impact on bacterial infection. Patent infection 
with L. sigmodontis does not alter Mycobacteria tuberculosis (MTB) infection. Despite 
instigating TH2 and hypo-proliferative responses, co-infection does not alter spleen cell 
proliferation to MTB antigen PPD or resulting IFNγ production, despite proximity of the two 
infections in the lung (Hubner, Killoran et al. 2012). Co-infection with Strongyloides stercoralis 
during TB infection however reduces mycobacterial specific TH1 and TH17 specific responses 
and circulating cytokines in an IL-10 dependent manner (George, Anuradha et al. 2014)  
demonstrating that co-infection can directly impact CD4
+
 T cell responses. 
1.6.7 Helminth-fungi co-infections 
A relatively recent observation is the correlation between some helminth and fungal infections. 
TH1 humoral responses are generally required for clearance of fungal infection and therefore 
TH2 responses are associated with susceptibility (Blanco and Garcia 2008). Schistosoma 
mansoni infection induces a lasting TH2 polarised immune response with increased production 
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of immunosuppressive IL-10 (Pearce and MacDonald 2002) that in a Sudanese cohort, (where 
S. mansoni infection is endemic) enables establishment of fungal infection with Madurella 
mycetomatis (van Hellemond, Vonk et al. 2013). Molecular identification of Pichia 
guilliermondii from the blood of 197 / 222 microfilaraemic, Wuchereria bancrofti infected 
individuals in an Indian (West Bengal) study identify fungi as common co-infections with 
filarial pathogens (Saini, Gayen et al. 2014). Other individual infections have also been reported 
in immunocompetent patients (Prakash, Gupta et al. 2011). These studies isolate opportunistic 
fungi and yeast infections as potentially pathogenic following helminth infection but 
contribution of helminths to the outcome of fungi is yet to be explored thoroughly in animal 
models. 
1.6.8 Helminth-viral co-infections 
Many viruses elicit type 1 pro-inflammatory immune responses. Helminths produce type 2 and 
regulatory responses that are capable of facilitating or decreasing susceptibility to different viral 
infections (Kamal and El Sayed Khalifa 2006). Suppression of immune responses can result in 
exacerbated co-infection.  
Following a 12 day infection with Trichinella spiralis, C57BL/6 mice were challenged with 
norovirus MNV-CW3. Co-infected animals showed reduced numbers and functional capacity of 
MNV specific CD8
+
 T cells as well as decreased MNV specific CD4
+
 T cells and reduced 
production of IFNγ and TNFα, compared with singly infected controls (Osborne, Monticelli et 
al. 2014). This was the same for oral and systemic infections suggesting the effect of such a 
suppressive helminth immune response can impact beyond the site of infection. 
 Infection with Heligmosomoides polygyrus, an intestinal nematode prior to MNV infection led 
to reduced MNV specific CD8
+
 T cell responses, decreased production of IFNγ and TNFα with 
significantly increased MNV titres in the ileum. These observations were found to be 
independent of microbiota when repeated in germ free mice (Osborne, Monticelli et al. 2014). 
Impaired anti-viral immunity was associated with STAT-6 dependent activation of AAMΦ 
determined by arginase 1 and YM1/2 expression (Osborne, et al. 2014).  
Initiation of such TH2 type responses can also effect the long term suppression of latent viruses. 
Murine gammaherpesvirus-68 (MHV-68) is reactivated in vivo from latency during 
Heligmosomoides polygyrus co-infection or as a result of challenge with Schistosoma mansoni 
eggs (Reese, Wakeman et al. 2014). In vitro stimulation of the MHV-68 infected bone marrow 
derived macrophages (BMDM) with IL-4 (antagonistic of IFNγ) resulted in expression of 
STAT6, a transcription factor induced during alternative activation of macrophages. Further 
analysis revealed that STAT6 directly binds MHV-68 gene 50 promoter allowing reactivation 
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from latency (Reese, Wakeman et al. 2014) thus TH2 polarisation directly altered the immune 
response to an inflammatory ‘TH1 inducing’ pathogen. 
This ability for helminth infection to alter viral pathogenesis and viral burden can also be seen 
in Puumala Hantavirus infection. In a study of Myodes glareolus bank voles (the natural 
reservoir species of Puumala Hantavirus), co-infection with helminth species Heligmosomum 
mixtum was associated with greater viral load. However Aonchotheca muris-sylvatici, (a rodent 
whipworm) co-infection showed significantly decreased viral loads of Hantavirus and incidence 
of co-infection (Salvador, Guivier et al. 2011). Infection with different helminths does not 
therefore always have similar influences on concomitant viral infection. 
 Some co-infections may even be beneficial. In an Egyptian cohort of human patients with 
Hepatitis C infection, (HCV) detection of Schistosoma mansoni antibodies correlated with 
decreased incidence of mixed cryoglobulinaemia, suggesting a protective effect of co-infection 
(Abbas, Omar et al. 2009). Mixed crypoglobulinaemia secondary to HCV is associated with 
increased type 1 cytokines, IFNγ and TNFα and T cell recruiting chemokines MIP-1α, MIP-1β 
and CXCR-3, (Saadoun, Papadopoulos et al. 2005) while Schistosoma mansoni infection 
induces a largely TH2 response (Kaplan, Whitfield et al. 1998).  
Co-infection effects have also been demonstrated in HIV infection. Peripheral blood 
mononuclear cells (PBMC) taken from patients with filariasis (Loa loa, Wuchereria bancrofti or 
Onchocerca volvulus) depleted of CD8
+
 T cells demonstrated greater viral replication when 
infected with human immunodeficiency virus (HIV) in vitro. Cells from patients with filariasis 
produced increased IL-4 but decreased expression of RANTES (Gopinath, Ostrowski et al. 
2000). In a human cohort of HIV infected individuals in Chennai India, 5 - 9.5% displayed co-
infection with Wuchereria bancrofti. Co-infected individuals showed a trend for lower filarial 
antigenemia than HIV negative individuals however this was not statistically significant 
(p=0.07) (Talaat, Kumarasamy et al. 2008). Similarly in a Tanzanian cohort with a HIV 
incidence of 7.9% and Wuchereria bancrofti-specific circulating filarial antigen (CFA) 
incidence of 43.5%, positive association was found between CFA and HIV infections whereas 
hookworm and HIV incidences shared no correlation (Nielsen, Simonsen et al. 2006). 
 Increased HIV susceptibility following filarial infection may be a result of changes to surface 
proteins on CD4
+
 T cells. CTLA-4 counteracts anti-viral CD28 expression and therefore 
unrestricted CTLA-4 expression by depleted CD28 expression (mAb) results in susceptibility to 
HIV infection (Riley, Schlienger et al. 2000). CTLA-4 is up-regulated on CD4
+
 T cells in a 
human population on the Cook Islands with Wuchereria bancrofti filarial infection, particularly 
during the microfilaraemic the stage of infection. An increase in IL-5 and decrease in IFNγ 
production suggests that CTLA-4 can also bias the TH1/TH2 paradigm in filariasis (Steel and 
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Nutman 2003). In the case of filarial co-infection, the stage of larval development may therefore 
alter outcome to viral resistance. 
 Helminth-influenza co-infection  
The immunosuppresive influence of helminth immune responses can significantly alter the 
progression of inflammation and subsequent disease by inducing a skew toward type 2 
immunity.  Respiratory infection with influenza is predominantly inflammatory and results in 
vast infiltration of immune cells and occlusion of alveolar spaces. Co-infection is hypothesised 
to dampen excessive type 1 responses to influenza infection. 
Early studies in pigs pre-patently and patently infected with Metastrongylus (lungworms) then 
co-infected with A/Swine/Iowa/15/30 (S-15) (H1N1) showed increased pathogenesis, increased 
lung size due to leukocyte infiltration as well as increased temperature and clinical signs at both 
stages of infection (Nayak, Kelley et al. 1964). Influenza / helminth co-infection was performed 
in laboratory mice in 1972 by Chowaniec et al. Female Ha/ICR strain mice were infected with 
the intestinal parasite Nematospiroides dubius (now renamed Heligmosomoides polygyrus 
bakeri) at increasing doses (50 – 1000 larvae). Mice were then co-infected with a sub-lethal 
dose of A/Japan/170/62 E3M22E2. Co-infected animals had reduced viral titre when compared 
with uninfected controls. Results also indicated co-infected mice showed significantly lower 
antibody levels to influenza haemagglutinin 21 days post infection than singly infected mice 
(Chowaniec, Wescott et al. 1972). Reduced antibody titres may be a result of IL-21 deficiency 
during Heligmosomoides polygyrus infection, a crucial cytokine for B cell differentiation 
(Reynolds, Filbey et al. 2012).  
Non-specific immune suppression is a characteristic of many helminth infections. Mice infected 
with the nematode Trichanella spiralis are also less susceptible to pathology during influenza A 
infection. Clinical signs and weight loss as a result of influenza infection were not altered in co-
infected mice however recovery from infection occurred quicker as a result of greatly reduced 




 cells, as well as reduced production of IFNγ and IL-10 
(Furze, Hussell et al. 2006). Mechanisms of reduced inflammation and influenza modulation 
may vary between parasites.  A reduction in T cells appears to be independent of IL-10 in this 
particular co-infection.  
T. gondii, is an intracellular protozoan capable of promoting NK cell derived IFNγ that is 
attributed to statistically increased survival rates in mice co-infected with lethal dose A/Hong 
Kong/483/1997 H5N1 influenza. This is an innate response, critical during the early stages of 
influenza infection that may be replicated by injection with exogenous IFNγ every 24 hours for 
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four days post infection (O'Brien, Schultz-Cherry et al. 2011). The viral titre 5 days post 
infection was significantly decreased following IFNγ treatment, (O'Brien, Schultz-Cherry et al. 
2011) however in this instance, susceptibility to influenza was reduced by pre-existing 
inflammation, demonstrating the complexity with which helminth infection can modulate 
influenza infection. Taenia crassiceps is an intestinal/lung tapeworm that induces TH2 
responses, and down regulates TH1 CD4
+
 T cells in the vicinity of the parasite. 8 week infection 
with the tapeworm T. crassiceps however had no effect on survival of BALB/c mice infected 
with Influenza A/Puerto Rico/8/34 (H1N1) (Apiwattanakul, Thomas et al. 2014). The site of 
infection may therefore contribute to the modulatory effect of co-infections.  
1.7 Impact of co-infection on acute immunity - influenza A viruses 
Chronic, latent and persistent infection can impact how the host responds to a second, unrelated 
infection. Both latent herpesvirus infections and persistent helminth infections have been shown 
to mediate the efficacy of the host immune response to a second pathogen. Influenza A viruses 
pose a significant health risk to the global population and are governed by highly inflammatory 
type 1 immune responses characteristic of respiratory viral infection. As the two previously 
discussed pathogens have high prevalence in human populations, and are resident in close 
proximity to the site of influenza infection, this project aims to determine if the influence of 
such co-infections can change the outcome of influenza A by adjusting the inflammation 
initiated by viral infection in the lung.  
1.7.1 Structure and genome 
Influenza  A viruses of the family Orthomyxoviridae are a family of single stranded, negative 
sense, segmented RNA genome viruses capable of causing severe and highly contagious 
respiratory disease in human and animal hosts. They are generally observed in a spherical virion 
of 80-120 nanometres in diameter, however filamentous forms have also been observed up to 
300 nm in length. The  influenza A and B genera contain 8 segments in their RNA genome. The 
viruses are identified according to their genus, the host in which they were discovered, isolation 
location, strain number, year of isolation and surface glycoproteins, (hemagglutinin (HA) and 
neuraminidase (NA)) e.g. Influenza A/Cygnus cygnus/Germany/R65/2006 H5N1 (Fields, Knipe 
et al. 2007). There are currently 11 neuraminidase and 18 hemagglutinin subtypes known. Wild 
aquatic birds are the natural host of most influenza A viruses.  
New strains occur as a result of reassortment of segments from two different influenza A viruses 
that infect the same cell. Successful reassortment results in increased fitness and the potential to 
infect a new host potentially resulting in pandemic influenza A outbreaks when a previously 
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naïve population with little immunity becomes subject to infection (Hay, Gregory et al. 2001). 
Of current importance is the possibility that individual avian and human tropic viruses capable 
of infecting the same mammalian host cells will recombine and introduce a novel, highly 
virulent strain capable of infecting the human population (Treanor 2004). 
1.7.2 Severity and disease in humans 
Influenza A viruses are a significant cause of morbidity and mortality worldwide and therefore 
pose large financial and socio-economic strain on both developed and developing countries. 
Influenza A infection occurs as both severe pandemic incidences such as the H1N1 outbreak in 
2009 estimated to have killed ~284,500 globally and more frequent seasonal strains that result 
in serious disease in the elderly and individuals predisposed to infection by other health issues.  
Symptoms of influenza A infections usually occur 2 days after infection by aerosol 
transmission, direct contact with infected individuals or contaminated surfaces. The height of 
viral replication in the lung occurs a few days after this (WHO 2014). Influenza can cause a 
combination of symptoms including muscle aching, cough, high fever, headaches and malaise. 
In severe cases strong inflammatory responses associated with immunopathology in lung 
epithelium known as a ‘cytokine storm’ has been reported as a result of cytokine profile 
changes, desensitization of toll receptors and alterations to apoptotic mechanisms (Chan, 
Cheung et al. 2005; Morens, Taubenberger et al. 2008). This can be life threatening depending 
on virulence and host susceptibility. 
1.7.3 Global pandemics of the last century 
The most severe example of an influenza A pandemic recorded occurred during the 1918 H1N1 
‘Spanish Flu’ outbreak, thought to have killed 50 million. Case-fatality rates were 2.5% 
compared to other pandemics around 0.1% (Johnson and Seifert 1998). The outbreak occurred 
in three ‘waves’ as a result of antigenic drift; mutations that increased the strain’s virulence 
(Fields, Knipe et al. 2007). It has now been determined that many of those who succumbed to 
infection, actually died as a result of pneumonia caused by secondary bacterial infection 
(Morens, Taubenberger et al. 2008). Surprisingly influenza has a basic reproduction number of 
only 2-3, (Mills, Robins et al. 2004) much lower than many infectious diseases, suggesting that 
the incubation period before onset of symptoms and susceptibility to secondary infection are 
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Table 1.2 Influenza pandemics of the last century 
 
1.8 Immune responses to acute influenza A infection 
The majority of influenza infections occur due to seasonal strains that circulate in human 
populations each year. While this accounts for an average of 8,000 deaths in the UK per year, 
(England 6 October 2014) the majority of immunocompetent people mount sufficient, 
neutralising immune responses that confer protection from repeat infection. The immune 
response to influenza A is a type 1 response and therefore requires inflammatory cytokine 
signalling (Monteiro, Harvey et al. 1998). Pre-existing inflammation in the lung as a result of 
latent herpesvirus infection or increased production of type 2 cytokines and regulatory cytokines 
by persistent filarial nematode infection may therefore impact the response to influenza A.  
1.8.1 Innate immunity 
 Initiation of response 
Initiation of the immune response to influenza occurs at the epithelial cell barrier in the lung. 
Pathogen recognition receptors, including NOD like receptors, Toll like receptors and dsRNA 
helicase enzymes, (RIG-I and MDA-5) identify pathogen associated molecular patterns 
(PAMPs) in virally infected cells. The signalling pathways activated by binding of these 
receptors leads to the production of type 1 (α/β) and 3 (λ) interferons and other pro-
inflammatory cytokines. Activation of the interferon system via JAK/STAT signalling leads to 
the up regulation of a number of interferon stimulated genes (ISGs) which produce proteins 
with anti-viral capacity e.g. Mx proteins. These anti-viral proteins and receptors are crucial for 
appropriate inflammatory responses and reduce the capability of influenza to replicate. NLRP3 
Year Name Subtype Fatalities 
1918 Spanish influenza H1N1 ~ 40 - 50 million 
1957 Asian influenza H2N2 ~ 1 million 
1968 Hong Kong H3N2 ~ 1 - 4 million 
1977 Russian influenza H1N1  
2009 Swine flu H1N1 ~ 284,500 
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inflammasome is also activated by type 1 interferon and changes to ionic concentrations caused 
by influenza infection. Further production of inflammatory cytokines, IL-1α/β and IL-18 and 
increased MHC-II expression in response to IFNγ production leads to antigen specific CD4
+
 T 
cell recruitment to the lung. Initiation of the response to influenza infection in the lung therefore 
requires systematic activation of inflammatory cytokine networks that could be impaired due to 
pre-existing infection with an infection that exacerbates or hinders type 1 anti-viral immunity.  
- Antigen presenting cells 
Innate immune cells including antigen presenting cells have a key role in activating adaptive 
immunity to influenza infection.  
Lung immunity is largely dependent on alveolar and tissue resident, interstitial macrophages 








) but provide different 
mechanisms of protection (Wissinger, Goulding et al. 2009). Alveolar macrophages are less 
readily activated. They produce IL-10 and TGF-β regulatory cytokines and express MHC-II at 
low levels (Thepen, Kraal et al. 1994). These cells have a role in regulating proliferation of T 
cells, through production of prostaglandins, (Roth and Golub 1993) whilst allowing activation 
and effector function (Upham, Strickland et al. 1995). Interstitial macrophages are more capable 
of IL-1β and IL-6 production, coupled with increased presentation of MHC-II, in line with 
maintenance of homeostatic environment in the lung (Steinmuller, Franke-Ullmann et al. 2000).  
Macrophages are required at early time points during influenza infection to phagocytose 
infected cells and limit viral replication. Macrophage responses can be polarised to heighten or 
suppress other immune responses. They are also critical for maintaining homeostatic balance 
within the lung and epithelial-macrophage interactions that are required in the initial response to 
influenza infection. CD200 receptor, a negative regulator of macrophage activation is engaged 
by increased CD200 on influenza infected epithelial cells (Snelgrove, Goulding et al. 2008). An 
absence of CD200 leads to a lower threshold of activation for macrophages in influenza infected 
mice and therefore greater immunity to viral infection (Goulding, Godlee et al. 2011). The 
impact of pre-existing infection on such molecules could influence the susceptibility of 
individuals to influenza.  
Polarisation of macrophages can result in the formation of distinct phenotypes. M1 
macrophages are defined by production of inflammatory mediators, TNF-α, IL-1β, IL-12 and 
iNOS in response to IFNγ, GM-CSF or LPS. M2 regulatory macrophages may be subdivided 
into a number of subsets but are ultimately identified by production of IL-10, IL-1Ra, arginase 
1, FIZZ and YM1/2 in the presence of IL-4/IL-13 or IL-10. M1 macrophages are associated 
with inflammatory responses during influenza infection whilst M2 macrophages are required for 
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tissue repair in the lung (Nicol and Dutia 2014). Polarisation of macrophages as a result of 
cytokine production can alter MHC-II expression, phagocytic capacity and their ability to 
produce of reactive oxygen species (that can contribute to lung pathology). Targeting 
polarisation of these cells has been identified as a novel strategy for mediating infection and 
inflammatory diseases (Labonte, Tosello-Trampont et al. 2014). 
As macrophages present in the lung are a heterogeneous population, it is unclear which 
macrophages change or respond to infection and whether all macrophages return to their basal 
state once inflammation is resolved. Increasing evidence suggests that tissue resident 
macrophages active during infection in the lung may be long-lived (Davies, Jenkins et al. 2013). 
Therefore persistent infection and resulting inflammation in the lung may alter the phenotype of 
these cells and their responsiveness to secondary infection with influenza infection (discussed 
further in 1.11.1).  
 Dendritic cells (DCs) are professional antigen presenting cells that sample antigen in the lung. 
While antigens displayed by MHC-II are usually exogenous and MHC-I endogenous, DCs have 
the capacity to cross-present antigen from exogenous source onto MHC-I (Waithman and 
Mintern 2012). The type of dendritic cells present in influenza infection is unclear. One study 





 cells. Resident CD8
+
 DCs were also known to present antigen to CD8
+
 T 
cells. (GeurtsvanKessel, Willart et al. 2008) Other studies indicated that CD103
+
 DCs were 
required for CD8
+
 antigen presentation. (Kim and Braciale 2009; Ho, Prabhu et al. 2011) 
Depletion of alveolar CD11c
+
 DCs with diphtheria toxin impacted CD8
+
 T cell responses to 
influenza suggesting a role for this cell type. (Belz, Smith et al. 2004) It is therefore likely many 
dendritic cell subsets are responsible for influenza antigen presentation.  
Polarisation of DCs (as seen in macrophages) is apparent during infection. IL-4R is integral in 
these cells in order to polarise T cell responses optimally through IFNγ production whilst 
RELMα is required for optimal IL-10 and IL-13 production (Cook, Jones et al. 2012). 
Polarisation of T cells is largely dependent on antigen. Influenza infection can produce a mixed 
phenotype of TH1, TH2 and TH17 responses (Oh and Eichelberger 2000). The impact of pre-
existing infection on polarisation of T cell responses to influenza is unknown.  
1.8.2 Adaptive immunity 
The adaptive immune response to influenza is complex and varies between sub-types and 
animal models tested. Production of cytotoxic lymphocytes and neutralising antibody is 
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 CD4+ T cells  
Activation of CD4
+
 T cells during influenza infection is due to antigen presentation by 
professional APCs; dendritic cells via MHC-II.  After activation, differentiated effector CD4
+
 T 





 cells secrete high levels of IFNγ and IL-2 and decline with viral clearance 
(Roman, Miller et al. 2002).  CD4
+
 T cells are polarised during infection. T helper cell profiles 
can be identified by cytokine production. Influenza A infection induces various levels of TH1, 
TH2 and TH17 cells. These cells are maintained in a careful balance in most individuals and 
subsequently activate appropriate CD8
+
 cytotoxic responses and neutralising antibody 
production following class switching on B cells. In some instances excessive production of 
inappropriate cytokines results in immunopathology in the lung. Potential unbalance due to pre-




 T cells in mice with antibodies does not alter the outcome of infection with 
influenza A H3N2 (HKx31). Viral replication was unaltered and cytolytic function of CD8
+
 T 
cells was unchanged.  Cytokine production by precursor cytolytic cells were impaired in H-
2IAb
-/-
 mice for months after infection suggesting an important role for CD4
+
 T cells in cytokine 
production and CD8
+
 T cell help (Tripp, Sarawar et al. 1995). Pro-inflammatory cytokine 
production (IFNα, TNFα, CXCL9, IL-6, and MCP-1) at early stages of infection is integral to 
the outcome of infection. At potentially lethal doses of influenza, (LD50, H1N1 PR8) cytokine 
disruption results in altered lung pathology at later time points (Vogel, Harris et al. 2014). 
Antibody-mediated protection is vital in influenza immunity. Classically CD4
+
 T cells have a 
significant role in mediating antibody production. Through production of the cytokine IL-21 and 
T cell costimulatory ICOS CD4
+
 T cells facilitate affinity maturation and germinal centre 
formation (Bauquet et al. 2009).  In μMT
-/-
 (B cell deficient) mice, the absence of CD4
+
 T cells 




 T cells are now also known to have direct cytolytic function. Adoptively transferred 
cytolytic CD4
+
 T cells were capable of conferring protection in naïve mice challenged with 
influenza H1N1 A/PuertoRico8/34 (Brown, Lee et al. 2012). CD4
+
 T cells increased the levels 
of anti-influenza antibodies. CD4
+
 T cells were protective by direct cytotoxic function in B cell 
KO mice (Brown, Dilzer et al. 2006).  
Cytolytic influenza-specific CD4
+
 T cells are perforin dependent. Perforin deficient CD4
+
 T 
cells are less capable of protecting naïve mice from influenza infection than WT CD4
+
 T cells 
 
 
Gareth Hardisty Introduction 25 
(Brown, Lee et al. 2012). During influenza infection perforin-mediated cytolytic CD4
+
 T cells 
express pro-inflammatory cytokines TNF-α and IL-2 in the draining lymph node and IFNγ and 
IL-10 in the lung at the site of infection, suggesting differing roles depending on location. 
Cytolytic CD4
+
 T cells are not however restricted to the TH1 phenotype and remain functional 
during influenza responses in the absence of IFNγ (Graham, Dalton et al. 1993). Although 
adoptive transfer of primed TH2 CD4
+
 T cell clones from BALB/c mice into naïve hosts offered 
no cytolytic activity against influenza challenge. (Graham, Braciale et al. 1994). Therefore 
correct polarisation of CD4
+
 toward inflammatory responses may be important for optimal 
resolution of infection. This is an important consideration during co-infection, as T cell 
responses may be altered by pre-existing infection and cytokine production. 
 CD8+ T cells 
CD8
+
 T cells are activated in the lymphoid tissues and in the lung during influenza infection. 
They are primed by CD8
+
 DCs in the lymph node and CD103
+
 migrating DC’s in the lung 
(Belz, Smith et al. 2004). Activation of CD8
+
 T cells requires direct antigen presentation 
through MHC-I by professional antigen presenting cells. Absence of dendritic cells migrating to 
the lung significantly impairs CD8
+
 T cell responses (McGill, Van Rooijen et al. 2008). CD8
+
 T 
cells have targeted lytic function, against infected cells through production of granzyme A and 
B and perforin. Granzymes punch holes in the infected cell membranes and encourage 
production of inflammatory cytokines that improve antigen presentation by MHC molecules. 
Perforin enters the cell and induces apoptosis. CD8
+
 T cells have an intrinsic role in limiting the 
replication of the virus and it’s progression into neighbouring cells (Metkar, Menaa et al. 2008). 
Cytotoxic lymphocytes (CTLs) also directly induce apoptosis via Fas/FasL interactions and 
TRAIL activation by DR5 expression on infected epithelial cells (Brincks, Katewa et al. 2008). 
CD8
+
 T cells interact with dendritic cells following infection. These interactions are also 
required during clearance of infection. This is dependent on inflammatory cytokine signalling. 
Treatment of mice with sphingosine-1-phosphate receptor agonist abrogated the cytokine storm 
and reduced efficacy of CD8
+
 T cell responses following influenza infection (Matheu, Teijaro et 
al. 2013). Changes to cytokine production at early time points of infection can therefore alter 
effector function and kinetics of adaptive immunity to influenza. Polarisation of the lung 
environment by pre-existing infection may alter the kinetics of the influenza CD8
+
 T cell 
response. 
 B cells and antibody production 
Neutralising antibody is the ultimate goal to create lasting and antigen specific protection in 
viral infection. Antibodies are capable of binding influenza directly and thereby limits 
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replication of the virus (Cooper and Nemerow 1984). A single antibody was identified in 2012 
that could bind to a conserved region of influenza haemagglutinin and therefore protected 
against H1,2,3,9 and 12 sub-types, (Ekiert, Kashyap et al. 2012) demonstrating the efficacy of 
appropriate antibody responses. A combination of IL-2 regulation by Foxp3
+
 TREGS and TFH 
germinal centre formation and production of polarising cytokines is critical to provide antibody 
responses during influenza infection (Leon, Bradley et al. 2014).  At the site of influenza 
infection, the epithelial surface, initial antibody production is largely of the IgA isotype.  
Production of IgA increases rapidly upon influenza infection and can bind the virus 
intracellularly. These antibodies tend to be targeted at the surface glycoproteins HA and NA. 
Similarly IgM antibody production is a first line defence against influenza infection and 
encourages complement mediated inhibition of viral entry into the cell until high affinity 
antigen specific responses are initiated. IgG responses are the dominant antibody in the lung 
(Renegar, Small et al. 2004). IgG is required for opsonisation of viruses, increased phagocytosis 
by Fc receptor bearing cells and increased cytotoxicity by NK cells [158]. IgG sub-type is 
determined by the CD4
+
 T cell response. In regards to influenza infection, BALB/c mice 
produce IgG1 (TH2 stimulated) responses whilst resistant strains and mice that survive infection 
had increased levels of IgG2a (TH1 stimulated) antibodies (Huber, McKeon et al. 2006). 
Vaccination strategies against influenza aim to increase IgG2a production (human IgG subtypes 
are named differently). CD4
+
 T cell dependent activation of B cell class switching is therefore 
vital to form resistance to re-infection. Co-infection and changes to CD4
+
 T cells by ongoing 
inflammation would therefore impair production of appropriate neutralising antibodies to 
influenza infection. 
 Memory responses 
M1 and NP proteins are the immunodominant targets of CD4
+
 T cells (Chen, Zanker et al. 
2014). Memory cells responding to these antigens, acquired during seasonal infections are 
broadly protective against other sub-types of highly pathogenic influenza (Lee, Ha do et al. 
2008). Memory CD4
+
 T cells have an important role in secondary infection and are the source 
of inflammatory cytokines within 48 hours of secondary infection (McKinstry, Strutt et al. 
2010). Memory CD4
+
 T cells can display great heterogeneity and vary in maintenance and 
quality of response to secondary infection (Richards, Chaves et al. 2011).  Memory CD8
+
 cells 
are subsequently produced to provide more rapid responses upon secondary infection. Memory 
CD8
+
 T cells are often specific for highly conserved influenza proteins PA, NP and M1 and can 
offer cross protection between strains (Wang, Lamberth et al. 2007). It is known that treatment 
of influenza with the anti-viral drug Oseltamivir reduces the efficacy of the CD8
+
 effector 
population and subsequent protection to re-infection. Generation of appropriate CD4 and CD8 
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memory responses during primary infection is therefore critical to developing neutralising 
immunity against re-infection. If pre-existing infection alters the CD4
+
 T cell function and 
changes the cytokine environment, memory responses may be compromised. 
1.9 Alteration to the lung by pre-existing infection 
The lung, unlike the blood or spleen is not a sterile environment. The lung immune system must 
respond appropriately to pathogenic invasion whilst ignoring the constant influx of harmless 
antigens (Raz 2007). The lung requires the ability to continuously adjust and regulate its 
responsiveness to antigen and danger signals through interactions between antigen presenting 
cells and the epithelial barrier (Raz 2007). Inflammation due to infection in the lung decreases 
CD200, IL-10 and TGF-β production by epithelial cells, allowing alveolar macrophages to 
untether, become inflammatory (increased OX40L expression) and increase TLR sensitivity. 
Resolution of inflammation is associated with increased CD200 expression and stunted TLR 
expression, reducing responsiveness and promoting regulation in the lung environment 
(Wissinger, Goulding et al. 2009). The impact of latent herpesvirus infections and helminth 
infection on homeostasis in the lung could demonstrate their potential impact on co-infection 
with influenza A. There is a high incidence of chronic, latent and persistent infections in human 
populations meaning influenza will rarely infect an individual that is not already infected with 
an on-going infection and the effect of such infections in the lung will likely impact the immune 
response to influenza. 
1.10 Imbalance in the immune response to influenza A 
As described in the previous section, successful immunity to influenza requires the careful 
balance of cytokine environment and subsequent stimulation of the inflammatory and regulatory 
arms of the human immune system. In pandemic outbreaks of influenza infection, young 
individuals can succumb to infection as a result of self-propagating inflammation and cytokine 
production known as hypercytokinemia or ‘cytokine storm’. 
1.10.1 Hypercytokinemia 
At the early stages of influenza infection, the respiratory tract becomes highly inflamed, 
identified by the levels of pro-inflammatory cytokines. Levels of IL-1β, TNFα, IL-6 and type 1 
interferons are all increased in bronchoalveolar lavage fluid and in lung homogenates in murine 
models of influenza infection (Julkunen, Sareneva et al. 2001). These cytokines are released 
from non-immune cells due to activation of the inflammasome by PRRs and production of type 
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1 interferon due to infection. This begins the signalling cascade and initiates pro-inflammatory, 
anti-viral immunity. The extent of hypercytokinemia is predictive of the outcome of infection, 
particularly in human infection with highly pathogenic strains such as H5N1, where chemokine 
and cytokine levels (IP-10, MCP-1, IL-8, IL-6 and IL-10) in serum may directly correlate with 
viral load (de Jong, Simmons et al. 2006). An excessive and damaging pulmonary increase in 
pro-inflammatory cytokines and chemokines is directly correlated with severe pathology, 
intensified symptoms of infection and increased chance of fatality in pandemic strains of 
influenza infection. This is evident if NFκB (a transcription factor integral for synthesis of a 
number of pro-inflammatory cytokines) is deficient.  Infection of mice with the p50 subunit of 
NFκB deleted leads to dramatically reduced pathology and lack of hypercytokinemia. Viral 
replication is unaltered. (Droebner, Reiling et al. 2008). Therefore co-infection may provide a 
selective pressure on the immune response to limit or exacerbate inflammatory signalling as a 
result of on-going infection.  
Table 1.3 Cytokines and chemokines involved in hypercytokinemia 
IL-1α/β  Neutrophil accumulation / activation of 
CD4
+
 T cells 
 Production of anti-viral IgM 
 Activation of the inflammasome 
(Schmitz, Kurrer et al. 2005; 
Ichinohe, Lee et al. 2009) 
TNFα  Earliest cytokine produced in epithelial 
cells 
 Primes cells to produce greater levels of 
other pro-inflammatory cytokines 
 Limits viral replication in vitro 
(Van Campen 1994; Seo and 
Webster 2002; Veckman, 
Osterlund et al. 2006) 
IL-6  Correlated with patients in intensive care 
 Associated with fever in human infection 
 IL-6-/- does not confer protection against 
A/Mexico/4108/2009 
 Initiates neutrophil mediated clearance of 
virus 
(Kaiser, Fritz et al. 2001; 
Dienz, Rud et al. 2012; 
Paquette, Banner et al. 2012) 
IL-8  Chemotaxis of neutrophils  
 Rapid clearance of necrotic cells  
 Potent pyrogen in humans (absent in mice) 
(Hammond, Lapointe et al. 
1995; Arndt, Wennemuth et 
al. 2002) 
MCP-1  Monocyte recruitment from the blood 
 TNFα and iNOS production by monocytes 
 MCP-/- leads to decreased epithelial 
integrity and apoptosis 
(Deshmane, Kremlev et al. 
2009; Pamer 2009) 
 
Specific cytokines and chemokines, seen in table 1.3 are associated with the initiation of  a 
cytokine storm. Collectively IL-1β and TNFα are initiators of immunopathology during 
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influenza infection. Mice lacking TNF-R1 TNF-R2 and IL-1R1 showed a significant delay in 
mortality when infected with H5N1 and further decreased cytokine production and cellular 
infiltration (Perrone, Szretter et al. 2010). IL-6 is associated in a natural human infection with 
onset of clinical symptoms, including fever. IL-6 expression in childhood infection with H1N1 
is associated with a high IL-1β response (Chiaretti, Pulitano et al. 2013). IL-8 (CXCL-8) and 
MCP-1 (Monocyte chemotactic protein 1, CCL2) are key to recruiting monocytes and 
lymphocytes to the site of infection and therefore require balanced production to stop excessive 
infiltration, (although IL-8 is absent in mice).  
In high pathogenicity influenza virus infection, IRF3 has been identified as a key signalling 
pathway for cytokine and chemokine induction, ablation of which leads to significantly reduced 
levels of IFNβ, IFNλ and MCP-1 while TNFα remains unaltered (Hui, Lee et al. 2009). Such 
responses require an intricate network of intracellular signalling and transcriptional regulation. 
Therefore disruption of these pathways by underlying infection or inflammation may directly 
impact the response to influenza infection.  
1.10.2 TH1 immunity during influenza infection – potential role of IFNγ  
The contribution of IFNγ appears to be integral to a variety of stages during influenza 
immunity, although it may also be causative in the cytokine storm response observed in fatal 
influenza infection. The role of IFNγ in influenza A infection is complicated. In the absence of 
IFNγ, CD4
+





 T cells cannot promote recovery in the lung as efficiently as WT CD4
+
 
T cells (Brown, Lee et al. 2012). Similarly targeted disruption of the IFNγ gene results in 
alterations to antibody production, increase in type 2 cytokines and production of IgG1 
(Graham, Dalton et al. 1993).  In rats, activation with IFNγ, led to increased MHC-II expression 
and TNFα production by alveolar macrophages which conferred protection from challenge with 
Listeria monocytogenes (Steinmuller, Franke-Ullmann et al. 2000). Following influenza 
infection, up regulation of IFNγ can result in decreased macrophage phagocytosis, which 
contributes to susceptibility from bacterial pathogens (Wang, Zhou et al. 2014). Similarly, 
infection impacts the ability of DC’s to cross present all exogenous antigens and therefore 
attenuates presentation of all MHC-I antigens (Smed-Sorensen, Chalouni et al. 2012). Induction 
of type 1 IFN during influenza infection results in decreased production of CCL2, impaired 
recruitment of macrophages and subsequently promotes the establishment of streptococcus 
pneumoniae colonisation (Nakamura, Davis et al. 2011).  IFNγ
-/-
 mice infected with influenza 
are also less susceptible to pneumococcal infection 48 hours after infection than WT mice (Sun 
and Metzger 2008). 
 
 
Gareth Hardisty Introduction 30 
Latent gammaherpesvirus requires IFNγ production to maintain latent infection. Persistent 
filarial nematode infection induces an opposing type 2 immune response and requires IFNγ for 
regulation.  IFNγ has been shown as a source of dysregulation during influenza infection and 
therefore IFNγ may be a key cytokine to determine the effect of co-infection.  
 IFNγ induced cytokines and chemokines 
IFNγ activates a prototypical inflammatory immune response. IFNγ is also important for a 
number of other immune responses. The impact on the immune response due to increased or 
decreased IFNγ will alter the levels of other cytokines and chemokines.   
IP-10 (Interferon gamma inducible protein 10 / CXCL10) has a significant T cell chemotactic 
role during influenza infection. Acute respiratory distress syndrome (ARDS) as a result of 
pandemic 2009 H1N1 influenza infection is correlated with serum levels of IP-10. IP-10 is a 
hallmark of severe respiratory distress (Bermejo-Martin, Ortiz de Lejarazu et al. 2009). IP-10 
deficient mice have weakened T cell responses when stimulated with antigen, poor trafficking to 
sites of infection and as a result, debilitated protection against virus infection (Dufour, Dziejman 
et al. 2002). CD8
+
 T cells have been shown to produce IP-10 in response to co-stimulation to 
promote generation of effector cell populations (Peperzak, Veraar et al. 2013). Monoclonal 
antibodies (mAb) to IP-10 are capable of decreasing severity of immunopathology in murine 
models of infection, (Wang, Yang et al. 2013) likely due to abrogated T cell responses and 
similarly decreased infiltration of neutrophils (Ichikawa, Kuba et al. 2013). IP-10 is induced by 
epithelial cells undergoing apoptosis, (Law, Lee et al. 2010) which in response to influenza 
infection may explain its expression in only the most severe human cases where 
hypercytokinemia is induced.  
MIG-1 (Monokine induced by IFNγ/ CXCL9) is often correlated with severity of 
hypercytokinemia and severity of clinical presentation (Lee 2009). It is a chemokine responsible 
for T cell recruitment in viral infections of the liver and central nervous system (Liu, Armstrong 
et al. 2001; Arai, Liu et al. 2002). During H1N1 PR/8 pandemic strain infection or H3N2 
seasonal infection, alveolar macrophages produce high levels of CXCL9 (Wang, Nikrad et al. 
2012). The particular contribution of MIG-1 in influenza infection is not fully elucidated; 
however serum levels in high pathogenicity infections (H5N1) are greatly increased, suggesting 
an influence on the cytokine storm (Peiris, Yu et al. 2004). 
RANTES (regulated on activation, normal T cell expressed and secreted / CCL5) is expressed in 
nasal and bronchial epithelial cells within 24 hours of infection in vitro. Expression of RANTES 
is dependent on PI3K transcriptional activation of NFκB and IRF-3 (Chiou, Chen et al. 2011). 
RANTES is required for T cell, dendritic cell and eosinophil recruitment to the lung and is 
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therefore up regulated between day 5 and 15 of influenza infection, however in a RANTES
-/-
 
mouse leukocyte transport was not impaired, suggesting functional redundancy between 
chemokines (Wareing, Lyon et al. 2004). 
1.11 Co-infection with influenza A 
The aim of this project is to determine if pre-existing concomitant infection during the acute 
response to influenza can regulate or unbalance the immune response, in turn modulating the 
outcome of infection, providing new insight into therapeutic targets and considerations in 
regards to vaccination in the human population.  
1.11.1 Influenza A and bacterial superinfection.  
The majority of research into influenza co-infection has looked at secondary infection as a result 
of influenza. Fatalities of the 1918 H1N1 influenza pandemic were almost always as a result of 
bacterial superinfection. Evidence suggests many of the bacterial pathogens were opportunistic 
infections of common bacteria usually found in the respiratory tract (Morens, Taubenberger et 
al. 2008). Death in the 1918 pandemic usually occurred at around day 7-9 post infection. 
Similarly in 2009, up to 34% of cases were complicated by secondary bacterial pathogens 
(Chertow and Memoli 2013). In a cohort of 183 co-infected, hospitalised children, the most 
common bacterial pathogens were Staphylococcus aureus (39%), Pseudomonas species (16%), 
S. pneumoniae (8%), Haemophilus influenzae (7%), and S pyogenes (4%) (Randolph, Vaughn et 
al. 2011). Such infections tend to occur around day 2-3 post infection in humans when viral 
shedding is at a peak (Rice, Rubinson et al. 2012). 
A number of animal models of viral / bacterial co-infection have helped establish the 
mechanisms behind co-infection. Influenza has a profound effect on epithelial integrity in the 
lung. Sialic acid cleavage as a result of viral entry and release, disrupted ciliary beat and 
epithelial cell death due to immune mediated cytotoxicity of infected cells contribute to hypoxic 
areas of necrosis and airway constriction; factors which promote increased bacterial growth 
(Horner and Gray 1973; McCullers 2006). Bacteria such as S. pneumococcus are more capable 
of adhesion in the already inflamed lung, with increased receptor availability as a result of 
damage to the epithelia (McCullers and Tuomanen 2001). Influenza A encodes a number of 
proteins capable of evading the immune system. Bacterial infection of the lungs following viral 
infection is therefore facilitated by an impaired immune response.  Anti-viral interferon α 
signalling decreases the number of γδ T cells in the lung, key producers of anti-bacterial IL-17a. 
Absence of IFNα therefore led to successful clearance of secondary infection with S. pneumonia 
and increased recruitment of neutrophils following influenza infection in a murine model (Li, 
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Moltedo et al. 2012). Correspondingly, IFNγ production by alveolar macrophages during 
influenza expression results in changes to receptor expression. Down regulation of the 
scavenger receptor MARCO on macrophages decreases their phagocytic capacity for bacterial 
pathogens, suppressing innate protection to heterologous infection (Sun and Metzger 2008). NK 
cell responses are also impaired by viral infection and cytokine production is vastly reduced in 
response to secondary pathogens (Small, Shaler et al. 2010). Synergistic inflammatory 
responses occur as a result of both bacterial and viral infection in the lung, therefore co-
infection mutually increases inflammatory mediators and induces an enlarged influx of immune 
cells which heavily contributes to the onset of fatal pneumonia (McCullers 2014). Impairment 
of wound healing responses due to viral or bacterial infection can also reciprocally facilitate the 
pathogenicity of the other infection. This is evident in a model of 2009 pandemic H1N1 
influenza and streptococcus pneumonia where co-infection was assisted by loss of repair 
responses and increased pulmonary damage (Kash, Walters et al. 2011). Onset of S. pneumonia 
infection is associated with a second ‘rebounding’ increase in viral titre, suggesting that 
bacterial infection is actively distorting the clearance of influenza from the lung (Smith, Adler et 
al. 2013). 
These infections are a result of influenza induced pathology however they provide insight into 
the specific regions of the immune system that are affected by influenza infection. Pre-existing 
infections that also alter these responses will likely alter the outcome of influenza infection and 
furthermore could pre-dispose individuals to further infection with the bacterial pathogens 
discussed above.  
1.11.2 Pre-existing conditions and influenza A 
The majority of co-infections address influenza A as the primary infection. This project aims to 
address the role pre-existing and on-going infections can play on influenza susceptibility. HIV 
and asthma along with co-infection by other respiratory viruses represent a group of co-
morbidities that have been addressed in this context of influenza co-infection.  
 Respiratory viral infection 
Human respiratory infection is often complicated by the number of potentially unidentified 
infectious agents. Clinical identification of viral agents in nasopharyngeal swabs or sputum 
samples in human infection has been greatly advanced by the introduction of multiplex PCR for 
common respiratory viruses (Deng, Ma et al. 2013). The influence of concurrent infection is 
evident in data collected during the H1N1 2009 pandemic.  
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Rhinovirus 
 
Patients identified with rhinovirus co-infection tended to have less 
severe symptoms whilst non-rhinovirus infections were associated 
with worsened influenza prognosis (Esper, Spahlinger et al. 2011). 
Influenza B Co-infection with seasonal influenza B is significantly correlated with 
increased fatality and admission into intensive care units in 
hospitalised patients with H1N1 2009pdm strains (Goka, Vallely et al. 
2013). 
Adenovirus In a cohort of ‘high risk’ military trainees during the 2009 pandemic, 
adenovirus co-infection was rare and not associated with worsened 
severity (Yun, Fugate et al. 2014). Individual cases of adenovirus co-
infection with either RSV or H1N1 influenza have been identified as 
contributing factors to severity of disease (Yun, Fugate et al. 2014). 
Respiratory syncytial 
virus 
RSV co-infection shows an increased trend in influenza severity, for 
both hospitalisation and requirement for intensive care treatment with 
mechanical ventilation (Torres, Iolster et al. 2012). RSV infection is 
generally associated with increased chance of hospitalisation in young 
children (Bourgeois, Valim et al. 2009). 
Seasonal influenza A Co-infections with other H1N1 strains is rare and was only detected 
during the initial wave of 2009 cases. Other influenza A strains are 
often not detected by multiplex PCRs for respiratory co-infection and 
therefore their effect is under reported. (Peacey, Hall et al. 2010) 
Significance of such infections is therefore prominent for research into 
potential reassortment.  
Others Coronaviruses, metapneumovirus and parainfluenza viruses have all 
been identified as co-infectors during the 2009 pandemic however 
their specific clinical impact has not been identified (Stefanska, 
Romanowska et al. 2013). 
 
 Human immunodeficiency virus (HIV) 
There is very limited research addressing the effect of pre-existing HIV infection (despite the 
high prevalence) on influenza infection. Some individual studies have identified increased 
prevalence of acute lower respiratory tract infection and increased incidence of pneumococcal 
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secondary infection in influenza patients with HIV (Cohen, Moyes et al. 2013). However, others 
have shown decreased incidence of virally induced severe acute lower respiratory tract infection 
in young HIV patients (Madhi, Schoub et al. 2000). Despite individual reports, overall studies 
excluding for factors of co-morbidity are extremely limited. Early reports from the 2009 H1N1 
pandemic reveal HIV positive individuals were not overrepresented in the initial wave of 
susceptible individuals (Gilsdorf and Poggensee 2009) however prevalence of morbidity and 
mortality from influenza in those with AIDS was increased in a number of case reports during 
2009 H1N1 (Lee, Wu et al. 2010). This likely reflects the negative impact of HIV on the 
adaptive (CD4
+
) immune response.  
 Asthma 
In a cohort of H1N1 2009 pandemic suffers, morbidity of patients with and without an 
underlying asthmatic condition was characterised.  Despite the increased likelihood of chronic 
obstructive pulmonary disease, the requirement for mechanical ventilation, development of 
pneumonia and likelihood of death were all significantly reduced in patients with asthma 
(McKenna, Bramley et al. 2013). Similarly in a mouse model of asthma, during peak allergic 
response influenza infection was cleared rapidly, resulted in no weight loss and reduced 
interferon response, while infection with influenza during remodelling after an allergic response 
had no significant impact compared to WT controls (Samarasinghe, Woolard et al. 2014). In 
another study of human infection, increased resistance to influenza was associated with early 
inhaled steroid use (Semple, Strathdee et al. 2011). Both studies however point to mediation of 
responses to influenza due to pre-existing type 2 inflammation in the lung, an observation that 
could be key to understanding the variation in responses by individuals infected with influenza 
A. 
1.12 Aims 
The effect of persistent and latent co-infection on acute influenza A infection is poorly 
understood. 
This project therefore aims to identify changes to innate and adaptive immune responses during 
latent infection with a murine model of gammaherpesvirus infection (MHV-68) and a murine 
model of persistent filarial nematode infection (Litomosoides sigmodontis). 
The effect of these changes will then be observed in a co-infection model during an acute 
respiratory infection with a murine strain of influenza A. 
The role of macrophages, inflammatory cytokines produced in the lung and CD4
+
 T cell 
activation in the lung draining lymph nodes will be investigated to determine if alterations to the 
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Chapter 2 -  Materials and Methods  
2.1 Preparation of virus stocks 
 Influenza A/WSN/33 H1N1 
The original virus stock of mouse adapted H1N1 A/WSN/33 was provided by Dr D. Jackson, 
University of St Andrews, UK.  A T175 flask (Thermo, MA USA) containing Madin-Darby 
Canine Kidney (MDCK) cells in Dulbecco’s minimum essential medium (DMEM) (Sigma, 
UK) with 100 μg/ml penicillin and streptomycin (Invitrogen, UK), 100μg/ml L-glutamine 
(Invitrogen) and 5% v/v foetal calf serum (FCS) were grown to confluence at 37ᵒC with 5% 
CO2 and infected at a multiplicity of infection of 0.001 by addition of virus in 2 ml serum free 
DMEM for 1 hour on a rocking platform at 37°c. After incubation, media was removed and 
cells were incubated in DMEM + 2.5μg/ml N-acetyl trypsin. After 48 hours infected cells had 
lifted from the monolayer. The supernatant, from the flask containing the virus was centrifuged 
at 8000 x g, 4ᵒC for 10 min to remove cell debris. Supernatant containing the virus was frozen at 
-80ᵒC in 50μl and 1ml aliquots. Thawed viral titre is determined by plaque assay on MDCK 
cells. 
 A/WSN/33 Plaque Assay 
Homogenised samples or viral stock samples were diluted in 10 fold serial dilutions in serum 




. 400μl of each dilution was added to confluent monolayers of 
MDCK cells grown in 6 well plates (Thermo, MA USA); each dilution in duplicate. Plates were 
incubated at 37ᵒC for 1 h, rocking every 10 mins to ensure complete monolayer coverage with 
the sample. After incubation samples were aspirated from the cell monolayer. 2ml overlay 
media (see below) was added to each well and when set (approximately 15 mins), the plates 
were turned upside down and incubated at 37ᵒC for three days. 
After 3 days plates were removed from 37ᵒC and turned upright. Each well was fixed by the 
addition of 4ml 10% NBF (Leica, UK) and left for 24 h in a fume hood. The fixative and 
agarose plug were then removed and cells were stained with 0.1% toluidine blue O (Sigma) in 
dH2O for 1 h. Plates were washed in H2O and plaques counted under a light microscope. 
Plaques visible at the lowest two dilutions are used to calculate viral titre.  
Overlay medium: 2% w/v agarose (Biogene, NJ USA) dissolved in dH2O and warmed to 56ᵒC 
was added in equal parts to 2x overlay media, composed of 100ml 10x Eagle’s minimum 
essential media (EMEM) (Invitrogen CA USA), 28ml 7.5% w/v BSA (Fraction V, Sigma, UK), 
10ml L-glutamine (Invitrogen), 20ml 7.5 NaHCO2 (Invitrogen), 10ml 1M Hepes, 5ml 1% w/v 
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dextran, 10ml penicillin and streptomycin (Invitrogen) and 517ml dH2O stored at 4ᵒC. Overlay 
media was place in a 37ᵒC water bath in 25ml aliquots on the day of titration. 
 MHV-68 g2.4 
T175 flasks of baby hamster kidney (BHK) cells were grown at 37ᵒC to confluence in 
Glasgow’s minimum essential medium (GMEM) containing 100 μg/ml penicillin and 
streptomycin (Invitrogen, UK), 100μg/ml L-glutamine (Invitrogen), 10% v/v tryptose phosphate 
broth and 5% v/v FCS. Cells were removed from each flask with trypsin EDTA (Sigma) and 
resuspended at 1x10
7
/ml in 5ml medium. MHV-68 virus was added at a multiplicity of infection 
0.001 and cells were incubated at 24ᵒC on a shaker for 1 hr. Infected cells were seeded at low 
concentration (3x10
6 
cells) per T175 flask and incubated for 7 days at 37ᵒC until the cell 
monolayer was lysed by infection. After incubation, the cell suspension was collected and 
centrifuged at 18000 x g for 20 min at 4ᵒC. The supernatant was discarded and cells were 
resuspended in a minimal volume of PBS. The cell pellet was then homogenised with a sterile 
glass Dounce homogenizer and the resulting cell suspension transferred to a glass universal and 
sonicated in an ice water bath for 15 min. After centrifugation at 18000 x g for 20 min at 4ᵒC the 
supernatant containing the virus was collected. The remaining cell pellet was homogenised in 
PBS as before and centrifuged again. The second supernatant was pooled with the first and 
aliquots of 50 or 200μl were frozen at -80ᵒC. The viral titre was determined by plaque assay 
using BHK cells. A cell lysate for use in sham infections was also prepared as above.  
 MHV-68 g2.4 Plaque Assay 
Homogenised sample or virus stock was diluted in 10 fold serial dilutions in complete GMEM 




. 0.2ml of each dilution was added to a single cell 
suspension of 1x10
7 
BHK cells, vortexed and shaken at 27ᵒC for 1 h. After incubation, tubes 
were vortexed and each sample was added to two 60mm plates with 3 ml GMEM containing 
100 μg/ml penicillin and streptomycin (Invitrogen, UK), 100μg/ml L-glutamine (Invitrogen) 
and 5% v/v FCS and incubated for 4 days at 37ᵒC. After incubation, cells were fixed with 10% 
NBF overnight. Fixative was removed and the cells stained with 0.1% toluidine blue O for 1 h. 
Plates were washed in H2O and plaques were counted under a light microscope. The lowest two 
dilutions of each sample are used to calculate titre. 
2.2 Litomosoides sigmodontis life cycle 
Litomosoides sigmodontis life cycle is maintained in gerbils. Ornithinyssus bacoti, a mite vector 
takes a blood meal from the infected, microfilaraemic gerbils. The larvae then develop through 
the L1-L3 stages of the life cycle inside the mite. The mites were harvested after 15 days and 
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suspended in RPMI media. L3 larvae were extracted and counted under a light microscope.  
See: Hubner et al (Hubner, Torrero et al. 2009). 
2.3 In vivo  
BALB/c mice used in MHV-68 experiments were purchased from Harlan UK Ltd. Those used 
for L. sigmodontis co-infection were bred in house at the University of Edinburgh. 129 Sv/Ev 
and 129 Sv/Ev IFNγR-/- were purchased from B+K universal and bred in house. See: Huang et 
al (Huang, Hendriks et al. 1993). All work was reviewed by The University of Edinburgh ethics 
committee and carried out under a UK Home Office licence according to the Animals 
(Scientific Procedures) Act 1986. Project license: 60/4479 (19b8).  
 Intranasal inoculation of A/WSN/33 or MHV-68 g2.4 
Mice were anaesthetised using 5% isofluorane (Abbot Animal Health, IL USA) Animals were 
sedated within 1-2 min, where they may be retained short term (min) before intranasal infection.  
 Viral inoculum A/WSN/33 and MHV-68 g2.4 




 PFU in 40μl 
sterile Dulbecco’s minimal essential medium (DMEM).  Mock infected mice were inoculated 
with 40μl DMEM alone. Mice infected with MHV-68 g2.4 were inoculated intranasally with 
5x10
4
 PFU in 40μl sterile phosphate buffered saline (PBS) pH 7.4 (Invitrogen). Sham infected 
mice were inoculated with 40μl sterile PBS containing baby hamster kidney (BHK) cell lysate. 
(See MHV-68 g2.4 viral isolation above). 
 Subcutaneous injection of L. sigmodontis L3 larvae 
Mice were injected S.C. in the lower back with 25 x L3 L. sigmodontis larvae in <100μl RPMI-
1640 media. 
 
 Tail bleed (L. sigmodontis infected mice only) 
Microfilaria count was determined in 50 μl blood collected from the lateral tail vein. Blood was 
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2.4 Dissection 
 Blood samples 
Blood samples were drawn within a minute of death by severing the hepatic artery or by cardiac 
puncture. These samples were chilled immediately to 4ᵒC on ice. On the same day blood 
samples were centrifuged at 500 x g for 15 mins at 4ᵒc, serum aspirated and stored at -80ᵒC. 
 Spleen samples 
The spleen was removed and cut into three sections. The upper half was fixed into 10% neutral 
buffered formalin (NBF) for histology. The central segment was frozen on dry ice for DNA 
extraction and the bottom piece was placed in RNA Later (Invitrogen) at 4ᵒC for subsequent 
RNA extraction.  
 Pleural lavage (Litomosoides sigmodontis infected mice only) 
12 ml RPMI was flushed into and collected from the pleural cavity to recover adult worms.  
 Lymph nodes 
Parathymic, posterior mediastinal and paravertebral lymph nodes were collected as a source of 
lymph nodes draining the lung and pleural cavity. Lymph nodes were passed through a 40μm 
cell strainer and resuspended in RPMI-1640 with 0.5% mouse serum (Caltag-Medsystems, UK) 
100U/ml penicillin, 100μg/ml streptomycin and 2mM L-glutamine. 
 Lungs 
The left superior bronchi was tied off with elastic thread and the left lobe cut away and divided 
into three pieces. The top half was frozen on dry ice for homogenisation for ELISA analysis and 
influenza A/WSN/33 titre. The central segment was frozen on dry ice for DNA extraction and 
the bottom piece was placed in RNA later for subsequent RNA extraction. 
The lungs were flushed with 3 x 1ml Hanks balanced salt solution (HBSS) (Invitrogen) 
containing 3mM EDTA (Invitrogen) using a cannulised needle in the trachea. BAL was stored 
at 4ᵒC on ice before centrifugation at 500 x g for 5 min at 4ᵒc. The lungs were inflated and fixed 
with 5ml 10% w/v NBF, the trachea tied off with elastic thread and the lungs removed and 
placed in 10% w/v NBF for histology. 
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2.5 Flow cytometry 
 Intracellular cytokine staining 
Prior to staining, lymph nodes were strained through 40μm cell strainers and the cells were 
suspended in 1ml RPMI.  After centrifugation of the BAL fluid (BALF) or lymph node samples, 
the cell pellet was resuspended in 1ml FACS buffer (PBS + 2% foetal calf serum and 0.01% 
sodium azide) containing red blood cell lysis buffer (Imgenex, CA USA) at room temperature 
for 5 mins. 1ml FACS buffer was added before cells were centrifuged at 500 x g for 5 mins. The 
supernatant was discarded and cells were washed twice by resuspension in FACS buffer and 
centrifugation. After the second wash step, lymph node cells were counted and plated into 96 
round bottomed well plate (Co-star, NY USA) at 2x10
6
 cells in 100μl RPMI per well. BAL cells 
were not counted due to the low cell numbers. 0.5 μg/ml phorbol myristate acetate (PMA) 
(Cambridge Bioscience, UK) and 1μg/ml Ionomycin (Sigma) were added to each well and cells 
incubated for 2 hours at 37ᵒC to stimulate T lymphocyte activation and cytokine production. 
After 2 hours 10μg/ml Brefeldin A (Acros Organics) was added to each well to indirectly inhibit 
transport of intracellular proteins from the Endoplasmic Reticulum to the Golgi. The cells were 
incubated at 37ᵒC for a further 2 hours. Cells were centrifuged at 500 x g for 5 mins and washed 
twice in 200μl PBS. PBS was removed and cells were live/dead stained with 1:500 Zombie 
Cyan live/dead stain (Biolegend) in PBS. Cells were incubated at 4ᵒC for 30 min before being 
washed twice in 200μl PBS. After the final wash, PBS was removed and cells were fixed in 
100μl cytofix/cytoperm (BD) for 20 mins at 4ᵒC. Cells were centrifuged at 500 x g for 5 mins 
and washed twice in 200μl 1:10 perm/wash buffer in dH20 (BD). Cells were stored in 
perm/wash buffer at 4ᵒC overnight. The following day non-specific antibody staining was 
blocked with 200μg/ml rat IgG for 20 min at 4ᵒC and then washed twice in 200μl perm/wash 
buffer. Cells were then stained for cell surface markers and intracellular cytokine production 
(Table 2.1). Samples were run on a LSR II Fortessa (BD) and analysed with Flow-Jo V10 
software (Flow-Jo, OR USA). 
 Analysis 
Analysis of FACS data was performed as outlined in Appendix Figure 6.2. Initially dead cells 
were removed by identification with Zombie live/dead stain (biolegend). Zombie dies are 
fixable live / dead stains that react with primary amine groups on proteins. Live cells therefore 
exclude the dyes and dead cells appear labelled and can be detected in the aqua channel 
(525/50nm) by excitation with a violet 405nm laser. Doublet cells that passed through the 
machine attached to another cell were then excluded by comparison of FSC-height vs. FSC-
area. Lymphocytes were then identified by size on a SSC-area vs. FSC-area plot. Cells that 
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 lymphocytes were used to gate out cell types and intraceullar staining 
used to identify relevant cytokine production. Identification of non-specific antibody staining 
was performed with appropriate isotype stained controls for each respective antibody used. 
Non-specific binding was subtracted from each positive sample. Compensation was performed 
in multi-colour staining by pooling samples of lymphocytes and staining for individual 
cytokines / markers. Single positive samples were then used to create a compensation template 
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Table 2.1 Intracellular flow cytometry staining  
The cells were stained for the following markers and intracellular cytokines for detection with the BD 
LSRFortessa Cell Analyser.  
BAL 
Lymph Nodes 
Fluorochrome Brightness FL 
Excitation Detection 
Th1/Th2 Th17 Laser nm % Filter 
CD4 CD4 CD4 Alexafluor 700 2 11 Red 640 48.1 730/45 
CD8 CD8 CD8 PerCP-Cy5.5 3 3 Blue  488 98.4 710/50 
Live/Dead Live/Dead Live/Dead Aqua 5 5 Violet 405 36.7 525/50 
IFNγ IFNγ IL-6 FITC 3 2 Blue 488 88.0 530/30 
IL-5 IL-5 IL-17a APC 5 10 Red 640 71.2 670/14 
IL-4 IL-4   PE 5 7 Y/Green 561 94.3 586/16 
TNFα TNFα   BV605 5 8 Violet 405 99.1 610/20 
IL-10 IL-10   BV421 5 4 Violet 405 98.2 450/50 
IL-17a   PE-Cy7 4 17 Y/Green 561 94.9 780/60 
 
Cells were stained in a final volume of 20μl in wash/perm buffer for 30 min in the dark at 4ᵒC. 
Cells were then washed twice with wash/perm buffer and resuspended in MACS buffer 
(Miltenyi Biotec, Germany) containing 1% NBF.  
Table 2.2 Antibody isotypes and clones 
Marker Fluorochrome Marker 
Type 
Dilution Clone Isotype Distributer 
CD4 Alexafluor 700 T cell 1:200 GK1.5 IgG2b к Biolegend 
CD8 PerCP-Cy5.5 T cell 1:200 53-6.7 IgG2a к Biolegend 
Live/Dead Aqua Live/Dead 1:500 Zombie Cyan N/A Biolegend 
IFNγ FITC Cytokine 1:100 XMG1.2 IgG1 к Biolegend 
TNFα BV605 Cytokine 1:100 MP6-XT22 IgG1 к Biolegend 
IL-4 PE Cytokine 1:100 11B11 IgG1, κ Biolegend 
IL-5 APC Cytokine 1:100 TRFK5 IgG1 к Biolegend 
IL-6 FITC Cytokine 1:100 MP5-20F3 IgG1 к eBioscience 
IL-10 BV421 Cytokine 1:100 JES5-16E3 IgG2b к Biolegend 
IL-17a PE-Cy7 Cytokine 1:100 TC11-18H10.1 IgG1 к Biolegend 
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2.6 ELISAs 
ELISAs for inflammatory or regulatory cytokines were performed on lung homogenates. Each 
ELISA was tested for efficacy using homogenate samples. All buffers were stored at 4ᵒC and 
antibodies at -20ᵒC. Reagents were brought to room temperature prior to use. Immulon 4HBX 
flat bottom 96 well plates (Thermo MA, USA) were coated in pre-titrated capture antibody in a 
coating buffer, (50μl per well) sealed and incubated at 4ᵒC overnight.  Plates were washed 5 
times by adding and decanting 150μl wash buffer (PBS + 0.05% Tween-20 (Thermo) pH 7.5) 
per well and patting plate against paper towels. To block the plate, 100μl blocking buffer was 
added to each well; the plate was sealed and left at room temperature on a shaker at 90 rpm for 1 
hour. During this time standards were made by diluting the top concentration standard (either 
1000 or 2000pg/ml) in halving serial dilutions. The plate was washed as before and 50μl neat 
samples and standards added to relevant wells. The plate was sealed and placed on a shaker for 
2 hours at RT.  The plate was washed and 50μl detection antibody added per well. The plate was 
sealed and shaken for 1-2 hours. The plate was washed and 50μl streptavidin-HRP or avidin-
HRP added per well. The plate was protected from light and shaken at room temperature for 30 
min. The plate was washed and 50μl 3,3',5,5'-Tetramethylbenzidine (TMB) substrate added per 
well. The plate was protected from light and incubated at RT without shaking for 15-30 min 
until colour developed. When the lowest standard well showed a colour change the reaction was 
halted by addition of 50μl 2N sulphuric acid (H2SO4) (SLS, UK) per well. Plates were read at 
450 nm and 570 nm on a BioTek (VT, USA) absorbance plate reader. 570 nm background level 
was subtracted from 450 nm reading and the average of each duplicate sample was taken and 
analysed using http://elisaanalysis.com/app (4 parameter logistic regression) using the known 
standard curve. Alternatively optical density for each sample was divided by the mean optical 
density of all uninfected samples to determine the fold change compared with baseline 
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Table 2.3 ELISA reagents and dilutions 
ELISA Coating Buffer Blocking Buffer Assay Diluent HRP 
IFNγ 
8.4g NAHCO3 + 
3.56g Na2CO3  in IL 
dH20 pH9.5 
Assay diluent 10% FCS in PBS 1:1000 Avidin-HRP 
TNFα PBS Assay diluent 1% BSA in PBS pH 7.2 1:100 Streptavadin-HRP 
IL-10 PBS Assay diluent 10% FCS in PBS 1:1000 Avidin-HRP 
TGFβ PBS 
5% Tween-20 in 
PBS +0.05% NaN3  
R and D reagent 
diluent concentrate 1 
1:200 Streptavadin-HRP  
IFNβ PBS Assay diluent RD1W Anti-rabbit HRP 
IL-2 Pre-coated plate Pre-coated plate RD1-14 1:100 Streptavadin-HRP 
CXCL2 (MIP 2) Pre-coated plate Pre-coated plate RD1W 1:100 Streptavadin-HRP 
IL-1 β Pre-coated plate Pre-coated plate RD1N 1:100 Streptavadin-HRP 
GM-CSF Pre-coated plate Pre-coated plate RD1W 1:100 Streptavadin-HRP 
 
2.7 RNA extraction 
Total RNA extraction was performed following the ‘RNeasy Mini Kit’ (Qiagen) protocol: 
Tissues were stored in RNALater at 4
o
C. 30mg or less of each lung or spleen sample was 
disrupted by homogenisation in a tissuelyser II (Qiagen) and suspended in buffer RLT 
containing β-mercaptoethanol to inactive RNases. RNA was precipitated by adding ethanol and 
then a series of washing steps were performed according to Qiagen protocol before elution of 
the RNA in 50 µl RNase-free water. RNase-free DNase 1, (Qiagen) an endonuclease was used 
during the washing stages to remove DNA contamination. 
2.8 DNA extraction 
Total DNA extraction was performed following the ‘DNeasy Blood and Tissue Kit’ (Qiagen) 
protocol: Up to 25mg of spleen or lung samples stored at -80ᵒC were lysed and disrupted in 
buffer ATL containing proteinase K (Qiagen) by vortexing periodically during incubation at 
56ᵒC for 24 hours. DNA was precipitated by the addition of buffer AL and 100% ethanol and 
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purified by spin column centrifugation and a number of wash steps with AW1 and AW2 
buffers. The DNA was then eluted in Buffer AE (10 mM Tris-Cl, 0.5 mM EDTA; pH 9.0) and 
stored at -20◦C. 
2.9 cDNA production 
cDNA was produced using RNA extracted from spleens (see above) according to Invitrogen 
Superscript III reverse transcriptase protocol:  First strand synthesis was undertaken by addition 
of 1μl 0.5μg/μl random primers or 1μl 0.5μg/μl Oligo(dT)15 primers, 1μl dNTPs and up to 11μl 
of total RNA (500ng - 1μg total) to a final volume of 13μl in nuclease free dH20. This was 
heated to 65°C for 5 min, then incubated on ice (4°C) for at least 1 minute to stop the reaction.  
After brief centrifugation to collect the contents of the tube, 4μl 5x first-strand synthesis buffer, 
1 μl 0.1M DTT, 1μl RNaseOUT and 1 μl Superscript III RT were added. Samples were mixed 
by pipetting and incubated at 25°C for 5 min followed by 45 min at 50 °C and finally 
inactivated for 15 min at 70 °C. The cDNA was then stored at -20°C. (All reagents Invitrogen) 
2.10 ORF73 MHV-68 qPCR  
MHV-68 genome copy number was determined by an established qPCR in the Dutia group for 
ORF 73. The standard curve was previously determined to have a single product at >95% 
efficiency. 100 ng of sample DNA was added to a master mix containing fast start universal 
SYBR green (Roche, Switzerland) and 400 nM forward ACCCTCGGGATCAAATAACC and 
reverse CCCATCACCACCAGTGCC primers. Samples were then run on a Rotorgene 3000 
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Table 2.4 Q-PCR template 
Cycle Step Temperature (
o
C) Time (seconds)  Cycles 
     
Hold 95 600  1 
     
Denaturation 95 15  
40 
Extension 62 50 
Hold 94 20  1 
     
Melt 60  99 -  1 
 
2.11 Macrophage Q-PCRs  
BALF sample were added to a flat bottom 96 well plate (Costar) for 1 hour. Samples were then 
removed and adherent cells washed twice in sterile PBS. Adherent cells were lysed in 200 µl 
RLT lysis buffer and RNA was isolated from samples as outlined above. Alveolar macrophages 
comprise the predominant adherent cell population within the BALF. No further positive or 
negative isolation was performed. Macrophage specific QPCR was then performed to identify 
phenotypes. 
Q-PCRs used to determine macrophage subtype were designed and optimised by Gillian 
Campbell (previously of Dutia group). Primer sequences for genes of interest are listed in Table 
2.5. Optimal primer concentrations and annealing temperatures are listed in Table 2.6. Each Q-
PCR was measured as relative concentration against SDHA. 
Table 2.5 Primer sequences for macrophage Q-PCRs 
Gene Forward Reverse 
SDHA gctcctactgatgaaacctg aactcaatcccttacagcaa 
Arginase 1 ggcctttgttgatgtcccta atgcttccaactgccagact 
CD206 tgaacccaaatgtccagaaa ctcgtaatcagcctccaaatc 
IL-10 ctttgctatggtgtcctttca atctccctggtttctcttcc 
iNOS tgctactgagacagggaag gacagtctccattcccaa 
TNFα caccaccatcaaggactcaa gacagaggcaacctgaccac 
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Table 2.6 Optimal primer concentrations and reaction conditions for macrophage Q-PCRs 
Gene Forward Reverse MgCl Anneal 
SDHA 400 nm 400 nm 2.5 mM 62°C 
Arginase 1 400 nm 400 nm 3.0 mM 62°C 
CD206 400 nm 400 nm 3.0 mM 62°C 
IL-10 400 nm 400 nm 2.5 mM 62°C 
iNOS 400 nm 400 nm 3.0 mM 62°C 
TNFα 400 nm 400 nm 3.0 mM 65°C 
SOCS-1 400nm 400nm 2.5 mM 62°C 
 
2.12 Mouse cytokine protein array  
Lung homogenate samples were thawed at room temperature. The array was performed 
following the protocol provided by R and D systems (MN USA). Membrane identification 
numbers were removed and the protocol for use with the Li-Cor imager (Li-Cor, NB USA) was 
followed for secondary staining. Protein Array membranes are blocked from non-specific 
binding by incubation for 1 hr at RT on a rocking platform shaker in wells containing buffer 6. 1 
ml of each sample was added to 0.5 ml of buffer 4 and 15 μl of reconstituted Mouse Cytokine 
Array Panel A Detection Antibody Cocktail. These samples were incubated at RT for 1 hr. 
Buffer 6 was removed and each sample was added to a well containing an antibody coated 
membrane. They were then incubated overnight at 4°C on a rocking platform shaker. 
Membranes were washed in 1x wash buffer and dH20 in individual containers and secondary 
staining was performed. See: Protein array protocol here 
http://www.rndsystems.com/Products/ARY006). Membranes were dyed with IRDye 800cw 
infared dye streptavidin (Li-Cor) at 1:2000 dilution for 30 min on a rocking shaker at room 
temperature. Membranes were then washed and stored in PBS protected from light. The 
membranes were scanned wet on a Li-Cor Odyssey (Li-Cor) at a resolution of 84 μm, medium 
quality, 0.0mm focus offset. Optimal intensity was 3 and all membranes were analysed using 
Image Studio Lite version 4.0 (Li-Cor). Results are reported as fold change in fluorescence 
intensity compared with expression levels in uninfected mice.  
2.13 Histology 
10 μm sections of lungs fixed in 10% NBF were stained with hemoxylin and eosin at the 
veterinary pathology unit, R(D)SVS, University of Edinburgh. Slides from each mouse were 
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scored and imaged using a Nikon Eclipse Ni series microscope and camera (Nikon, Japan) and 
Zen X software (Zeiss, Germany). 
Pathology scores were valued from 0-3 for a number of observations with the help of Dr 
Phillipa Beard, University of Edinburgh. Influenza infection was assessed by peribronchial and 
perivascular infiltration / presence of inflammatory cells which were identified and described. 
Interstitial inflammation and necrosis along with epithelial necrosis were also evaluated and 
scored as determinants of infection severity. The total area of the lung was observed and 
damage caused by infection described as 0, 25, 50, 75 or 100%.  For Litomosoides sigmodontis 
infection lungs were scored for different pathology, again on a scale of 0-3. Hypertrophic 
mesothelium and broncho-alveolar lymphoid tissue hyperplasia were recorded along with 
infiltration of neutrophils, lymphocytes and multi-nucleated giant cells.  
2.14 Statistics 
All statistical analysis was performed using Minitab 16. 
During design of in vivo experiments data from previous experiments, predicted outcomes and 
variation in assay techniques were used to determine power of the experiment. Numbers of mice 
used per experimental group were calculated using ‘sample size for estimation’ in Minitab 16 
allowing for statistical judgements that are accurate and reliable and responsible hypothesis 
testing.  This method is in accordance with Home Office guidance for the 3 R’s (reduce, refine 
and replace) of using animals for experimental procedures.  
Initially all data were tested for normality using an Anderson Darling probability test, individual 
distribution identification or visualising data with a distribution histogram. If data was normally 
distributed then parametric statistical methods were used. If the data was not normal then 
transformation using either log, log (x+1) for positively skewed data or square root for 
negatively skewed data was used preferentially to normalise. If the data could not be normalised 
then non-parametric methods were undertaken.  
 In cases where 2 groups were being compared, for example with influenza titre data then 
students 2 sample t test was used. If the data could not be normalised then analysis with Mann-
Whitney test was used.  
In the case of 4 groups being compared, if all groups had equal numbers of values then a 2-way 
ANOVA was used to determine significance. If groups were unbalanced, for example if the 
control group was of smaller size then a general linear model was constructed on the same 
principles. All pairwise comparisons were performed by Tukey analysis at 95%, 99% and 
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99.9% confidence levels in comparison to the co-infected group. Similarly if data from two 
independent experiments was analysed then ‘experiment’ was added to the model as an 
additional variable, controlling for technical variation between experimental repeats. If the data 
required for such comparisons could not be normalised then Kruskal-Wallis analysis was used. 
Data was treated as in the case of a 1 way ANOVA and variation between all individual 
experimental groups was measured. If this analysis presented any suggestion of significant 
differences between groups of interest then Mann-Whitney analysis was undertaken to 
determine significance between individual groups. This measure was undertaken to avoid false 
positives by repeat testing and cross comparison of all groups.  
Results are always represented with standard deviation as error and averages as mean average 
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Chapter 3 -  Latent gammaherpesvirus and influenza A co-infection  
3.1 Introduction 
All humans are infected with a range of commensal and pathogenic organisms. 
Gammaherpesviruses are common latent viruses present in all human populations. Latent 
viruses require an on-going immune response to control viral replication and prevent disease. 
Acute influenza A infection will often occur in individuals that harbour latent 
gammaherpesvirus infections.  
This chapter aims to identify modulation to the host immune response by a latent murine 
gammaherpesvirus, MHV-68 and determine if its effect on the innate and adaptive immune 
response can alter subsequent infection with mouse attenuated influenza A/WSN/33 (H1N1). 
3.2 MHV-68 - Murid Herpesvirus 4 (MuHV 4)  
Murid herpesvirus 4 (MuHV 4) is a gammaherpesvirus in the genus rhadinovirinae. Five strains 
were originally isolated from  bank voles (Clethrionomys glareolus) and wood mice (Apodemus 
flavicollis) in Slovakia, 1980 (Blaskovic, Stancekova et al. 1980). The archetypal strain MHV-
68 readily infects laboratory strains of mice (Mus musculus). 
3.2.1 Pathogenesis 
Although the natural infection route is unknown, intranasal infection (a likely route) of BALB/c 
mice causes an acute infection of the lung alveolar epithelium and mononuclear cells for 10 
d.p.i.  Lymphoproliferation is also observed in the lungs, with homology to infectious 
mononucleosis caused in EBV sufferers (Sunil-Chandra, Efstathiou et al. 1992). The lytic 
infection is largely cleared in the lung within two weeks, with an observed decrease in 
inflammation. From here the virus enters the lymph node via macrophages and dendritic cells 
leading to establishment of latent infection in B lymphocytes (which spread the virus to distal 
organs e.g. spleen), macrophages and splenic dendritic cells for the life of the animal, 
Splenomegaly, a CD4
+
 T cell induced expansion of lymphocytes in the spleen occurs around 
day 10 (Simas and Efstathiou 1998; Nash, Dutia et al. 2001). In the long term latent virus is 
present in the lymph node and spleen as well as the lung where it is present at low levels in 
epithelial and lymphoid cells (Stewart, Usherwood et al. 1998).  MHV-68 makes a useful 
animal model for the study of gammaherpesviruses such as EBV and KSHV in vivo, especially 
in regards to the lung and spleen immune responses. The kinetics of the acute MHV-68 murine 
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model of infection can be seen in Figure 3.1. A hypothetical dual infection is introduced at day 
28, when latent infection is established in BALB/c mice. 
Figure 3.1 Schematic representation of latent MHV-68 infection prior to co-infection 
 
3.2.2 Co-localisation of infections 
MHV-68 has been shown to persist in the epithelial cells in the lung, even after latency is 
established in the spleen (Stewart, Usherwood et al. 1998). Influenza viruses are usually 
restricted to a few cell types in the lung including epithelial cells and in some cases 
macrophages (Tate, Schilter et al. 2011). Cellular proteases play a role in the ability of influenza 
progeny virus to cleave from the surface of an infected cell (Choppin and Scheid 1979). 
A/WSN/33 virus encodes a neuraminidase capable of binding plasminogen. Active plasmin (a 
serine protease) then cleaves the virus hemagglutinin allowing the virion to infect new target 
cells. A/WSN/33 may therefore replicate in other tissues including the brain and spleen. In this 
model, MHV-68 and A/WSN/33 viral infections may therefore be present in both the lung and 
spleen. 
3.2.3 Genome 
MHV-68 has at least 73 identified genes, many of which are co-linear and homologous to both 
KSHV and EBV. The virus encodes homologues of cellular genes including Bcl-2 (M11), 
Cyclin D (ORF 72), complement regulatory protein (ORF 4) and an IL 8 receptor (ORF 74) 
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allowing suspension of apoptosis, manipulation of the host cell cycle, reductions in complement 
activation and chemokine attraction respectively (Simas and Efstathiou 1998). 
3.2.4 MHV-68 as a model for EBV / KSHV 
MHV-68 provides a model of KSHV and EBV human infections. All gammaherpesviruses have 
narrow host tropism. Whilst EBV will infect some primate species, the pathogenesis is very 
different to a natural infection (Tripp, Hamilton-Easton et al. 1997) and is therefore limited. 
MHV-68 is capable of causing a mononucleosis-like disease in laboratory mice with great 
similarity to that of EBV in a human host. It should however be noted that wood mice 
(Apodemus sylvaticus) are the natural host of MHV-68 (Blasdell, McCracken et al. 2003) and 
variations in response have been observed. The natural host displays lower viral replication 
during lytic infection, greater neutralizing antibody and more delineated secondary follicles in 
germinal centres in comparison to BALB/c mice (Hughes, Kipar et al. 2010).  
A BALB/c model of infection was used in the following co-infection experiments. 5-6 week old 
female BALB/c mice were infected with 5x10
4 
MHV-68 in PBS and 28 days later, once the 
MHV-68 infection has established latency, mice were infected with varying doses of A/WSN/33 
influenza virus in DMEM. Figure 3.2 shows the time line of the experiments. An additional 3 
experimental groups were used as controls. 




Increasing evidence from murine models is demonstrating the ability of herpesvirus latency to 
increase resistance to further infection by modulation of host immunity. These viruses have co-
evolved with the human immune system and establish infection for the life of the host however 
very little is known of the positive influence of herpesvirus infection in humans. Discovery of 
potentially beneficial effects of such infections on acute concurrent infections may provide 
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3.4 Results  
The initial co-infection experiments with latent MHV-68 and A/WSN/33 were performed at a 
relatively low influenza dose. It was unknown how these two viruses would interact and 
therefore a low dose of 5x10
2
 PFU A/WSN/33 was used to reduce the likelihood of a severe or 
negative outcome during co-infection. These co-infection experiments are referred to as ‘low 
dose’ from this point forward. 
 
3.4.1 Co-infection with latent MHV-68 and ‘low dose’ A/WSN/33 
 Effect of latent MHV-68 on co-infection with  A/WSN/33  
Co-infection experiments with a low dose A/WSN/33 were performed intranasally at 28 days 
post MHV-68 infection. After the A/WSN/33 infection, the mice were monitored for signs of 
clinical signs and weight loss every 24 hours. Clinical signs of influenza infection including 
respiratory effort, decreased mobility, hunched stature, staring coat, trembling and pointed face 
were all scored 0 on a ranked scale of 0-3 for all experimental groups throughout the 6 day time 
course. This is a sub-threshold level on the severity rating system. There was no associated 




A/WSN/33 infection and all experimental groups reached day 6 
at a similar percentage of weight measured prior to infection. Mean percentages were 99.34%, 
100.71%, 101.22% and 100.31 % for co-infected, MHV-68 infected, A/WSN/33 infected and 
uninfected groups respectively, with less than 2.5% variation within experimental groups 
(Figure 3.3A). Therefore there were no differences in clinical outcome of co-infection compared 
to singly and mock infected controls. Results are gathered from 4 independent experiments with 
cull dates at day 2 (single experiment), day 4 (2 experiments) and 6 days (2 experiments) post 
A/WSN/33 infection. 
At these three time points following A/WSN/33 infection, animals were culled and lungs were 
harvested and frozen at -80°C. The left lobe of the lungs was homogenised and the homogenate 
was titrated in a dilution series as described in section 4.1 to determine the infectious viral load 
of A/WSN/33. In these experiments lung A/WSN/33 titre was normally distributed in all of the 
experimental groups. A two sample t test was performed to determine significant difference. 




 lung homogenate) 
and co-infected mice (mean of 1.81x10
4 
PFU) did not significantly differ at day 2 (p=0.526). 
There was also no difference at the peak of viral replication at day 4 (p=0.825) where co-






. At day 6 post infection the difference in lung titre was significantly lower (p=0.045)  
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Figure 3.3 Co-infection has no effect on low dose A/WSN/33 pathogenesis 
A. Weight loss 
 
B. Influenza lung titre 
 
 
Figure 3.3 - 6 week old female BALB/c mice were inoculated I.N. with either 5x10
4
 MHV-68 or 40 μl baby hamster 
kidney cell lysate. After 28 days, groups were infected I.N. with either low dose
 
A/WSN/33 H1N1 or 40 μl Dulbecco’s 
minimum essential medium. A. Influenza induced weight loss B. Mean A/WSN/33 titre in the lung. N=6 at day 2 
from a single experiment. N=12 at day 4 and 7 from 3 repeat experiments. Error bars represent ±1 standard 
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) than mice 




) and greater standard deviation from the 
mean, 14,500 PFU compared to 10,600 PFU in the co-infected mice (Figure 3.3B). The 
reduction in titre is subtle, however for this time point there were an increased number of mice 
per group (n=12).  
 Pathology in the lung 
Low dose A/WSN/33 infection is sufficient to cause significant changes to the lung 
environment. Viral replication results in epithelial cell death in the respiratory tract. Six days 
post infection with A/WSN/33, an increase in macrophages, lymphocytes and 
polymorphonuclear cells can be found in the lung, cuffing the airways and blood vessels. Extent 
of inflammation and cell infiltration was scored visually on a scale of 0-3 (Figure 3.5). There is 
some mild inflammation in the lung due to haemorrhage following cull by rising C02 and also 
lavage of the lungs to gather immune cells for FACS analysis (3.4A and 3.4B). Pre-existing 
infection with latent MHV-68 does not significantly alter the integrity of the lung (Figure 3.4C) 
however small lymphocyte foci accumulations are apparent in the interstitial spaces around the 
lung, (Figure 3.4D and 3.4E). There may be 1-4 of these foci within a cross section of the 
latently MHV-68 infected lung.   
A/WSN/33 infection at low dose causes mild pathology. Infiltrations of cells (predominantly 
lymphocytes) are seen 6 days post infection around the blood vessels and airways within the 
lung (Figure 3.4F-H). These infiltrations are seen the same extent in mice co-infected with a 
pre-existing latent MHV-68 infection (Figure 3.4I-K). Co-infected mice therefore do not display 
a significant change in pathology in the lung compared with A/WSN/33 infected mice.  
 Cytokine environment in the lung 
Pathology caused by low dose A/WSN/33 was not altered by on-going co-infection with latent 
MHV-68. The reduction in infectious A/WSN/33 titre suggests an attenuated phenotype due to 
co-infection so to determine if the inflammatory environment in the lung is moderated, cytokine 
levels in the lung were measured at days 4 and 6 post infection by ELISA. 




Standard deviation within these groups was also similar, with variation around the mean of 
around 25-60 pg ml
-1
. IFNγ levels were therefore not significantly different between groups.  
TNFα levels at this time point were also not altered by infection. TNFα was expressed at lower 
levels than IFNγ and on average was detected at between 10 and 25 pg ml
-1
 in all samples. The 
standard deviation was much greater, (up to 30 pg ml
-1
 in the co-infected mice) as these results 
are often below the limit of detection in this ELISA and give results of 0 pg ml
-1 
(Figure 3.6A).  
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Figure 3.4 Low dose A/WSN/33 pathology is not affected by pre-existing MHV-68 infection 
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Figure 3.4 The right lung was inflated and fixed with 10% neutral buffered formalin. Lung sections were stained for 
hematoxylin and eosin. Representative sections are shown. Dashed arrows show areas of unaffected airways and 
blood vessels. Solid arrows demonstrate regions of lymphocytes infiltration and inflammation. A-B Lungs from 
uninfected mice. C-E Lungs from MHV-68 latently infected mice. F-H Lungs from A/WSN/33 infected mice. I-K. 
Images are representative from each infection group. Magnification is identified in the bottom right corner of each 
image.  
 
Figure 3.5 Low dose A/WSN/33 pathology score is not affected by pre-existing MHV-68 infection 
A. Pathology score 
 
Figure 3.5 A. Complete lung cross-sections were scored for signs of inflammation and cell damage, N=6. 
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Such results were not discounted as they still hold value statistically, and these results represent 
2 independent experiments. Non-parametric testing was applied to account for zero values 
which cannot be normalised. There was no significant difference between the groups. 
The regulatory cytokines IL-10 and TGFβ were also not significantly changed by infection at 
day 4. Expression was detected between 25 and 80 pg ml
-1
 in all groups for these two regulatory 
cytokines; however, there was a general trend for decreased expression in the influenza 
A/WSN/33 infected groups. Co-infected mice expressed 43.69 pg ml
-1
 TGFβ (±22.76) and 
A/WSN/33 infected mice 32.64±15.64 pg ml
-1
. On average this was lower than uninfected 
(73.89±31.13) and MHV-68 infected mice (75.17±52.10) however the variation in expression 
within these groups was high and therefore the decrease was not significant (Figure 3.6A).  
A similar pattern was observed for IL-10 expression where uninfected and MHV-68 infected 
mice express 64.58 and 59.29 pg ml
-1 
of IL-10 whilst co-infected and A/WSN/33 infected mice 
had lower levels of 39.50 and 26.43 pg ml
-1 
respectively. The standard deviation was similar 
across all groups (~25-30 pg ml
-1
) and therefore the decrease was not sufficient to gain any 
statistical significance.  
A significant increase (p<0.05 by GLM) in MIP2 (CXCL2) was observed in the co-infected 
mice 4 days post infection when compared with the uninfected group (29.19±17.38 pg ml
-1
 
compared with 2.71±1.82 correspondingly). A small increase in MIP2 in the MHV-68 infected 
group to 7.14±3.49 and a larger increase to 26.69 ± 9.63 in the A/WSN/33 infected group was 
also observed however due to the low numbers of replicates in the case of this cytokine (data 
gathered from a single experiment) these differences are not statistically significant compared 
with the uninfected group. A significant increase in IL-1β is also observed in both A/WSN/33 
infected groups. Expression at 167.39 ± 19.77 in the co-infected mice and 189.42±65.51 pg ml
-1 
in the A/WSN/33 infected animals compared with mean expression of 56.01 and 56.78 pg ml
-1
 
in uninfected and MHV-68 infected control groups. 
IL-2 and IFNβ did not change in expression between experimental groups. IL-2 was only 
detectable in some samples as expression was at the point of detection in all groups. Mean 
averages of 3.67, 8.77, 7.65 and 23.89 pg ml
-1
 were recorded in co-infected, MHV-68 infected, 
A/WSN/33 infected and uninfected groups respectively (Figure 3.6A). The uninfected group 
contained a single sample with 66.89 pg ml
-1 
IL-2 which caused an increase in the average for 
this group and greater standard variation of ±27.21 pg ml-1.  This did not significantly increase 
the amount of IL-2 in the uninfected group compared with other experimental groups and 
standard deviations within the remaining groups were similar.  
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Figure 3.6 A/WSN/33 infection significantly increases IL-1β and MIP2 at 4 days post infection and 
IFNγ and IL-10 6 days post infection 
A. Day 4 
 
 
B. Day 6 
 
Figure 3.6 Lung homogenates were assayed by ELISA for IFNγ, TNFα, IL-10, TGFβ, MIP2, IL-1β, IL-2 and IFNβ 
cytokines. Results are displayed as mean averages. Error Bars represent ±1 standard deviation from the mean. A. 
Lung homogenates measured 4 days post infection. N=7, representative of 2 experiments excl. MIP2 / IL-1β, IL-2 
and IFNβ where N=4 and is representative of a single experiment. Statistics measured by general linear model. 
Experimental groups with different letters are significantly different at 95% confidence. B. Lung homogenates 
measured 6 days post infection. Uninfected N=5, All others N=14, 2 experimental repeats. Statistics were measured 














































































Gareth Hardisty Latent gammaherpesvirus and influenza A co-infection 60 
 
IFNβ levels at day 4 post infection were much higher than IL-2. All groups expressed ~100 pg 
ml
-1
 of IFNβ on average with similar variation within groups of 17-31 pg ml
-1
. Co-infected mice 
had a subtle trend for increased IFNβ with a mean average of 120 pg ml
-1 
however this was 
again not statistically significant. 
At day 6 of the low dose co-infection with MHV-68 and A/WSN/33, IFNγ levels were 
significantly increased in both co-infected (p=0.0052 measured by Kruskal-Wallis and Mann-
Whitney test) and singly A/WSN/33 infected mice (p=0.0006). IFNγ level in co-infected mice 
was on average 260.59 pg ml
-1
 compared with 395.00 pg ml
-1
 in the A/WSN/33 infected mice 
(Figure 3.6B). Uninfected mice and MHV-68 infected mice have similar levels of IFNγ to those 
recorded at day 4 for these groups, 79.21±53.19 and 54.59±38.88 respectively. The increase in 
IFNγ is on average much greater in the A/WSN/33 infected mice than the co-infected group 
however large variation between biological replicates means this trend is not significant.  
TGFβ and TNFα levels were recorded at similar levels to that at day 4, and again did not show 
significance between groups (TGFβ ~75 pg ml
-1
 and TNFα ~ 30-35 pg ml
-1
). IL-10 levels in 
both A/WSN/33 infected groups appear significantly greater than in uninfected and MHV-68 
infected mice however the latter two groups contain mostly results below the level of detection. 
At day 4 IL-10 was detectable in all groups and therefore this difference is treated with caution. 




A/WSN/33 infected mice express 90.15 pg 
ml
-1
 which is similar to that at day 4. The IL-10 ELISA should therefore be repeated to clarify 
the variability in this result.  
 Effect of A/WSN/33 co-infection on latent MHV-68 
Influenza viral titre at day 6 was reduced as a result of co-infection (see Figure 3.3B). MHV-68 
preferentially infects B cells of the spleen and lies dormant in a state of latency but also persists 
in the lung epithelial cells. A/WSN/33 strain of influenza primarily infected epithelial cells of 
the upper respiratory tract but also spreads out of the lung to other tissues in the mouse. To 
assess if co-infection impacts the persistent replication of MHV-68 in the lung or causes 
reactivation of MHV-68 in the spleen, viral load was measured. 
MHV-68 is a DNA virus and may therefore be detected by qPCR with primers specific for a 
gene in the viral genome, (see section 2.10). Using primers designed for the orf 73 gene, MHV-
68 viral load was quantified in the lung and spleen to determine the effect of A/WSN/33 
induced inflammation on pre-existing MHV-68 latency. At day 2, 4 and 6 post A/WSN/33 
infection MHV-68 levels in the spleen were similar, on average between 30 and 300 copies per 
100ng of splenic DNA with occasional outliers at greater viral load (Figure 3.7A). Outliers were  
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Figure 3.7 Latent MHV-68 is not altered by low dose A/WSN/33 infection  
A. Spleen MHV-68 viral load 
 
B. Lung MHV-68 viral load 
 
Figure 3.7 DNA was extracted from a segment of the spleen and the left lobe of the lung. Quantitative PCR for orf 
73 in the MHV-68 genome was performed on 100 ng of DNA. A. MHV-68 viral load in spleen samples 2, 4 and 6 days 
post A/WSN/33 infection (30, 32 and 34 days post MHV-68 infection). N=7-15, 2 experimental repeats. B. MHV-68 
viral load in the lung at 6 days post A/WSN/33 infection (34 days post MHV-68 infection), N=5. Results are displayed 
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not specific to one experimental group. Average viral load was 242.2, 311.42 and 127.9 copies 
in the co-infected group on days 2, 4 and 6 and comparable levels of 198.2, 199.0 and 189.9 
copies per 100ng on days 2, 4 and 6 were observed in the MHV-68 singly infected mice. 
Variation within the two groups was relatively large (between 100 and 200 copies) however this 
was similar in all groups tested at all time points and is therefore considered highly accurate for 
such low copy number at a high efficiency.   
MHV-68 levels in the lung showed some discrepancy between experimental groups. Co-
infected mice showed a trend for decreased lung titre however this was not significant (p=0.077, 
by 2 sample t test, Figure 3.7B). The mean average lung viral load was 40.5 copies with a small 
standard deviation of 20.6 copies in the co-infected group. The singly MHV-68 infected group 
varied to a greater degree (164.7) and averaged at 190.1 copies of MHV-68 per 100ng of DNA 
when measured in a reaction with an efficiency of 1.02.  
3.4.2 Co-infection with latent MHV-68 and 5x102 A/WSN/33 
At this time point the A/WSN/33 stock virus that was used during the co-infection experiments 
required thawing, aliquoting and re-titring. Latent MHV-68 infected mice were again infected 
with 5x10
2 
PFU A/WSN/33. In the previous ‘low dose’ experiments 5x10
2
 PFU A/WSN/33 
infection caused no weight loss. The re-titred virus caused weight loss and clinical signs. The 
re-titred virus concentration was verified by two independent plaque assays. It is therefore likely 
that the previous infections were performed at a dose lower than 5x10
2
 PFU due to a 
miscalculation. The following experiments are therefore referred to as ‘5x10
2
 A/WSN/33’ 
infected while the previous experiments are referred to as ‘low dose’ infections.   
 Effect of latent MHV-68 on co-infection with 5x102 A/WSN/33  
Low dose A/WSN/33 infection did not cause any clinical signs. The increased dose caused 
moderate evidence of disease in singly A/WSN/33 infected mice. In this higher dose model it 
was possible to see if MHV-68 co-infection could moderate the pathogenesis of A/WSN/33 
infection by alleviating or exacerbating the observable changes to behaviour and weight 
variation during the experimental time course. 
At 5x10
2
 dose, A/WSN/33 infection results in moderate clinical signs (Figure 3.8B). Mice 
showed increased respiratory effort, scored on average above 1 at day 5; decreased mobility, 
scored at an average of 1.5 by day 5; a staring coat, scored on average at 1.5 on day 5 and 
hunched appearance scored on average at 1.0 by day 5, accumulating to a sum of 4.9 (moderate 
severity). On day 6 all categories were scored at 1.5 for each mouse, increasing the sum total to 
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also showed significant weight loss at day 5 (Figure 3.8A), with a reduction of 4.39% (p<0.01); 
at day 6 with a reduction of 11.41% (p<0.01) and at day 7 with a reduction of 16.51% (P<0.001) 
compared with their respective staring weights. Standard deviation within this group increased 
during the time course with 0.84%, 1.32%, 2.28% and 2.60% variability from the mean on days 
4, 5, 6 and 7 following A/WSN/33 infection (Figure 3.8A). 
Mice co-infected with latent MHV-68 showed less weight loss during the time course. Co-
infected mice began to show anorexia at day 6, with a significant decrease of 4.15% compared 
with MHV-68 infected and uninfected mice (p<0.05). Weight loss in the co-infected mice 
increased to an average of 6.74% at day 7 (p<0.01) which was significantly greater than MHV-
68 infected and uninfected controls and a significantly lower reduction than singly A/WSN/33 
infected mice despite greater variation in weight loss within this group (Figure 3.8A). Standard 
deviation of the co-infected group was 1.80% and 2.31% on days 6 and 7 respectively.  
Clinical signs were also much less severe in the co-infected group. Some, but not all, mice 
showed mild clinical signs from 5 days post infection, a day later than A/WSN/33 solely 
infected mice. The mice did not show severe staring coat (scored at 0.5 on average on day 6 and 
day 7) and incurred only a mild decrease in mobility (on average scored 0.5) by the cull date 
(Figure 3.8B). Summation of these clinical signs with mild (0.5) average scoring of hunched 
stature and increased respiratory effort (0.5), means that co-infected mice were scored on 
average at a severity score of 2 by day 7 and were therefore only showing mild signs of 
infection compared to the moderate clinical manifestations observed in the singly A/WSN/33 
group. 
The uninfected and MHV-68 infected mice showed no signs of infection and are not clinically 
scored. Weights are maintained close to 100% compared with day 0. The uninfected mice were 
99.93±0.68% of their original weight on day 7 and MHV-68 infected mice were 102.65±5.50% 
of their original weight on day 7.  
In the low dose infection, there was no change in influenza titre in the lung or weight loss 
(Figure 3.8C). Therefore to determine if the clinical manifestations and weight loss differences 
observed during the co-infection with 5x10
2 
A/WSN/33, viral titres were measured at the peak 
of replication, day 4 and during the clearance of infection at day 7. At day 4 and day 7 lungs 
were excised and influenza titre calculated by plaque assay as described in section 2.4. 
Normality of the data was tested by probability plot (Anderson Darling test).  
At day 4 the data were normally distributed (p=0.051) however at day 7 the data were not 
normally distributed (p<0.01). Day 4 has fewer values (n=7) and was close to the limit of 
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normality testing, therefore all titres were log transformed to produce normal distribution. At 
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Figure 3.8 Pre-existing latent MHV-68 infection reduces susceptibility to 5x102 A/WSN/33 infection 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza titre 
 
Figure 3.8 – 5-6 week old female BALB/c mice were infected I.N. with 5x10
4
 MHV-68 and 28 days later infected I.N. 
with 5x10
3
 A/WSN/33 in 40 μl Dulbecco’s minimum essential medium or medium alone. A. Influenza induced 
weight loss. Error bars represent ±1 standard deviation of the mean. Significance determined by students two-way 
ANOVA (†/*= p<0.05, **/†† = p<0.01, ***/††† = p<0.001). B. Clinical severity was measured by 4 signs. Each was 
scored on a scale of 0-3 and the sum reported ±1 standard deviation as clinical severity score, N=6. C. Mean 
A/WSN/33 titre in the lung, N=7 at day 4, N=13 at day 7, 2 experimental repeats. Significance determined by 
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of lung homogenate with a standard deviation of ±14,716 PFU 




with an almost identical standard deviation 
of ±14,726 PFU (Figure 3.8C). The two groups were therefore not statistically different. At day 





 albeit with a greater standard deviation of ± 65,000 PFU. Co-infected mice had a much 




; almost a log decrease compared to the singly 
infected mice. All except a single value were below 1x10
4 
PFU, with 4 mice demonstrating 
infectious titres below 100 PFU ml
-1
, (n=13 from 2 independent experiments). This difference 
was therefore statistically significant, (students 2 sample T-test p=0.023).  
 Pathology in the lung 
The pathology in the lung at this dose of A/WSN/33 infection was more severe. The uninfected 
mice however had no evidence of pathology. Lungs were inflated in 10% neutral buffered 
formalin and scored for histological evidence of disease. Uninfected mice (Figure 3.9A-C) had 
no inflammation or infiltration of cells and clear alveolar spaces (Figure 3.9C).  
MHV-68 infection had no significant impact on the integrity of the lung (Figure 3.9D and 3.9F) 
however as discussed in 3.4.1, MHV-68 infection resulted in small, sporadic foci of lymphocyte 
accumulations in the interstitial spaces in the lung, Figure 3.9D and 3.9E). MHV-68 infection 
was therefore scored in some cases with very mild pathology in the lung (Figure 3.10) 
distinguishing this group from the uninfected mice.  
5x10
2
 A/WSN/33 infection caused moderate pathology in the lungs. Infiltration of lymphocytes 
into the spaces surrounding the large and small airways (scored at an average of 2.00, Figure 
3.10) and blood vessels (scored at 2.30) and subsequent inflammation was evident (Figure 3.9G 
and 3.9H) alongside more severe epithelial necrosis (scored at 1 in all mice) than was measured 
in the low dose experiments. Cell infiltration into the alveolar spaces in the lung was also more 
prevalent in the higher dose infection. Cells including lymphocytes and macrophages were 
identified in the alveolar spaces (Figure 3.9I). 
Co-infection with latent MHV-68 reduced the pathology of the A/WSN/33 infection in the lung. 
Peri-vascular infiltration of lymphocytes was scored at an average of 1.5 for this group and peri-
bronchial infiltration of cells was 1.58 on average (Figure 3.9J and 3.9K). While epithelial 
necrosis did not significantly differ compared with the A/WSN/33 infected mice, there was 
more variation in the co-infected group, which averaged at a score of 0.75, (Figure 3.10).  Cell 
recruitment into the alveolar spaces was also reduced in these mice, as seen in Figure 3.9L). 
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Figure 3.9: The right lung was inflated and fixed with 10% neutral buffered formalin. Lung sections were stained 
with hematoxylin and eosin. Representative sections are shown. Dashed arrows show areas of unaffected airways 
and blood vessels. Solid arrows demonstrate regions of lymphocyte infiltration and inflammation. A-C Lungs from 
uninfected mice. D-F Lungs from MHV-68 latently infected mice. G-I Lungs from A/WSN/33 infected mice. J-L. Lungs 
from MHV-68 + A/WSN/33 infected mice. Images are representative averages from each infection group. 




Figure 3.10 A/WSN/33 pathology score is reduced by latent MHV-68 infection 
A. Pathology score 
 
Figure 3.10 A. Complete lung cross-sections were scored for signs of inflammation and cell damage, N=6. 
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 Cytokine environment in the lung 
Influenza virus titre is altered at day 7 post infection by pre-existing co-infection with latent 
MHV-68. Pathology in the lung is also alleviated. To determine if reduced inflammation, or 
increased regulation of inflammatory viral responses by cytokines were responsible for this 
attenuation and subsequent reduction in clinical signs, lungs were excised 4 and 7 days post 
infection and cytokines in lung homogenates measured by ELISA.  
At 4 days post infection, all experimental groups had similar levels of inflammatory and 
regulatory cytokines. The levels of IFNγ, TNFα, TGFβ and IL-10 were similar to those detected 
in the low dose infection group. Inflammatory IFNγ showed an increase on average in all 
infected groups, however this was not significant due to a large variation in all experimental 
groups infected with A/WSN/33. A low baseline level of 5.68±7.58 pg ml
-1 
IFNγ was evident in 
the uninfected group (Figure 3.11A). A slight increase to 32.49±7.91 pg ml
-1 
was recorded in 
MHV-68 infected mice and then a large average increase to 60.38 and 40.35 pg ml
-1 
was seen in 
the co-infected and A/WSN/33 infected mice respectively. These increases however were 
coupled with an increase in standard deviation of ±51.69 in the co-infected mice and ±46.74 in 
the A/WSN/33 infected mice. Therefore when this was measured statistically, the difference 
was not significant. 
TNFα levels were shown with a highly similar pattern of detection, with 5.15±5.56 pg ml
-1 
observed in the uninfected mice, a subtle increase to 20.79±5.09 pg ml
-1 
and then slightly larger 
mean averages seen in the co-infected (25.37 pg ml
-1
) and A/WSN/33 infected (21.60 pg ml
-1
) 
groups, again coupled with larger standard deviations of ±32.93 and ±27.50 correspondingly. 
Regulatory cytokine levels were also monitored to determine if variation was due to increased 
suppression of inflammation.  
IL-10 levels in the uninfected mice were 5.68±7.58 pg ml
-1 
and increased to 32.49±7.49, 
16.87±11.19 and 15.57±14. 53 in the MHV-68 infected, A/WSN/33 infected and co-infected 
mice (Figure 3.11A). There was no statistical significance between group averages. TGFβ also 
showed little variation in averages and standard deviations between groups, with all groups 




4 days post infection. 
At 7 days post infection both singly A/WSN/33 infected and co-infected groups demonstrated a 
significant increase in IFNγ (p=0.0022 and 0.0019 respectively by Mann-Whitney test) 
compared with the uninfected mice. Uninfected mice and MHV-68 infected mice had 14.25 and 
14.28 pg ml
-1 
IFNγ present in the lung whilst the co-infected mice increased to a mean average 
of 305.52 pg ml
-1 
and A/WSN/33 infected mice increased further to 391.45 pg ml
-1 
(Figure 
3.11B). As with the response of this cytokine at day 4, increased averages were coupled with an  
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Figure 3.11 5x102 A/WSN/33 infection increases IL-10 and IFNγ in the lung 7 days post infection 
A. Day 4  
 
B. Day 7 
 
Figure 3.11 Lung homogenates were assayed by ELISA for IFNγ, TNFα, IL-10 and TGFβ cytokines. Results are 
displayed as mean averages. Error Bars represent ±1 standard deviation from the mean. A. Lung homogenates 
measured 4 days post infection. B. Lung homogenates measured 7 days post infection. N=6-14, 2 experimental 
repeats. Statistics measured by Kruskal-Wallis analysis and Mann-Whitney test. Infected groups were compared 
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increase in the standard deviation within these groups of 261.17 and 147.29 pg ml
-1 
respectively. 
There was therefore no apparent significant difference due to MHV-68 latent co-infection. A 
single value (920 pg ml
-1
) however in the co-infected group was responsible for the high mean 
value and variation. There was no reason to exclude this value however, so it remained in the 
analysis.  
TNFα was detectable at levels similar to those seen at day 4, however the uninfected group 
contained samples that were below the level of detection. Averages of 22.72, 1.61 and 24.74 pg 
ml
-1 
were recorded in co-infected, MHV-68 infected and A/WSN/33 infected mice. No statistics 
were performed due to the absence of a detectable uninfected control.  
TGFβ was detected at similar levels to that seen at day 4. Once again all experimental groups 
had mean averages of ~30 pg ml
-1 
in the lung and standard deviations of ~10 observed in all 
groups.  
IL-10 was increased at day 7 in both A/WSN/33 infected groups. MHV-68 and uninfected mice 
had a baseline level of IL-10 of 1.27±3.04 and 1.66±4.06 pg ml
-1 
(Figure 3.11B). A significant 
increase to 83.01±53.53 in the co-infected group (p=0.0014) and 60.96±27.60 pg ml
-1
 in the 
A/WSN/33 infected group (p=0.0015) was in accordance with similar increases in IFNγ in these 
groups. Many of the ELISA results contained groups with values below the limit of detection. 
Therefore non-parametric tests were used.   
 Effect of A/WSN/33 on latent MHV-68 co-infection 
Due to the altered kinetics of A/WSN/33 infection in the co-infected mice, it was hypothesised 
that MHV-68 latency may also now be affected by the presence of increased inflammatory 
cytokines in the lung. MHV-68 viral load is unaltered by 5x10
2
 A/WSN/33 infection in the 
spleen but significantly reduced in the lung. Spleen levels of MHV-68 were measured 7 days 
post A/WSN/33 infection (35 days post MHV-68 infection). Similar levels were observed to 
day 34 in the previous experiment infected at the same dose of 5x10
4
 MHV-68 (3.12A). On 
average 74.12±37.63 copies per 100ng spleen DNA were detected in the co-infected mice whilst 
114.21±99.60 copies were detected in the MHV-68 infected mice. The two groups were similar 
in their distribution and are therefore not significantly different.  
However, there was a significant decrease in the expression of MHV-68 in the lung following 
A/WSN/33 infection, p=0.045 by student’s t test on log normalised data. Co-infected mice had 
on average, 73.8 copies of the MHV-68 genome per 100 ng of lung DNA (Figure 3.12B). 
However this value, along with the large standard deviation of ±103.41 was due to a single 
(clearly outlying) value of 340 copies skewing the results (n=8). With this result included in the 
analysis there were still significantly lower levels of MHV-68 present in the co-infected mice 
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Figure 3.12 MHV-68 viral load is unaltered by 5x102 A/WSN/33 infection in the spleen but 
significantly reduced in the lung 
A. Spleen MHV-68 viral load - Day 7 
 
B. Lung MHV-68 viral load - Day 7 
 
 
Figure 3.12 DNA was extracted from a segment of the spleen and left lobe of the lung. Quantitative PCR for orf 73 in 
the MHV-68 genome was performed on 100 ng of DNA. A. MHV-68 viral load in spleen samples 7 days post 
A/WSN/33 infection (35 days post MHV-68 infection). B. MHV-68 viral load in the lung at the same time point. N=7-
8 representative of 2 experimental repeats. Results are displayed as individual values. Statistical analysis performed 
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than in the lungs of solely MHV-68 infected mice, where 233.3±200 copies per 100ng was the 
average. These results were observed in 2 independent experiments. 
 CD4+ lymphocyte phenotype in the mediastinal lymph nodes 
Alterations to the cytokine environment in the lung and its resulting impact on both pathogens 
suggest that adaptive immune responses may be modified in response to the A/WSN/33 as a 
result of MHV-68 co-infection. Day 7 is a critical time point in the response to A/WSN/33, as it 




 cells in the lung and lung 
draining lymph nodes (mediastinal) were stained for intracellular cytokine production. 
7 days post infection cells from the lung draining lymph nodes were harvested and analysed by 
FACS for CD4
+
 intracellular cytokine production. IFNγ, IL-4 and IL-10 production by CD4
+
 
cells were raised in mice infected with 5x10
2
 A/WSN/33 (p<0.01 for all groups). CD4
+
 cells in 
uninfected mice were only 1.3% positive for production of IFNγ when stimulated with PMA 
and ionomycin. Latent MHV-68 infection increased this number to 4.95±2.89%. 
 IFNγ production was raised in 2 mice in the MHV-68 infected group, and therefore IFNγ was 
not significantly different between this group and the A/WSN/33 infected and co-infected mice 
(Figure 3.13A). When comparing these results to the higher dose infection and day 0 mice it 
was only these 2 mice that appeared to have raised IFNγ levels in the MHV-68 infected group.  
The single infection with A/WSN/33 and similarly co-infection increased IFNγ production 
further to 7.83±1.10% and 8.69±2.40% in turn. A/WSN/33 infected groups therefore produced 
significantly greater amounts of IFNγ than uninfected mice while the increase in MHV-68 
infected mice was not significant. 
 IL-4 production by CD4
+
 cells was also increased by A/WSN/33 infection. IL-4 in uninfected 
mice was produced in 1.19±0.86 % of cells and to a similar level of 1.04±0.84 % in cells taken 
from the mediastinal lymph nodes of MHV-68 infected mice (Figure 3.13B). A/WSN/33 
infection increased this number to 4.96±1.66 % and co-infected mice show an equally increased 
percentage of IL-4 production to 3.98±1.58 %. The significant increase in IL-4 production in 
co-infected mice was lower than in the singly A/WSN/33 infected mice, as demonstrated by the 
reduction in p value, p<0.05. 
 IL-10 production by CD4
+
 cells followed the same pattern (Figure 3.13C). Uninfected mice and 
MHV-68 infected mice were 0.70 ± 0.48% and 1.23 ± 4.10 % positive for IL-10 whilst co-
infected mice increased to 4.88 ± 2.63%. This increase was slightly skewed by a single result 
with 10.20% of CD4
+
 cells producing IL-10, however, this particular mouse also demonstrated a  
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Figure 3.13 TH1 CD4





Figure 3.13 Mice were culled 7 days post A/WSN/33 infection. Lung draining lymph nodes were harvested. 1x10
7
 
cells were stained for CD4
+
 T cell markers. Samples were run on a BD LSR II Fortessa. Results are displayed as 
individual percentages and mean per group ± 1 standard deviation, N=6. Statistics calculated by general linear 
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larger production of IFNγ (13.4%). A/WSN/33 infection alone increased IL-10 production to 
5.52±1.51% which was not significantly greater than the co-infected mice.  
TNFα production was not significantly raised in any experimental group and was much more 
variable within groups (Figure 3.13D).  The mean averages of CD4
+
 TNFα positive cells were 
between 17 and 23% and varied up to 9.8% which meant that this cytokine was not notably 
altered by either of the infections.  
 CD4+ and CD8+ lymphocytes in the lung 
While the CD4
+
 cell response in the lung was not significantly altered there was evidence of 
decreased IL-10 and IFNγ production in the co-infected group. To determine if this effect has 




 cells at the site of infection in the lung, cells from 





 cells were not different in the BAL fluid (Figure 3.14A and 
3.14C). Co-infected mice had an average of 11.39% CD4
+
 lymphocytes and 34.16% CD8
+
 
lymphocytes. This was comparable to an average of 12.3% CD4
+
 and 42.24% CD8
+ 
lymphocytes recorded in singly A/WSN/33 mice. The variation from the mean was much 
greater for the CD8
+
 lymphocytes in both groups however co-infected mice demonstrated 
greater variation in both groups of cells. The number of cells in BAL fluid was low and was 
predominantly composed of macrophages and other non-lymphocyte populations. Therefore 





cells and are not shown.   





 cells, the cytokine production may vary, in reflection of the altered cytokines detected 
by ELISA and reduced weight loss.  
CD4
+
 cells did not show differences in their inflammatory cytokine (IFNγ and TNFα) 
production. CD4
+
 cells from co-infected mice were on average 30.87±2.57% positive for IFNγ 
production whilst A/WSN/33 infected mice were 33.60±5.85% positive. TNFα was produced at 
much lower levels however this also did not vary between experimental groups with an average 
of 11.64±4.16% CD4
+ 
cells in the co-infected mice and 9.90±6.58% in the A/WSN/33 infected 
mice (Figure 3.14B).   
Whilst not statistically significant, the most notable difference in cytokine production was seen 
as a trend for increased production of inflammatory cytokines IFNγ and TNFα by CD8
+ 
cells in 
the co-infected mice. IFNγ was produced by 41.90±12.79% CD8
+
 cells in A/WSN/33 infected 
mice and at a lower percentage of 58.3±9.58% in the CD8
+
 cells from co-infected mice. An 
 
 


























MHV-68 + A/WSN/33 A/WSN/33
Figure 3.14 CD8+ cells in the lungs of co-infected mice produce increased levels of inflammatory 

















Figure 3.14 Mice were culled 7 days post A/WSN/33 infection and cells in the lung were harvested by broncho-





 T cell markers. The samples were run on a BD LSR II Fortessa. Results displayed as individual percentage per 
sample and mean average per group ± 1 standard deviation, N=4-5. All statistics are calculated on data from a single 
experiment, (*=p<0.05, **=p<0.01, ***=p<0.001). A. Total CD4
+








 cells C. Total 
CD8
+






























































































 IFNγ           TNFα 
 IFNγ           TNFα 
 
 
Gareth Hardisty Latent gammaherpesvirus and influenza A co-infection 78 
increase in the number of biological replicates would likely improve the outcome of this 
difference statistically (p=0.104).  
As with the CD4
+
 lymphocytes, TNFα production was detected at a much lower frequency than 
IFNγ. CD8
+
 cells taken from the co-infected mice were 5.66±2.20% positive for TNFα whilst 
A/WSN/33 infected mice were on average 3.22±1.13% positive for this cytokine (figure 3.14D).  
Regulation of inflammation by IL-10 production was also hypothesised to be part of the 




 cells was 
also measured however this cytokine was only expressed in a low number of cells and is 
therefore not reported.  
3.4.3 Co-infection with latent MHV-68 and 5x103 A/WSN/33 
Increasing the A/WSN/33 dose to a moderate severity increased the observed clinical signs 
during the course of infection. The co-infected mice were less susceptible to infection with 
A/WSN/33. To determine whether this protective effect was dose dependent and could still 
confer protection during a more severe pathogenesis, the dose of influenza A was increased 
again to 5x10
3
 PFU.  
 Effect of latent MHV-68 on co-infection with A/WSN/33 
As previously described, mice were scored for clinical signs and weight loss every 24 hours. At 
the 5x10
3
 dose, A/WSN/33 infection resulted in severe clinical signs. At day 4 mice were 
showing moderate signs of infection. This was a day earlier than in the 5x10
2
 infection although 
there was greater variation within the group. By day 5 increased respiratory effort, staring coat, 
hunched stature and reduced mobility were all scored above 2 for all animals (Figure 3.15B). 
The sum therefore reached an average of 9.5 and clinical signs were now consistent amongst all 
mice in the group. This was maintained through to day 6 and then worsened at day 7 when 
hunching, staring coat and respiratory effort were scored at 3 and reduced mobility at an average 
of 2.5. The mean severity rating reached an average of 11.5 on this day.  
Mice infected with 5x10
3 
A/WSN/33 alone also showed significant weight loss compared with 
uninfected and MHV-68 infected groups from day 4 onwards, (p<0.05). At day 4 7.4±2.3% was 
the mean weight loss, increasing to 10.53% by day 5 (p<0.001) and 15.02% on day 6 (p<0.001) 
(Figure 3.15A).  By day 7 A/WSN/33 infected mice had lost a mean average of 22.38% of their 
weight recorded at day 0 (p<0.001). The standard deviation from the mean was less than ±3.0% 
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Figure 3.15 MHV-68 latency significantly reduces susceptibility to high dose 5x103 A/WSN/33 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza lung titre
 
Figure 3.15 – 6 week old female BALB/c mice were infected I.N. with 5x10
4
 MHV-68 and 28 days later infected I.N. 
with 5x10
3
 A/WSN/33 in 40 μl Dulbecco’s minimum essential medium or medium alone A. Influenza induced weight 
loss. Error bars represent ±1 standard deviation of the mean. Significance determined by two-way ANOVA, (†/*= 
p<0.05, **/†† = p<0.01, ***/††† = p<0.001) * signifies significant difference between A/WSN/33 infected and the 
uninfected groups. †signifies significant difference between co-infected and A/WSN/33 infected groups. B. Clinical 
severity was measured by 4 signs, each was scored on a scale of 0-3 and the sum reported ±1 standard deviation as 
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The co-infected mice now showed much more significant weight loss and clinical signs than 
was observed in the same group infected with 5x10
2
 A/WSN/33 in the previous experiments. A 
significant decrease in weight occurred at day 5 with a 7.33±4.9% weight loss compared with 
day 0, increasing to 15.30±3.92% at day 6 and 19.72±4.10% (Figure 3.15A). The variation from 
the mean was recorded by standard deviation and was much greater within this group and 
increased over the time course as some mice appeared to be better protected than others.  
Weight loss was directly associated with increasingly severe clinical signs. Co-infected mice 
showed a more gradual increase in severity over the time course than A/WSN/33 alone with an 
onset of clinical signs in some of the mice as early as 4 days post infection. The hunched stance 
and slight staring in the coat (averaged at 0.5) was not coupled with an increased respiratory 
effort or decreased mobility. Day 5 was the onset of increased respiratory effort and slowed 
movement in some mice, however, at this point clinical signs varied widely within the group, 
with some mice showing few signs of infection and others scored at 4, in the ‘moderate’ 
severity category. Mean scoring increased to 6.8 at day 6 and 8.7 at day 7 when all mice showed 
an increased respiratory effort (2.5 average), decreased mobility (2.0 average), staring coat (2.3 
average) and hunched stature (2.0). The standard deviation at this time point was ±0.4 (Figure 
3.15B). Co-infected mice were still protected from A/WSN/33 at this dose however to a lower 
degree. Statistical significance was recorded at days, 4, 5 and 7 (p<0.05, p<0.01, p<0.05, tested 
by general linear model).  
The uninfected mice and latent MHV-68 singly infected mice had no significant changes in 
weight and did not produce any clinical signs of infection. Uninfected mice were on average 
101.57% of their original body weight at day 0 and MHV-68 infected mice were 99.70%.   
At day 4 and day 7 the lungs were excised and the influenza titre was calculated by plaque 





; a log increase compared
 
with the lower dose infection. Co-infected mice had 









 at day 7, which 
is still a log greater than the virus seen at this time point in the lower dose infection (Figure 




 replicating virus in the lungs on 
average on day 7. At this time point in the lower dose infection these mice were nearing 
complete clearance. At the day 4 and day 7 time points there was no statistically significant 
difference in lung A/WSN/33 titres, (p=0.242 and p=0.152 respectively). Students 2 sample T-
test, log normalised data). There is again a repeat trend for decreased titres in the co-infected 
mice however this is less apparent than at the lower dose infection. 
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 Pathology in the lung 
The effect of 5x10
3
 A/WSN/33 infection is recorded in Figure 3.16. Uninfected mice once again 
showed no signs of disease, with clear alveolar spaces and no changes to peri-bronchial and 
peri-vascular inflammation. MHV-68 infected mice also maintained lung integrity however the 
small foci of lymphocyte accumulations described in previous experiments were once again 
evident in the interstitial spaces. These results are therefore not shown.  
Infection with 5x10
3
 A/WSN/33 caused severe inflammation around the large and small airways 
and around the blood vessels in the lung. Infiltration of lymphocytes was scored at an average of 
2.4 at both the peri-vascular and peri-bronchial surfaces. This inflammation is evident in Figure 
3.16A and 3.16B. Epithelial necrosis was scored at an average of 1.8, which is a small increase 
from the previous dose of infection (see Figure 3.16F for pathology scores). 
Co-infected mice showed a trend for less severe inflammation. The inflammation in these mice 
was more prevalent than at the lower dose of infection (Figure 3.16C-F). Peri-vascular 
infiltration of lymphocytes was scored at 1.8 and peri-bronchial infiltration of cells was also 
scored at an average of 1.8 (Figure 3.16F). Epithelial necrosis however was scored at a similar 
extent to that scored in the A/WSN/33 infected group (mean average of 1.9). 
 Cytokine environment in the lung 
Hypercytokinemia in the lung, associated with fatality in influenza A infection appears after the 
peak viral replication when the virus is starting to clear. In the mouse model of infection this is 
around day 6-8 post infection. Inflammatory IFNγ and regulatory IL-10 levels appeared to be 
attenuated in the lungs by co-infection with MHV-68 in the lower dose infections and so a 
cytokine array of cytokines and chemokines with key roles in different pathways of the immune 
response to infection was used to identify individual targets that may be crucial to the protective 
effect conferred by co-infection.    
The cytokines and chemokines in the array may be divided into four broad groups relating to 
inflammation observed during influenza A infection. All cytokines associated with the cytokine 
storm (Figure 3.17A) in human infections were significantly increased in A/WSN/33 infected 
mice. TNFα, IL-1α, IL-1β and IL-6 were all significantly (p<0.01) increased in A/WSN/33 
infected mice compared with the co-infected group after normalisation to the uninfected 
controls. Of interest in this group were TNFα and IL-6. TNFα was also not elevated 
significantly in MHV-68 mice or co-infected mice however this cytokine was highly increased 
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Figure 3.16 Co-infection with latent MHV-68 does not significantly reduce pathology of 5x103 
A/WSN/33 infection  
5x10
3
 A/WSN/33 infected 




 A/WSN/33 infected 















 Normal lung structure 
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F. Histology scoring 
 
Figure 3.16 The right lung was inflated and fixed with 10% neutral buffered formalin. Lung sections were stained 
for hematoxylin and eosin. Representative sections are shown. Dashed arrows show areas of unaffected airways 
and blood vessels. Solid arrows demonstrate regions of lymphocytes infiltration and inflammation. A-B Lungs from 
A/WSN/33 infected mice. C-E. Lungs from MHV-68 + A/WSN/33 infected mice. Images represent averages from 
each infection group. Magnification is identified in the bottom right corner of each image. F. Complete lung cross-
sections were scored for signs of inflammation and cell damage, N=6. Representative of 2 experiments. Results are 
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Figure 3.17 The cytokine environment following 5x103 A/WSN/33 is significantly ameliorated by 
pre-existing latent MHV-68 infection 
A. ‘Cytokine storm’ cytokines 
 















































Gareth Hardisty Latent gammaherpesvirus and influenza A co-infection 85 
 
C. TH2, TH17 and TREG cytokines 
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E. Chemokines 2. 
 
F. Adhesion, stimulation and proliferation cytokines 
 
Figure 3.17 Cytokine environment in the lung was measured by protein array on lung homogenates 6 
days post 5x10
3
 A/WSN/33 infection. Results represented as mean fold change per experimental group 
compared to expression in the uninfected mice. Error bars are ±1 standard deviation, N=4. Statistics are 
conducted by general linear model on raw or log transformed (normalised) data. Otherwise by Kruskal-
Wallis and Mann-Whitney non-parametric tests, (*/† = p<0.05, **/†† p<0.01, ***/††† p<0.001). 
Asterisks, (*) display significant differences between co-infected and singly A/WSN/33 infected groups. 
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increased by 6.7 fold (p<0.001) on average compared with uninfected mice, whereas co-infected 
mice only show a 1.5 fold increase and was not significantly increased. MHV-68 infection alone 
did not differ significantly from the uninfected mice. IL-6 followed a similar pattern; 
A/WSN/33 infected mice produced around 21.5 times the amount of IL-6 compared with 
uninfected mice. There was no significant change in the other experimental groups however.   
 IFNγ (p<0.05) was also significantly increased in the A/WSN/33 infected mice compared with 
the co-infected group. The A/WSN/33 mice had an increase of 26.5 fold compared with the 
uninfected mice and 8.19 fold increase compared with the co-infected animals. The cytokine 
array is more sensetive than previous detection with ELISA and may therefore validate the trend 
observed at lower doses of infection. IFNγ was not significantly elevated in latently MHV-68 
infected mice alone by this method of detection and therefore the co-infected mice had 
significantly higher (p<0.001) levels than MHV-68 infected and uninfected mice.  
The cytokines that are subsequently altered by IFNγ signalling (Figure 3.17B) were also 
increased in A/WSN/33 infected mice. IP-10, MIG and RANTES are all significantly increased 
by A/WSN/33 infection. Pre-existing co-infection with MHV-68 however reduced the levels of 
these cytokines significantly compared with A/WSN/33 singly infected mice, (p<0.01, p<0.001 
and p<0.001 respectively). IP-10 levels increased significantly 16 fold whilst levels in co-
infected mice increased by 2.6 fold and therefore were not significantly different when 
compared with uninfected mice. MHV-68 infected mice also showed similarity to the 
uninfected group. RANTES however was increased in co-infected mice (98 times) and in 
A/WSN/33 infected mice (271 fold). MHV-68 infection alone also increased expression of this 
chemokine as discussed later. The pattern and levels of MIG expression were very similar to 
RANTES in each experimental group. IL-12p70 was the exception to this group of cytokines 
and did not significantly increase compared with MHV-68 and uninfected mice. This may in 
part be due to the large variation in these two groups (E.g. measured pixel density on the array 
varies from 107 to 131,424 in the uninfected mice whereas A/WSN/33 infected mice were 
measured within the range of 2,000-4,500). 
Influenza virus induced hypercytokinemia induces type 1 and 2 cytokines. Three cytokines 
associated with ‘TH2 immunity’ were measured (Figure 3.17C). A/WSN/33 infection alone 
increased IL-4 (p<0.01) 5.1 fold and IL-13 (p<0.001) significantly to 5.6 fold compared to the 
uninfected mice. All other experimental groups had similar levels of these cytokines to the 
uninfected mice, MHV-68 showed a 0.8 and 1.1 fold difference and co-infected mice were 
altered by 0.8 and 1.6 for IL-4 and IL-13 respectively. IL-5 did not alter significantly for any 
group.  Expression was highly variable for IL-5 levels in the uninfected group which may 
explain this lack in variation. 
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 Two cytokines associated with TH17 immunity were also measured. As with the type 2 
cytokines, A/WSN/33 infection alone increased the levels of IL-23 and IL-17 significantly 
higher (p<0.001) than the co-infected or MHV-68 infected mice. IL-23 increased by 5.4 times 
and IL-17 by 5.8, demonstrating the mixed phenotypic response in influenza infection. Co-
infected mice had similar levels of these cytokines to the MHV-68 singly infected group. IL-23 
was expressed at 0.6 and 0.9 fold change to the uninfected mice for MHV-68 and co-infected 
mice and IL-17 varied by 0.5 and 0.9 fold compared with the uninfected mice. This was not 
statistically significant.  
 The regulatory cytokine IL-27 was also significantly increased by A/WSN/33 infection alone 
(p<0.001) to 3.75 times the amount detected in uninfected mice but was not increased during 
co-infection (0.95). Similarly IL-10 expression was up-regulated by A/WSN/33 infection by 
6.08 fold to a significantly higher level (p<0.001) than seen in co-infected mice which only 
increased by 2.92 fold. This cytokine did increase significantly (p<0.001) in the co-infected 
group when compared with solely MHV-68 infected and uninfected mice. This is the only 
cytokine in this group to increase significantly during co-infection.  
All chemokines tested (Figure 3.17D and 3.17E) were at significantly higher levels in the 
A/WSN/33 singly infected mice compared with the co-infected mice at day 7 post infection, 
with the exception of MIP-1β which increased to a similar degree in co-infected mice. 
 I-309 (CCL1), SDF-1 (CXCL12), KC (CXCL1), MIP-1α (CCL3), MIP-1β (CCL4), MCP-5 
(CCL12) and JE (CCL2) all increased significantly in the co-infected mice as well whilst the 
other chemokines in this group did not significantly differ from uninfected mice during co-
infection. MCP-5 (CCL12) showed the greatest increase of 390 fold compared with uninfected 
animals during A/WSN/33 infection and co-infected mice increased by 78.6 fold. A 5.8 fold 
increase in eotaxin (CCL11) in the A/WSN/33 infected mice however was equally significant 
(p<0.01). Larger increases were hence more variable between mice of the same experimental 
group. 
Cytokines associated with adhesion, stimulation and proliferation of immune cells (Figure 
3.17F) were all significantly increased in the singly A/WSN/33 infected mice but only M-CSF 
increased significantly in the co-infected group, (p<0.01). GM-CSF, for example, increased by 
5.2 fold in the A/WSN/33 infected mice, however, MHV-68 infection and co-infection did not 
significantly alter its expression (1.60 and 1.75 fold difference). M-CSF increased by 47.5 times 
due to the influenza infection compared with uninfected mice while the co-infected mice only 
increased by 8.3 fold. IL-2 was also an exception in this group and was surprisingly not 
significantly increased in any of the experimental groups.  
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 Effect of A/WSN/33 on co-infection with latent MHV-68 
Persistent MHV-68 was reduced in the lung by co-infection with 5x10
2
 A/WSN/33. A/WSN/33 




 doses although 
protection was less apparent at the high dose. To determine if this protective effect was less 
efficient due to an increased suppression of MHV-68 by the second infection, MHV-68 viral 
load was calculated in the lung and spleen. 
Seven days after 5x10
3 
A/WSN/33 infection, (35 days after MHV-68 infection), the levels of 
MHV-68 in the spleen, detected by QPCR for ORF 73 were similar in both MHV-68 and co-
infected mice (Figure 3.18A). In both groups the viral load was variable although the majority 
of results were below 1000 copies. The mean copy number in MHV-68 infected mice was 780.2 
whilst co-infected mice had a much lower average of 386.7 copies however variation within the 
groups meant that this was not significantly different. These results were also in line with viral 
loads observed in the spleens in previous experiments.  
In the lung, co-infected mice had significantly decreased levels of MHV-68 compared to singly 
infected mice (p=0.002, measured by 2 sample t test) as with the lower dose experiments 
(Figure 3.18B). MHV-68 infected mice averaged 69.8±28.6 copies per 100ng of lung DNA. The 
co-infected mice had 13.2±10.2 copies. A single sample in this group had no detectable MHV-
68 in the lung.  
 CD4+ lymphocytes in the mediastinal lymph nodes 
TH1 cytokine production was unaltered in the mediastinal lymph node at the low dose of 
infection. To confirm normal function in the CD4
+
 cells in the lymph node, cells were harvested 
and stained for intracellular cytokines 7 days post infection. 
IFNγ and IL-4 production by CD4
+
 cells was significantly raised in mice infected with 5x10
3
 
A/WSN/33 (p<0.05 for all groups). In uninfected mice 1.12±0.59% of CD4
+
 lymphocytes were 
producing IFNγ and 0.71±0.73 % were producing IL-4. A/WSN/33 infection increased IFNγ 
producing cells to 8.71±2.09% of the total CD4
+
 lymphocytes and IL-4 producers increased to 
4.69±3.33%. The MHV-68 latently infected mice show similar levels of IFNγ and IL-4 
production to the uninfected mice (2.63% IFNγ positive and 0.41% IL-4 producing cells). CD4
+
 
lymphocytes in the mediastinal lymph nodes of co-infected mice were also significantly raised 
in their production of IFNγ and IL-4, with an average of 6.99±3.07% IFNγ positive and 
2.26±1.76 % IL-4 producing cells (Figure 3.19A and 3.19B). The standard deviation within this 
group was greater than the A/WSN/33 singly infected mice due to a single mouse with 
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 Figure 3.18 Infection with 5x103 A/WSN/33 reduces the MHV-68 viral load in the lung 
A. Spleen MHV-68 titre– Day 7 
 
B. Lung MHV-68 titre – Day 7 
 
 
Figure 3.18 DNA was extracted from a segment of the spleen and the left lobe of the lung. Quantitative PCR for orf 
73 in the MHV-68 genome was performed on 100 ng of DNA. A. MHV-68 viral load in spleen samples 7 days post 
A/WSN/33 infection (35 days post MHV-68 infection), N=5. B. MHV-68 viral load in the lung at the same time point. 
N=6. Results are displayed as individual values. Statistical analysis performed by two sample student’s t test (** = 
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Figure 3.19 TH1 CD4+ T cell phenotype in lung draining lymph nodes is the same in 5x103 





Figure 3.19 Mice were culled 7 days post A/WSN/33 infection. Lung draining lymph nodes were harvested. 1x107 
cells were stained for CD4
+
 T cell markers. Samples were run on a BD LSR II Fortessa. Results are displayed as 

























































































































Gareth Hardisty Latent gammaherpesvirus and influenza A co-infection 92 
increased IFNγ (13.4%) and IL-4 (5.81%) production. In the absence of this result there would 
have been a strong trend for decreased production of both cytokines in the co-infected mice 
compared with the A/WSN/33 singly infected group.  
IL-10 and TNFα production by CD4
+
 T cells, were not significantly raised at this dose in any 
experimental group (Figure 3.19C and 3.19D) however there was greater variation within the 
uninfected group (2.37±1.58% and 18.67±6.34% for IL-10 and TNFα respectively). There were 
no significant differences between the singly A/WSN/33 infected and co-infected mice. TNFα 
was produced at an average of 3.36±1.56% in the co-infected mice and 5.05±2.16% in the 
A/WSN/33 infected mice. IL-10 was expressed by 8.91±3.83% of CD4
+
 lymphocytes in the co-
infected mice and 9.54±1.91% in the A/WSN/33 infected mice. While the results were not 
significant, similar patterns of expression could be seen in all cytokines, with A/WSN/33 
infected mice always averaging a greater production of IL-10, TNFα, IFNγ and IL-4 by CD4
+
 
lymphocytes than the co-infected mice.  
 CD4+ and CD8+ lymphocytes in the lung 
Differences in the pathology were less evident in the lungs of co-infected and A/WSN/33 
infected mice at this dose. To determine if this was reflected in the adaptive immune response in 
the lung at this time point cells from BAL fluid were stained for CD4, CD8 and intracellular 
inflammatory cytokines.  
Numbers of lymphocytes in lavage samples from uninfected and MHV-68 infected mice were 
too low to report and are therefore not shown. There were no significant differences in the 




cells in the lung between co-infected and A/WSN/33 
infected mice (Figure 3.20A and 3.20C). Co-infected mice had 14.24 ± 4.40% CD4+ 
lymphocytes and A/WSN/33 infected mice had 12.38 ± 0.56% CD4+ cells. Production of 
cytokines by these cells was significantly different between experimental groups. Co-infected 
mice had a significantly increased production of TNFα, (p=0.009) with 15.83 ±4.12 positive 
CD4
+
 cells compared to 8.42 ± 1.86% in the A/WSN/33 infected group (Figure 3.20B). IFNγ 
production was similar in these cells with 26.20 ± 5.13% in the co-infected and 22.30 ± 4.90% 
in the A/WSN/33 infected mice.  
The proportion of CD8
+
 lymphocytes in the lungs did not differ between co-infected mice 
(46.57±6.57%) and A/WSN/33 infected mice (38.46±3.97%). However, production of cytokines 
by these cells was significantly different. IFNγ production was observed in 58.30±9.84% of 
CD8
+
 lymphocytes in co-infected mice (Figure 3.20D) whilst CD8
+
 lymphocytes from 
A/WSN/33 infected mice averaged 41.90±12.79% (p=0.001). Similarly TNFα production was 
apparent in a greater percentage (p=0.001) of CD8
+
 cells in the co-infected mice (5.66±2.20%)  
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Figure 3.20 CD8+ cells in the lungs of co-infected mice produce significantly increased levels of 















Figure 3.20 Mice were culled 7 days post A/WSN/33 infection and cells in the lung were harvested by broncho-
alveolar lavage (BAL). Maximum numbers of cells in the BAL fluid were stained for a range of intracellular CD4+ and 
CD8
+
 T cell markers. The samples were run on a BD LSR II Fortessa. Results displayed as individual percentage per 
sample and mean average per group ± 1 standard deviation, N=5-6. All statistics are calculated on data from a single 
experiment, (*=p<0.05, **=p<0.01, ***=p<0.001). A. Total CD4
+
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compared with singly A/WSN/33 infected mice (3.22±1.13%). As in previous experiments IFNγ 
levels exceeded TNFα production in both cell types.  
 
3.4.4 Co-infection with latent MHV-68 and 5x103 A/WSN/33 in WT 129 
Sv/Ev mice  
Changes to IFNγ levels and cytokines and cheomkines induced by IFNγ in the co-infected mice 
suggested that this cytokine may be integral to the reduction in susceptibility seen in this group. 
It was hypothesised that an IFNγR
-/-
 mouse would therefore lose this phenotype. The IFNγR
-/-
 
mice are on a 129Sv/Ev background and so a repeat of the 5x10
3
 experiment was undertaken in 
WT 129 Sv/Ev mice to determine the effect of co-infection in this particular background strain 
prior to the ‘removal’ of IFNγ signalling from the system.  
As before, 5-6 week old female mice were infected with 5x10
4
 MHV-68 and 28 days later with 
5x10
3
 A/WSN/33 intranasally and compared with uninfected and singly infected controls. As 
with BALB/c mice, latent MHV-68 infection caused no clinical signs or weight loss.  
 Effect of latent MHV-68 on co-infection with A/WSN/33 
Infection of these mice with A/WSN/33 resulted in less severe presentation of clinical signs and 
weight loss progression compared to the BALB/c mice. Significant weight loss occurred at day 
4 with a 5.56±1.83% (p<0.01) decrease, a day later than in the BALB/c counterparts. Weight 
loss increased at day 5 to an average of 11.05±1.41% (p<0.001) and a peak total weight loss of 
14.87±1.59% (p<0.001) was observed in A/WSN/33 infected mice at day 6 post infection 
(Figure 3.21A). Standard deviation was very low within this group and did not reach any higher 
than 2%.  
Clinical signs were slightly different compared with the BALB/c mice. The first sign of 
infection was a hunched stature recorded at day 4 (average score of 1). By day 5 hunching score 
averaged 2 and was coupled with increased respiratory effort and decreased mobility, both 
scored at 1. This combination gave an overall ‘moderate’ severity to this group (Figure 3.21B). 
By the final day, some mice were scored at 3 in the hunched category and varied greatly in 
clinical score for respiratory effort, reduced mobility and increased respiratory effort, unlike the 
BALB/c mice which had previously shown cohesive symptom severity within the same group. 
A final severity score was 9.16, however, this varied from 7-12 from mouse to mouse.  In this 
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Figure 3.21 Effect of MHV-68 latency co-infection on pathogenesis of 5x103 A/WSN/33 (129Sv/Ev) 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza lung titre 
 
Figure 3.21 5-6 week old 129 Sv/Ev female mice were infected I.N. with 5x10
4
 MHV-68 and 28 days later infected 
I.N. with 5x10
3
 A/WSN/33 in 40 μl Dulbecco’s minimum essential medium or medium alone. A. Influenza induced 
weight loss. Error bars represent ±1 standard deviation of the mean. Significance determined by students two-way 
ANOVA (†/*= p<0.05, **/†† = p<0.01, ***/††† = p<0.001). * represents significant difference between A/WSN/33 
infected and uninfected groups. B. Clinical severity was measured by 4 signs. Each was scored on a scale of 0-3 and 
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8.91±1.76% was seen by day 4, increasing to 15.38±0.89% by day 5 and 18.88±1.27% at the 
final time point. Variation from the mean was again very low within this group. A significant 
difference compared with the A/WSN/33 infected group was seen at day 5 and 6 post infection 
(p<0.01). Clinical signs followed the same progression as A/WSN/33 infected mice, however, 
did not appear until day 5 (a day later than singly infected mice) and reached similar average 
severity scores of 6.4 and 7.6 on days 5 and 6 respectively (Figure 3.21B). Clinical signs 
therefore they did not appear to be directly correlated to weight loss in these mice as has been 
seen previously in BALB/c mice. 
Uninfected mice maintained similar weights to that measured on day 0 with an average of 
101.31±1.17% by day 6. Unexpectedly 3/5 mice solely infected with MHV-68 began to increase 
in body weight over the course of the experiment. These mice began to gain weight at day 3 
skewing the average weights in this group up to 108.37±5.03%. This was not coupled with any 
signs of disease and the remaining 2 mice in the cage remained at 102% and 103% by day 6. 
This increase was significant compared with uninfected mice (p>0.01) which is completely 
unanticipated.  
An important consideration for this experiment became apparent after the cull date. During this 
experiment mice were unknowingly housed in abnormal lighting conditions, extending the light 
period beyond the normal biphasic light cycle. This may have contributed to the unexpected 
increase in weight seen in the MHV-68 infected mice although all mice were housed in the same 
conditions. A repeat of this experiment is therefore required to interpret data from all 
experimental groups accurately. 
(A comparison of differences in A/WSN/33 induced weight loss between strains can be seen in 
Appendix 6.1) 
Influenza titre was measured in the lung to determine if the apparent loss of protective 
phenotype in this mouse strain had any bearing on A/WSN/33 viral load. A/WSN/33 infection 
led to very high titres of infectious virus at 6 days post infection. A/WSN/33 singly infected 




in lung homogenate samples. (In comparison to 
BALB/c mice this appears much higher however these measurements are made at day 6 instead 
of day 7. Figure 3.21C). Similar high levels were observed in co-infected mice however once 




) compared with 
singly infected mice but this was not significant. 
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 Pathology in the lung 
The pathology of A/WSN/33 infection was analysed in the 129Sv/Ev strain to determine 
differences from the BALB/c mice of comparable age. 
 Uninfected mice showed no signs of infection or inflammation (Figure 3.22A-B). Latent MHV-
68 infection in these mice caused similar pathology to that seen in the BALB/c strain. Small, 
sporadic foci of lymphocyte accumulations were evident in the interstitial spaces of the lung 
(Figure 3.22C).  
5x10
3
 A/WSN/33 infection in these mice caused similar pathology to the comparable infection 
in the lungs of BALB/c mice however the severity of the pathology was scored much lower and 
there was greater variation within groups (Figure 3.22K). Infiltration of lymphocytes around the 
bronchioles (Figure 3.22D and 3.22F) was scored at an average of 1.38. This was the same for 
peri-vascular inflammation (score of 0.88). Epithelial necrosis was reduced compared with the 
BALB/c mice and alveolar spaces appeared to contain less infiltrating cells than in the other 
mouse strain (Figure 3.22E and 3.22G).  
Co-infected mice were scored on average at a greater level of inflammation for peri-vascular 
and peri-bronchial infiltration of cells (1.6 and 1.6 respectively, Figure 3.22H and I). There was 
also greater variation in this group than was seen in the BALB/c infected mice. Epithelial 
necrosis was scored at a similar level to the singly A/WSN/33 infected mice (0.4 mean average) 
and recruitment of immune cells into the alveolar cells was at a comparably low amount (Figure 
3.22). 
 Cytokine environment in the lung 
A loss of protective phenotype in the co-infected mice of this strain was surprising. As such 
cytokine environment in the lung was measured in these samples to determine if a different 
cytokine response was present in response to any of the infections due to strain differences. 
Lungs were removed and homogenised 6 days post infection with A/WSN/33. As with BALB/c 
mice at a similar time point, TNFα levels were not significantly altered in the lung homogenates 
by either infection, however, base levels of TNFα were much higher in these mice, as seen in 
the mean levels in uninfected mice which averaged at 415.18 pg ml
-1 
(Figure 3.23).  
IFNγ levels were 12.36 pg ml
-1 
in the uninfected mice and 5.70 pg ml
-1
 in the MHV-68 infected 
mice. An increase in IFNγ, to a mean value of 157.70±67.31 pg ml
-1 
(p=0.072) was observed in 
the co-infected mice and an even greater increase to an average of 439.18 pg ml
-1
 (p=0.007, 
Mann-Whitney test) in the A/WSN/33 infected mice. Variation from the mean is large within 
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Figure 3.22 Co-infection with latent MHV-68 does not alter pathology caused by A/WSN/33 
infection in 129Sv/Ev mice 
Uninfected  





 A/WSN/33 infected 





 Normal lung structure 
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K. Pathology score 
 
  
Figure 3.22 The right lung was inflated and fixed with 10% neutral buffered formalin. Lung sections were stained 
for hematoxylin and eosin. Representative sections are shown. Dashed arrows show areas of unaffected airways 
and blood vessels. Solid arrows demonstrate regions of lymphocyte infiltration and inflammation. A-B Lungs from 
uninfected mice. C Lungs from MHV-68 latently infected mice. D-G Lungs from A/WSN/33 infected mice. H-J. Lungs 
from MHV-68 + A/WSN/33 infected mice. Images represent averages from each infection group. Magnification is 
identified in the bottom right corner of each image. K. Complete lung cross-sections were scored for signs of 
inflammation and cell damage, N=6. Representative of 1 experiment. Results are displayed as mean average per 
group ± 1 standard deviation. 
 
Figure 3.23 Co-infection has no significant impact on cytokine environment in WT 129Sv/Ev mice   
A. Lung cytokine environment 
 
Figure 3.23 6 days post A/WSN/33 infection, the left lung was homogenised in Dulbecco’s minimum essential 
medium and the homogenate used for ELISA detection of cytokines TNFα, IFNγ, IL-10 and TGFβ. Results are 
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this group (304.38) and therefore despite the large difference in means the change does not 
reach significance (p=0.055).  
IL-10 was not altered significantly by either infection. This was in contrast to the response in 
BALB/c mice where A/WSN/33 infection caused a robust increase in IL-10 regardless of co-
infection with MHV-68.  As is the case with TNFα, IL-10 was detected at relatively high levels 
compared with BALB/c mice (Figure 2.23). For example the level of IL-10 in uninfected mice 
was on average 610 pg ml
-1
. Similarly TGFβ was unaltered by either infection, however, this 
cytokine was present at much lower amounts than IL-10. Uninfected mice had an average of 
179.94 pg ml
-1 
TGFβ and no other group had significantly more or less than this amount. 
 Effect of A/WSN/33 on co-infection with latent MHV-68 
In the BALB/c mice, A/WSN/33 infection resulted in significantly reduced MHV-68 loads in 
the lung but not the spleen. To determine if this effect still occurred when A/WSN/33 
pathogenesis was exacerbated by co-infection, levels of MHV-68 were measured in lung and 
spleen samples for comparison.  
Whilst copy numbers were detectable at similar amounts in both organs when compared to 
BALB/c mice there was no decrease in MHV-68 viral load in the spleen and (more importantly) 
in the lungs of co-infected 129 Sv/Ev mice (Figure 3.24A and 3.24B). Mean spleen copy 
numbers of MHV-68 were 918 per 100ng DNA in co-infected mice and 287 per 100ng DNA in 
the singly MHV-68 infected mice. Whilst not significant, MHV-68 in the spleen shows an 
increased presence in the co-infected mice. In the lung MHV-68 copy number averaged 220 
copies per 100ng DNA in the co-infected mice and a similar copy number of 120 in the MHV-
68 infected mice. The reduction in MHV-68 viral load was therefore not apparent in this co-
infection.  
3.4.5 Co-infection with latent MHV-68 and 5x103 A/WSN/33 in IFNγR-/- 
129Sv/Ev mice 
In the BALB/c mice, IFNγ expression was decreased in the co-infected mice at all doses of 
A/WSN/33 co-infection. In the 129 Sv/Ev mice, where protection due to co-infection was not 
observed, IFNγ levels still appeared to be regulated by co-infection with MHV-68. To 
determine the effect of the inflammatory cytokine IFNγ and factors induced by IFNγ, female 5-
6 week old 129Sv/Ev mice lacking the IFNγ receptor were infected with 5x10
4 
MHV-68 and 
after 28 days were infected intranasally with 5x10
3
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Figure 3.24 A/WSN/33 infection does not alter MHV-68 viral load in 129Sv/Ev mice  
A. Spleen – Day 6 
 
 
B. Lung – Day 6 
 
Figure 3.24 DNA was extracted from a segment of the spleen and left lobe of the lung. Quantitative PCR for orf 73 in 
the MHV-68 genome was performed on 100 ng of DNA. A. MHV-68 viral load in spleen samples 6 days post 
A/WSN/33 infection (34 days post MHV-68 infection), N=5. B. MHV-68 viral load in the lung at the same time point. 
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 Effect of MHV-68 on co-infection with A/WSN/33 
Weight loss and clinical signs of infection were compared to singly infected and uninfected 
controls. MHV-68 and uninfected controls showed no significant difference in weight 
throughout the time course. Uninfected mice were on average 102.94% of their original weight 
at day 0 by day 6 (Figure 3.25A). MHV-68 infected mice were similarly 100.70% of their 
original weight on day 0 by day 6.  
A/WSN/33 infected IFNγR
-/- 
mice lost more weight than their WT 129Sv/Ev counterparts 
following 5x10
3
 PFU infection (see Appendix 6.1). Significant weight loss appeared at day 3 
post infection (p<0.01) with a reduction of 4.99 ± 3.17%, increasing to 9.73±3.3% on day 4 
(p<0.001), 15.79±2.3% on day 5 (p<0.001) and 20.09±2.68% by day 6 (p<0.001).  
Clinical signs were also evident by day 3 post infection, (Figure 3.25B) with decreased mobility 
scored at an average of 1 for this group. On day 4, mobility was scored at an increased severity 
of 2 on average and is coupled with signs of hunching (0.5 average). On day 5 pointed face was 
identifiable (score of 1 on average), raising the severity score to an average of 4.5 overall. On 
day 6, mice were scored around 3 for decreased mobility, 2 for hunching and 1.5 for pointed 
face, raising the total score to 7 on average which is an overall ‘moderate’ severity. 
Co-infected mice demonstrated a highly attenuated response in the absence of IFNγ. Weight 
loss was not observed as a result of A/WSN/33 until 5 days post infection. An average reduction 
in weight of 3.49±3.42% increased to a total of 8.79±3.4% on day 6 (Figure 3.25A) which was 
the only day that a reduction in weight in the co-infected mice was significantly different to the 
uninfected group (p<0.01). Therefore significant reduction in weight loss, afforded by co-
infection was evident from day 3 to 6 at a confidence level of 99.9%. Clinical signs in these 
mice were also highly reduced. Co-infected mice began to show decreased mobility on day 5 
(average score of 1.5) and reached a total severity score of 4.5 on day 6, (Figure 3.25B), similar 
to that of the A/WSN/33 infected group.   
Influenza replication has thus far been unhindered by co-infection. To verify this in the IFNγR
-/-
 
mice, which had shown the most attenuated phenotype during co-infection, mice were culled at 
day 4 and day 7 post A/WSN/33 infection and lung viral load was calculated by plaque assay 
(Figure 3.25C). At both time points, similar levels of infectious A/WSN/33 were present in the 
lung and there was no significant difference detected between A/WSN/33 and co-infected mice. 
(2-sample Student’s T test on log transformed data). At day 4, singly A/WSN/33 infected mice 









 at day 7. Co-infected mice had a similar average titre of 5.0x10
5
 PFU at day 4 and an 
equally high titre of 6.07x10
5 
PFU in the lung at day 7 post infection. Both time points are  
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Figure 3.25 Effect of latent MHV-68 co-infection on pathogenesis of A/WSN/33 in an IFNγR-/- 
model 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza lung titre 
 
Figure 3.25 5-6 week old 129Sv/Ev IFNγR
-/-
 female mice were infected I.N. with 5x10
4
 MHV-68 and 28 days later 
infected I.N. with 5x10
3
 A/WSN/33.A. Influenza induced weight loss. Error bars represent ±1 standard deviation of 
the mean. Significance determined by students two-way ANOVA (†/*= p<0.05, **/†† = p<0.01, ***/††† = p<0.001). 
* signifies significant difference between A/WSN/33 infected and uninfected groups. † signifies a significant 
difference between co-infected and A/WSN/33 infected mice. B. Clinical severity was measured by 4 signs. Each was 
scored on a scale of 0-3 and the sum reported ±1 standard deviation as clinical severity score, N=12. C. Mean 
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therefore not significantly altered by co-infection however an interesting observation was that 
these titres in the singly A/WSN/33 infected mice were once again reduced compared with the 
129Sv/Ev (more resistant) mice and shared greater similarity with the BALB/c (more 
susceptible) mice.  
 Pathology in the lung 
The pathology in the lung, in the absence of IFNγ was markedly different to that of the WT 
infections. Uninfected mice displayed no significant signs of pathology or disease (Figure 
3.26A-C).  
Latent MHV-68 infection however had a drastic and complex effect in the lungs of IFNγR
-/-
 
mice. Inflammation and infiltration of cells around the large airway vessels was severe and 
widespread throughout each lung cross section. Large areas of lymphocytic infiltration (Figure 
3.26D-F) were coupled with areas of macrophage infiltration (Figure 3.26G-I). These 
macrophage cells were enlarged and contained crystal like structures that have been observed by 
others as alternatively activated macrophages in fibrotic lungs following MHV-68 infection of 
IFNγR-/- mice (Mora, Torres-Gonzalez et al. 2006). Peri-vascular infiltration was scored at 1.5 
and peri-bronchial inflammation was scored at a mean average of 1.75. This is much greater 
than the mild pathology observed in the wild type mice.  
A/WSN/33 infection of these mice lead to similar pathology to that in the wild type mice. Peri-
bronchial and peri-vascular infiltration of lymphocytes was scored at an average of 1.9 and 2.0 
respectively (Figure 3.26V). Variation within this group was also minimal (Figure 3.26 J-L) 
however some areas of inflammation were more severe and more focal than in the wild type 
mice. There was also extensive epithelial necrosis, apoptotic debris and infiltration of 
macrophages in these mice (Figure 3.26N-P). 
Co-infected mice were scored slightly higher than either of the singly infected groups. Peri-
vascular inflammation was 2.17 and peri-bronchial inflammation was 2.00 on average for these 
mice. The severity of the pathology was extensive and areas of lymphocyte infiltration were 
vast within the interstitial spaces (Figure 3.26Q-U). It was difficult to assess the contributions of 
each infection to the extensive pathology, as both single infections caused severe disease in the 
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Figure 3.26 Latent MHV-68 infection causes severe pathology in the lung but is not exacerbated by 
co-infection with A/WSN/33 
Uninfected 
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V. Pathology score 
 
Figure 3.26 The right lung was inflated and fixed with 10% neutral buffered formalin. Lung sections were stained 
for hematoxylin and eosin. Representative sections are shown. A-C Lungs from uninfected mice. D-I Lungs from 
MHV-68 latently infected mice. J-P Lungs from A/WSN/33 infected mice. Q-U Lungs from co-infected mice. Images 
represent averages from each infection group. Magnification is identified in the bottom right corner of each image. 
V. Complete lung cross-sections were scored for signs of inflammation and cell damage, N=6. Representative of 1 
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 Cytokine environment in the lung 
In the absence of IFNγ, the protective effect is enhanced in the co-infected mice. To determine 
if this tempering in response was due to redundancy or overlap with other inflammatory 
cytokines, lung homogenates from IFNγR
-/- 
129 Sv/Ev mice were analysed for TNFα by ELISA 
at 4 and 6 days post infection with 5x10
3 
A/WSN/33. In the absence of IFNγ signalling, TNFα 
levels were not altered in any experimental group measured. At day 4 TNFα was detected at an 
average of 7.58 pg ml
-1 
in the co-infected mice and 8.36 pg ml
-1 
in the A/WSN/33 infected mice 
(Figure 3.27B). At day 7, levels of TNFα were very similar, with co-infected mice expressing an 
average of 9.92 pg ml
-1
 and A/WSN/33 infected mice expressing 7.67 pg ml
-1
. Uninfected and 
MHV-68 infected controls were also measured to ensure that these levels were not increased or 
reduced due to either infection. Both groups expressed very similar levels of TNFα, 4.79pg ml
-1
 
in uninfected mice and 19.72 pg ml
-1
 (larger due to a single outlier) in MHV-68 infected mice.   
IFNβ production in lung homogenates from co-infected and A/WSN/33 infected mice was also 
measured at day 4 during the peak of viral replication. This type 1 inflammatory cytokine was 
not detected at significant levels, however there was a general trend for an increase in IFNβ in 
co-infected mice (24.54 pg ml
-1
) compared with A/WSN/33 singly infected mice (3.21 pg ml
-1
) 
4 days post infection (Figure 3.27A). This difference between these groups was not statistically 
significant. 
 Effect of A/WSN/33 on co-infection with latent MHV-68 
Considering that the protective effect of co-infection is restored in 129 Sv/Ev mice in the 
absence of the IFNγ receptor it was of interest to determine if the reciprocal suppression of 
latent MHV-68 by A/WSN/33 infection in the lung was also evident. 
Lung and spleen DNA was analysed by qPCR for ORF73. As in BALB/c mice but unlike WT 
129 Sv/Ev mice, MHV-68 viral load in the lung appears to decrease 6 days after A/WSN/33 
infection of IFNγR
-/- 
129 Sv/Ev mice (Figure 3.28B). Co-infected mice had on average 39.5 
copies of the MHV-68 genome per 100ng DNA. MHV-68 infected mice however had 155 
copies per 100ng DNA. This decrease is not significant, (p=0.068, Mann-Whitney test) likely 
due to the low number of replicates which could be strengthened with a repeat experiment at the 
same day 6 time point. In the spleen there is no reduction in MHV-68 frequency in the co-
infected mice. Both groups harbour similar levels of MHV-68. Co-infected mice have and 
average of 685 copies whilst singly MHV-68 infected mice have 402 copies per 100ng splenic 
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Figure 3.27 ELISA analysis of lung homogenates in IFNγR
-/- 
129 Sv/Ev mice were performed at day 4 and day 6 post 
infection with 5x10
3 




Figure 3.28 A/WSN/33 infection in IFNγR-/- 129Sv/Ev mice reduces MHV-68 in the lung 
            A. Spleen – Day 6     B. Lung – Day 6 
 
Figure 3.28 DNA was extracted from a segment of the spleen and left lobe of the lung. Quantitative PCR for ORF 73 
in the MHV-68 genome was performed on 100 ng of DNA. A. MHV-68 viral load in spleen samples 6 days post 
A/WSN/33 infection (34 days post MHV-68 infection), N=5. B. MHV-68 viral load in the lung at the same time point. 
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3.4.6 Latent MHV-68 infection  
Co-infection with latent MHV-68 infection causes attenuation to the pathogenesis of 
A/WSN/33. Likewise, infection with A/WSN/33 decreases the viral load of MHV-68 in the 
lungs of co-infected mice. MHV-68 latency has been shown to increase the circulating  
inflammatory cytokines in the blood and subsequently offset the immune response to bacterial 
pathogens (Barton, White et al. 2009). To determine how MHV-68 alters the lung environment 
prior to A/WSN/33 co-infection, latently infected mice were analysed for cytokine production, 
changes to resident macrophages in the lung and alterations to the CD4
+
 cell responses in the 
lung draining lymph nodes.  
The lytic phase of the MHV-68 life cycle is resolved 21 days after infection. The majority of the 
MHV-68 lytic infection is cleared from the lungs after 10 days although some virus persists for 
much longer (Stewart, Usherwood et al. 1998).  
Latency is established in the spleen around 20 days post infection. Splenomegaly, caused by 
acute infection is resolved by 21 days post infection. MHV-68 infection causes no observable 
clinical disease or associated signs in female BALB/c mice during the latent stage of infection. 
MHV-68 infected mice 28 days post-infected are considered to be harbouring a latent MHV-68 
infection. This time point was used in all co-infection experiments as the point of influenza 
infection. Prior to infection with influenza A/WSN/33 mice were weighed. At this age the mice 
were between 18 and 22 g. There was no difference in weight between mice infected with 
MHV-68 for 28 days and uninfected mice of the same age.   
Mice infected for 28 days with MHV-68 were culled and compared with uninfected litter mates. 
 
 Cytokine environment 
The cytokine environment in the lung was not altered due to MHV-68 latency (Figure 3.29A). 
Pro-inflammatory cytokines, IFNγ and TNFα were not different between groups. IFNγ was 
measured at 92.65±19.63 pg ml
-1
 in the MHV-68 infected mice and 88.73±8.61 pg ml
-1
 in the 
lungs of uninfected mice. TNFα was much lower at 8.65±1.42 pg ml
-1
 in MHV-68 infected mice 
and 8.73±1.55 pg ml
-1 
in the uninfected mice.  
Likewise, regulatory cytokines IL-10 and TGFβ were not differentially expressed due to latent 
MHV-68 infection. IL-10 was undetectable in the lungs of both uninfected and MHV-68 
infected mice while TGFβ was expressed at 35.72±20.96 pg ml
-1 
in uninfected and 40.83±12.93 
pg ml
-1 
in MHV-68 infected mice.  
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Figure 3.29 Lung cytokine environment and CD4+ cells in the draining lymph node are not altered 
by latent MHV-68 infection 




 cells in the lung draining lymph nodes 
 
C. Production of cytokines by CD4+ cells in the lung draining lymph nodes 
  
Figure 3.29 Female BALB/c mice were culled 28 days post MHV-68 infection. A. lung homogenates were analysed 
for cytokines by ELISA. Results are mean averages ± 1 standard deviation, N=6. B/C. Cells from the lung draining 
lymph nodes were harvested and 1x10
7
 cells were stained for CD4
+
 and cytokine production. Samples were run on a 
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Further information on the cytokine environment could be determined from the protein array 
discussed later. 
 Lymph nodes 
Mediastinal lymph nodes are also a site of latent MHV-68 infection. To determine if there was 
any effect of MHV-68 latency on responding CD4
+
 T cells in the lung draining lymph node, 
cells of the lymph nodes were analysed by FACS. There was no detectable difference in the 
percentage of CD4
+
 cells in the lymph node or in the production of cytokines by these cells 
when stimulated with PMA and ionomycin (Figure 3.29B). 
Uninfected mice had on average 57.53±8.77 % of CD4
+
 lymphocytes in the mediastinal lymph 
node. 0.5% of these cells produced IFNγ and 18.6% produced TNFα. In the MHV-68 latently 
infected mice 47.88±6.74 % of total lymphocytes were CD4
+
 and within this population 1.0% 
produced IFNγ and 19.13% produced TNFα. IFNγ and TNFα levels were therefore not 
significantly different between MHV-68 and uninfected mice (Figure 3.29B). IL-10 expression 
by CD4
+
 cells could not be detected in either group. Results were not analysed statistically.  
 Macrophages 
Lung cells were retrieved by broncho-alveolar lavage 28 days post MHV-68 infection.  
Adherent cells were lysed and cDNA was made using the maximum RNA available. 
Quantitative PCRs for macrophage polarisation markers were undertaken and normalised 
relative to SDHA, a cellular house-keeping gene. Macrophages in MHV-68 latently infected 
mice did not demonstrate increased M1 associated markers iNOS and TNFα compared with 
uninfected mice. On average iNOS was 73.08 fold more abundant than SDHA in uninfected 
mice and the standard variation within this group was ±67.01 (Figure 3.30D). The reason for the 
large mean average was a single value 188.5 fold the copy number of SDHA detected. Results 
from this same mouse skew the mean within the uninfected group for all markers tested. The 
SDHA level detected in this mouse was particularly low (2 copies in both replicates) and 
therefore all other markers were normalised by a small number which often led to high fold 
change compared with other mice within the same group. Analysis of the raw data gave no 
reason to exclude the sample and therefore it was not excluded. Median was not used as a 
measure of experimental group average due to the low number of animals per group, (n=6). The 
mice infected with MHV-68 for 28 days had an average fold increase of 9.08 iNOS verses the 
SDHA copy number and a smaller standard deviation of 11.2. Therefore despite differences in 
the mean averages, iNOS was not significantly different due to MHV-68 infection (Figure 
3.30D). TNFα levels showed a similar pattern to iNOS (Figure 3.30C). On average there was an  
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Figure 3.30 Adherent cells from broncho-alveolar lavage fluid of mice 28 days post MHV-68 infection were analysed 
for M1 and M2 macrophage markers by QPCR. Results are shown as individual values per copy of the house-keeping 
gene SDHA and means ± 1 standard deviation. N=5, results from a single experiment. Statistical analysis by 2 sample 
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8.08±1.74 and 13.92±9.58 fold more TNFα compared with SDHA copy number in the MHV-68 
infected and uninfected mice respectively (Figure 3.4C). A single outlier was again detected in 
the uninfected group with 32.82 fold more TNFα than SDHA. This is the same problematic 
sample identified in the iNOS group and is evident as an outlier on the graph. The levels of 
TNFα are therefore not different between experimental groups.  
M2 markers CD206, IL-10 and arginase 1 were similar between experimental groups (Figures 
3.30B, 3.30E and 3.30A). CD206 had an average 2.72±1.71 and 2.07±2.03 fold increase 
compared with SDHA in the MHV-68 and uninfected mice respectively. In this instance the 
outlier mouse (6 fold increase versus SDHA) appears to increase the mean average in the 
uninfected group. Overall there is a trend for slightly more CD206 expression in MHV-68 
infected mice than uninfected. This is again not significant. IL-10 levels are low in both 
experimental groups and all samples contained less IL-10 than SDHA, therefore results are 
lower than 1. Mean IL-10 fold change is 0.15±0.18 in the MHV-68 infected and 0.88±1.06. 
Despite the skew due to a single sample, the effect of MHV-68 infection was not significant on 
IL-10 production in adherent cells from the lung. The final M2 marker, arginase 1 was also 
detected at low levels and was expressed below that of SDHA level, 0.03±0.03 for MHV-68 
infected and 0.59±0.89 for uninfected mice. This was not significantly different between groups. 
SOCS1 expression (Figure 3.30F) was significantly (p=0.03) increased in the MHV-68 infected 
mice despite low expression in both experimental groups. Uninfected mice expressed 0.53±0.22 
SOCS1 normalised to SDHA whilst uninfected mice expressed 0.17±0.13; significantly lower. 
A second house-keeping gene expressed at low numbers in macrophages could be used to 
validate this result. The outlier from previous markers is highlighted although it does not seem 
to alter the response for this marker. Latent MHV-68 infection does not alter macrophage 
polarisation makers however SOCS1 is decreased in adherent cells from the lungs in mice 28 
days after MHV-68 infection.  
 Protein array 
During the MHV-68 + 5x10
3
 A/WSN33 co-infection experiments in BALB/c mice (see Figure 
3.17), lungs from each experimental group, 6 days post A/WSN/33 or A/WSN/33 mock 
infection were homogenised and protein arrays were performed. Differences between the MHV-
68 and uninfected groups show the effect of MHV-68 latency on protein levels in the lung and 
provide further evidence of changes to the immune environment in the lung caused by MHV-68 
persistence.  
Latent MHV-68 infection alone resulted in 5 cytokines increasing to significantly higher 
expression levels than the uninfected group. These cytokines may provide examples of 
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responses caused by MHV-68 latent infection that protect and alter the immune response to 
A/WSN/33 co-infection. GM-CSF increased significantly (p<0.05) by 1.68 fold, MIG (CXCL9) 
by 2.24 fold (p=0.014), M-CSF increased by 2.16 times (p<0.05), ICAM-1 by 2.8 fold (p<0.05), 
and RANTES (CCL5) showed the largest significant increase to 5.6 fold the levels seen in 
uninfected mice (P<0.001).  
3.5 Discussion 
3.5.1 Co-infection with latent MHV-68 and ‘low dose’ influenza A/WSN/33 
The influenza viral dose was chosen as 5x10
2 
PFU due to the unknown effect of co-infection, 
albeit the dose used in initial experiments was lower still, (see section 3.4.1). As the latent 
MHV-68 did not significantly alter the lung environment (Figure 3.29A) then subtle changes to 
the progression of influenza infection were more likely detectable in lower dose infections. At 
this initial dose, however, there were no clinical signs and no effect on weight during the time 
course (Figure 3.3A and 3.3B). Simultaneously, although the low dose was sufficient to cause 
cellular infiltration around the airways and blood vessels as well as minor epithelial necrosis, 
(Figure 3.5), it was not evident that pre-existing co-infection with MHV-68 was capable of 
mediating this minor pathological outcome of A/WSN/33 infection. 
The lung cytokine environment at this dose was monitored in lung homogenates 4 and 6 days 
post A/WSN/33 infection by ELISA. Four days post infection IL-1β is raised in the A/WSN/33 
infected groups (Figure 3.6A). IL-1β is an early pro-inflammatory cytokine activated by the 
inflammasome, associated with lung immunopathology and activation of CD4
+
 T cell responses 
to influenza (Schmitz, Kurrer et al. 2005). The co-infection, however, did not alter early 
inflammatory signalling via IL-1β production. (Influenza NS1 can inhibit inflammasome 
cleavage of pro-IL-1β).  
MIP2 (CXCL-2) was significantly increased in co-infected mice compared with uninfected 
mice. However, singly MHV-68 or A/WSN/33 infected mice also show evidence of increases in 
MIP2 but not to a significant level. MIP2 is a chemokine responsible for macrophage and 
neutrophil recruitment to the lung during low dose influenza infection (Wareing, Lyon et al. 
2007), however the histological results from day 6 (Figure 3.4F-H) do not show obvious 
differences in the number of macrophages or neutrophils in the alveolar spaces or co-infected 
mice. While this difference does not appear to alter the influenza response, chemokine 
dysregulation has often been implicated in contributing to bacterial susceptibility and super-
infection post influenza A infection (Zavitz, Bauer et al. 2010) and it is possible that underlying 
infection prior to influenza infection could alter an individual’s susceptibility to super-infection. 
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At day 4, interferons gamma and beta and inflammatory markers IL-2 and TNFα have not 
significantly increased in any group. Regulatory cytokines IL-10 and TGFβ have also not 
altered by either infection at this time point (Figure 3.6). Six days post infection however IFNγ 
and IL-10 levels are increased in all A/WSN/33 infected groups. IFNγ and IL-10 have counter 
regulatory roles in the other’s expression (Ito, Ansari et al. 1999; Hu, Paik et al. 2006) and are 
expected to peak during influenza infection at day 6 (Sun, Madan et al. 2009) thus their 
elevation is consistent with the peak in weight loss and significant inflammation in the lung 
pathology.  
Mean averages in IFNγ levels showed that there was a trend for increased expression in 
A/WSN/33 infected mice compared with co-infected mice and the same was seen in IL-10 
expression, however, this was not significant. In combination with this, the influenza titre at this 
final time point was significantly reduced in the co-infected mice (Figure 3.3C).  
The mean titre of the A/WSN/33 infected group was double that of the co-infected mice 6 days 
post infection. More rapid clearance of the virus would correlate well with increased presence of 
macrophages and inflammatory cells brought into the lung by the increase in chemokines such 
as MIP2 however this was not visible in the histology (discussed earlier) and epithelial necrosis 
was very similar in co-infected and singly A/WSN/33 infected mice suggesting replication of 
the virus was unhindered by the underlying MHV-68 infection. There was therefore no clear 
evidence that chemokine signalling as a result of co-infection can alter the kinetics of influenza 
pathogenesis. 
Spleen MHV-68 DNA load was measured by qPCR every 2 days post infection (Figure 3.7A). 
A/WSN/33 infection had no effect on latency of MHV-68 in the spleen. In the lung at day 6 
there was a general trend for a decrease in the levels of MHV-68 present during co-infection 
(Figure 3.7B). However this would need to be repeated with greater numbers of samples to 
clarify if a subtle decrease in MHV-68 load is due to the latent MHV-68 co-infection.  
3.5.2 Co-infection with latent MHV-68 and 5x102 influenza A/WSN/33 
Heterologous immunity as discussed in the introduction (section 1.4) has been observed in 
human herpesvirus infections. CD8
+
 T cells specific to Epstein Barr virus and human 
cytomegalovirus have been shown to attenuate subsequent unrelated infections such as hepatitis 
B (Sandalova, Laccabue et al. 2010).  
There were no changes in the percentages of total CD8
+
 cells in the lung following A/WSN/33 
co-infection however it is possible that the antigen specificity of these cells is different to that of 
the A/WSN/33 singly infected mice. The CD8
+
 cells in the co-infected mice have, on average, 
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increased levels of IFNγ and TNFα (Figure 3.14C and 3.14D) although this was not statistically 
significant. The increased production of cytokines other than IFNγ by CD8+ T cells is generally 
associated with a switch towards a memory phenotype (Kristensen, Madsen et al. 2004). This 
may suggest a contribution of memory cells specific for the herpes virus within the total 
population of responding cells or simply suggest a subtle change in the kinetics of the T cell 
response to A/WSN/33 due to underlying influence of the co-infection.  
In a co-infection with Trichinella spiralis, CD8
+
 lymphocyte infiltration was reduced when 
compared with influenza infection alone, leading to a more rapid recovery. Although total 
percentages were similar, extending the time course of the co-infection may give greater insight 
into whether alterations to cytokine production and potentially activation state in the CD8
+
 T 
cell population can change the resolution of inflammation.  
The reduced influenza viral titre at this time point (Figure 3.8C) would suggest alteration to the 
kinetics of the infection, however, CD8
+
 T cells, although integral for an acute response are not 
inversely correlated with viral load. Instead macrophage and neutrophil populations seen in the 
lung at early and late phases of the acute infection are more closely related to a reduction in 
influenza titre (Lv, Hua et al. 2014).  Macrophages and neutrophil numbers in the lungs of 
infected and co-infected mice were not noticeably different in the pathology (Figure 3.9).  
The most significant change in the co-infected group is an absence of clinical signs (Figure 
3.8B). A/WSN/33 infected mice show increasing clinical severity from 4 days post infection. 
Co-infected mice begin to show signs of infection at day 5 but signs do not increase over the 
time course. These changes are not reflected in the peak viral titres measured at day 4 which are 
not different in the lung between co-infected and singly A/WSN/33 infected mice. However, a 
decrease is evident at day 7 in co-infected animals. An earlier 24 or 48 hour time point may 
show differences in the initial stages of viral replication however, ultimately both experimental 
groups reach the same peak viral titre (Figure 3.8C). It could be important to understand if the 
initial stages of replication differ between experimental groups in order to determine if the 
decreased viral titre in the co-infected mice at day 7 was a result of increased clearance and 
therefore changes to adaptive immunity or was a result of altered kinetics in viral replication, 
point of infection and the decrease at day 7 is because viral replication occurred faster in the co-
infected mice. 
In human viral challenge experiments, a H3N2 derivative showed a direct association between 
clinical signs and viral shedding in the upper respiratory tract. It is well known that influenza 
will replicate in the nasal tissues of mice (Iida & Bang, 1963) and is predominantly an upper 
respiratory tract infection in humans.  The upper respiratory tract may be an interesting site to 
monitor for changes to influenza titre caused by co-infection, as MHV-68 will also replicate in 
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the nose and salivary glands (Hwang, Wu et al. 2008) and the upper respiratory tract ultimately 
is the initial site of infection through natural transmission.  
Early production of increased IFNγ by CD8
+
 cells and NK cells is usually associated with the 
development of strong TH1 CD4
+
 T cell responses (Teixeira, Fonseca et al. 2005). CD4
+
 T cells 
are vital for polarisation of the immune response, governing CD8
+
 T cells and differentiating B 
cells during viral infection. In the lung they are also producers of cytokines at the site of 
infection and have been shown to harness direct cytolytic function in influenza infection (Brown 
2010). CD4
+
 T cells and their cytokine production were therefore hypothesised to play a pivotal 
role in the protective effect observed during co-infection and may be a potential source of the 
long term production of IFNγ and TNFα seen in latent MHV-68 infection.  
Therefore CD4
+
 T cells were characterised in both the lung and lymph nodes. CD4
+
 T cells do 
not appear to be altered in the lung (Figure 3.13) or the draining lymph nodes (Figure 3.14) in 
the co-infected group compared with the singly A/WSN/33 infected mice. CD4
+
 T cells show a 
predominantly TH1 phenotype with high production of IFNγ, however IL-4 and IL-10 
production is also increased during A/WSN/33 infection. The increase in production of IFNγ by 
CD4
+
 T cells in the lung will contribute to increased levels measured in lung homogenates in 
Figure 3.11. Simultaneously, increased levels of IFNγ are likely responsible for the decrease in 
MHV-68 viral load seen in the lung and not the spleen (Figure 3.12).  
IFNγ actively suppresses the gene 50 promoter, controlling the switch from lytic to latent gene 
expression profiles (Goodwin, Molleston et al. 2010). Interestingly the opposite effect has 
recently been reported in helminth and MHV-68 co-infected mice, where IL-4 production by 
gastro-intestinal nematode infection encourages reactivation from latency (Reese, Wakeman et 
al. 2014). Co-infection therefore affects the prognosis of both pre-existing chronic and acute 
infections. Influenza virus may actively suppress reactivation of the latent MHV-68 or 
alternatively, as persistent MHV-68 virus in the lung is still replicating at low levels, influenza 
infection could cause an increase in IFNγ production and indirectly suppresses replication of the 
persistent virus. It would be interesting to understand the long-term effect following the 
resolution of the A/WSN/33 response and determine if the latent herpesvirus load was 
significantly changed. It would also be of interest to determine if changes to the expression of 
MHV-68 latency and lytic genes occurs in co-infected animals as a result of influenza infection. 
3.5.3 Co-infection with latent MHV-68 and 5x103 influenza A/WSN/33 
Subtle changes in the immune responses due to co-infection were identified more easily at the 
lower dose infections. This is also the case for changes in viral clearance seen at day 6 and 7. 
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Case-fatality statistics during the outbreak of the 1918 pandemic virus, (from which A/WSN/33 
is distantly derived from), demonstrate that there is a direct correlation with ‘infectious dose’ 
and hypercytokinemia. To determine if MHV-68 can still provide the same protective effect 
against a potentially severe ‘high dose’ A/WSN/33 infection another set of experiments was 
performed at 5x10
3
 PFU, (10 fold higher infection).  
As with the lower dose of infection, weight loss was reduced in the co-infected mice. However, 





that observed at the lower dose. As such, significant changes are observed at 4, 5 and 7 days 
post infection but not day 6. The co-infected mice are also subject to a second variable in the 
system due to the two separate viral infections and may therefore differ from one another to a 
greater extent than the individuals in the singly infected group.  
The level of statistical significance is also lower than in the lower dose experiments, suggesting 
that the protective effect afforded by co-infection with MHV-68 is less capable of attenuating 
high doses of influenza and its subsequent pathology. The pattern of clinical signs is similar, 
with clinical effects occurring a day earlier in both groups, (3 days post infection) but increasing 
in severity much more rapidly in the singly A/WSN/33 infected mice than the co-infected mice.  
Herpesviruses employ an arsenal of immune evasion strategies during lytic and latent infection. 
To understand the individual changes to cytokines and chemokines in the inflammatory 
environment, lung homogenates were used in a cytokine array. Cytokine storm associated 
cytokines, TNFα, IL-1β, IL-1α, IFNγ and IL-6 are all significantly reduced at day 6 post 
infection in the co-infected mice compared with singly A/WSN/33 infected mice. IL-6 is of 
particular interest within this panel of cytokines, as it was reported to have close association 
with progression of disease in patients during the 2009 H1N1 pandemic (Yu, Zhang et al. 2011). 
IL-6 is a necessary cytokine in mice however as it promotes neutrophil mediated viral clearance 
and in its absence sub-lethal infection leads to fatality (Dienz, Rud et al. 2012). A delicate 
balance in control of infection is therefore required by this cytokine. IFNγ at this dose is also 
significantly reduced in co-infected mice along with a number of IFNγ inducible cytokines, IL-
12p70, IP-10, MIG and RANTES. This was a trend seen at the lower dose infection but did not 
quite reach significance due to a single result within the co-infected group, (Figure 3.11A). The 
results from the protein arrays are likely more sensitive than the ELISAs performed at other 
time points. 
A TH17 secondary response following influenza vaccination has recently been identified as 
detrimental to influenza prognosis, increasing weight loss and clinical severity in mice (Maroof, 
Yorgensen et al. 2014). Therefore a significant decrease in IL-17 and IL-23 are likely 
contributing factors to the decrease in clinical signs seen in the co-infected mice. In IL-17R 
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knock-out studies, neutrophil mediated immunopathology and weight loss were greatly reduced 
during influenza infection. Both of these were decreased during the latent MHV-68 co-infection 
(Figure 3.17C). These changes occurred without an impact on recruitment of CD8
+
 T cell 
populations. Equal percentages of CD8
+
 T cells were identified in the lung in both singly 
A/WSN/33 infected and co-infected mice, increasing the likelihood that decreased TH17 
responses may be a critical difference in co-infected mice.  IL-17 knock-out mice however can 
exhibit reduced B cell recruitment to the lung during influenza A infection (Wang, Chan et al. 
2011). Consideration of the long term implications of co-infection and experiments to determine 
whether appropriate antibody responses are made to provide protection from re-infection with 
influenza may be required to determine if co-infection reduces secondary immunity due to 
mediated primary responses. 
Type 2 cytokines have a similar pattern of expression, with co-infected mice expressing much 
lower IL-4, IL-5 and IL-13 levels than singly A/WSN/33 infected mice (Figure 3.17C). IFNγ 
production is known to be increased in serum during MHV-68 latency (Barton, White et al. 
2009) however this was not evident in the lungs of BALB/c mice 28 days post infection (Figure 
3.29A). IL-4 has recently been identified as capable of reactivating MHV-68 into a lytic 
replication cycle, (Reese, Wakeman et al. 2014) therefore underlying inflammatory cytokine or 
suppression of type 2 cytokine production in order to maintain MHV-68 latency appears to 
mitigate an increase in the TH2 cytokines during influenza infection. The source of the 
additional IL-4 in the lungs of singly A/WSN/33 infected mice is unknown. CD4
+
 cells in the 
draining lymph nodes appear to have a similar TH1 phenotype in both singly and co-infected 
mice. There is limited description of type 2 cytokine production in influenza A infection, 
however in TLR7
-/- 
mice there is a shift towards TH2 cell phenotype in the lung and production 
of more IgG1 than IgG2a during the adaptive response (Jeisy-Scott, Davis et al. 2011). These 
mice are less resistant to infection despite not showing differences in the influenza titre in the 
lung. This may therefore contribute to the alleviated clinical effects seen in the co-infected mice 
which produce IL-4, IL-5 and IL-13 to similar levels to the uninfected mice.  
In an experiment with transgenic expression of IL-4 in the lung, secondary but not primary 
responses were impacted and viral clearance was delayed (Bot, Holz et al. 2000). It is therefore 
unlikely the type 2 cytokines are fundamentally required for protection from influenza. In the 
absence of CD4
+ 
T cells, however, cytokines signalling via the IL-4Rα can compensate for an 
absence of IL-2 mediated ‘help’ from CD4
+
 T cells required to activate cytotoxic function in 
CD8
+
 T cells (Marsland, Schmitz et al. 2005). The CD4
+
 T cell population is intact in this 
model, however, the influence of type 2 cytokines could hypothetically contribute to the subtle 
variations in CD8
+
 T cells discussed previously at the lower dose infection and later at this dose 
of influenza A infection.  
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Identifying the mechanism by which MHV-68 infection reduces inflammatory cytokine and 
chemokine activation could identify useful therapeutic targets for hypercytokinemia during 
human infection. For example MHV-68 and the human gammaherpesvirus Kaposi’s sarcoma 
associated virus (KSHV) have been shown to down regulate TLR signalling in macrophages 
and abrogate responses to TLR 2,4,7 and 9 stimulants (Bussey, Reimer et al. 2014).  Such 
changes to fundamental innate immunity would certainly impact the production of cytokines 
and chemokines in response to influenza co-infection. These changes are not evident in the 
macrophage profiling seen in Figure 3.30, where macrophages do not appear to be impaired in 
production of iNOS, CD206, Arginase 1 or cytokines IL-10 or TNFα, however, do show 
increased levels of SOCS-1 suggesting a more suppressed phenotype.  
Modification of the immune response during infection may be a realistic approach to treatment, 
as severe influenza only becomes clinically evident days after infection when the virus has 
already reached peak replication and the immune response is underway. A number of strategies 
to target the excessive inflammatory response have been previously discussed here: (D'Elia, 
Harrison et al. 2013). To determine which of the cytokines and chemokines are altered in the 
first 24 hours of co-infection, levels of TLRs and anti-viral surveillance molecules such as 
NOD-like receptors and retinoic acid inducible genes and RIG-I like helicase receptors would 
be useful in order to interpret the results from the later time point and delimitate the initiating 





 cells follow the same pattern of expression as in the 5x10
2
 infection with no 
significant changes between co-infected and A/WSN/33 infected mice in regards to CD4
+
 
responses in the lung and draining lymph nodes. CD8
+ 
cells in the lung produce increased 
percentages of IFNγ and TNFα however are not increased in total percentage. This phenotype is 
associated with memory CD8
+
 responses and TNFα in particular is associated with a contraction 
in the CD8
+
 T cell response, usually observed around day 9 as discussed in the lower dose 
experiment. Co-infection decreases the extent of inflammation and therefore these responses 
may be seen earlier than in the singly infected mice. Future experiments, incorporating markers 
of activation would be useful to conclude how these cells may contribute to the mediated 
immune response. 
3.5.4 Co-infection with latent MHV-68 and 5x103 influenza A/WSN/33 in 
wild type 129 Sv/Ev mice 
Due to the inhibited cytokine and chemokine environment in co-infected mice, it was 
hypothesised that removal of signalling by the highly inflammatory and prototypic TH1 cytokine 
IFNγ would diminish the immunophenotypic skewing and subsequent immune suppression 
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caused by pre-existing MHV-68 infection. In order to test this theory IFNγR
-/- 
mice on a 
129Sv/Ev background were co-infected with 5x10
4 
MHV-68 for 28 days followed by 5x10
3
 
A/WSN/33 for a further 6 days (see 3.4.6). Therefore age matched female WT 129Sv/Ev mice 
were also co-infected to quantify baseline responses in this strain.  
A/WSN/33 infection was less severe in this strain than in the BALB/c mice. Weight loss 
reached a maximum of 14.9% 6 days post infection compared with 21.7% in BALB/c mice at 
the same time point. Differences in severity of infection are attributed to mouse strain genetics, 
absence of Mx genes (Staeheli, Grob et al. 1988) and class I MHC molecules (Taylor, Davey et 
al. 1987). DBA/2J and A/J mice have a more severe inflammatory response and disease severity 
than other strains and are also susceptible to non-attenuated influenza strains (Alberts, 
Srivastava et al. 2010). Similar changes can be seen in human infections, for example the 
recently described IFITM3 alleles that can account for severe attenuation of influenza A 
prognosis (Everitt, Clare et al. 2012). Influenza titre was much higher in the 129Sv/Ev mice 
despite a lower clinical score.  
The pathology in the lungs of the 129Sv/Ev mice was also different to the BALB/c mice. Co-
infected mice appeared to have increased pathology in lungs on average although this was never 
significant (Figure 3.20K). There was no change in the lung due to MHV-68 infection alone, 
aside from the small foci of lymphocyte accumulations seen in the BALB/c infected mice. The 
A/WSN/33 infection was mediated however average lung scores were lower than that seen in 
the BALB/c mice, supporting the resistant phenotype present in the weight loss and clinical 
signs.  
Sixty percent (3/5) of the MHV-68 infected mice unexpectedly gained weight during the 
influenza time course of this experiment. While strain dependent differences in MHV-68 
infection have also been reported, both in lytic (Weinberg, Lutzke et al. 2004) and latent 
infection (Tsai, Hu et al. 2011) it is unlikely that this is responsible for the seemingly unstable 
weight changes in this experiment. After the time course it was discovered that the light cycle 
had been disturbed during the experiment and mice had been subject to longer light periods than 
in a normal cycle. This may account for some of the unusual feeding patterns in these mice and 
therefore other results are interpreted with caution.  
There was no significant difference in weight loss, clinical signs or influenza viral titre between 
co-infected and singly A/WSN/33 infected mice. Similarly MHV-68 viral load was not reduced 
by co-infection in the lung as seen in the BALB/c experiments. Levels of TNFα and IL-10 were 
much higher in these mice but not different between experimental group. Interferon gamma 
production follows the same expression on average as in the BALB/c mice, however, there was 
high variation within the co-infected group and this is therefore not statistically significant. A 
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repeat of this experiment is required to interpret these results accurately but this was not 
possible within the time available. 
3.5.5 Co-infection with latent MHV-68 and 5x103 influenza A/WSN/33 in 
IFNγR-/- 129 Sv/Ev mice 
Interferon gamma and inflammatory mediators up regulated in response to IFNγ signalling were 
elevated in singly A/WSN/33 infected mice compared with co-infected mice. Experiments were 
repeated in the absence of IFNγ to determine if an absence of inflammation due to MHV-68 
infection abrogates the protective effect against influenza A.  
The role of IFNγ in influenza infection is debatable. Influenza actively interferes with IFNγ 
signalling via the JAK/STAT pathway in epithelial cells (Uetani, Hiroi et al. 2008). This is a 
common tactic employed by viruses to avoid host up regulation of interferon stimulated genes 
(ISGs), anti-viral immune molecules and receptors. Such molecules target and limit viral 
replication however viral titres in the WT 129Sv/Ev mice and IFNγR
-/- 
mice are not significantly 
different between any of the A/WSN/33 infected experimental groups, suggesting a limited 
effect of IFNγ on viral replication.  
Weight loss in the A/WSN/33 singly infected mice is significantly increased in the absence of 
IFNγ. This isevident at the onset of clinical signs 3-4 days post influenza infection. IFNγ is not 
only inflammatory but also has a critical reciprocal role in the resolution of inflammation. Mice 
lacking IFNγ demonstrate accelerated autoimmune disease, (Feuerer, Eulenburg et al. 2006) 
including asthma (Teixeira, Fonseca et al. 2005) and IFNγ is required for resolution of listeria 
infection, (Buchmeier and Schreiber 1985) herpes simplex virus, (Milligan and Bernstein 1997) 
chlamydia (Lampe, Wilson et al. 1998) and contraction of CD8
+
 T cell responses to influenza  
as well  as regulating the extent of lung immunopathology (Prabhu, Ho et al. 2013). This 
appears to be evident in the reduced infiltration of cells in co-infected mice from the BALB/c 
experiments where CD8
+
 T cells show an altered phenotype in production of intracellular 
cytokines. 
Interestingly, co-infected mice still show a significant reduction in severity compared with 
singly A/WSN/33 infected mice in the absence of IFNγ. Weight loss is significantly reduced in 
co-infected mice in the absence of IFNγ. Clinical signs are also reduced, although still reach 
moderate severity as in the WT 129 Sv/Ev mice. IFNγ induction by MHV-68 was hypothesised 
to increase anti-viral immune surveillance and therefore reduce the extent of further 
inflammation by A/WSN/33 infection. IFNγ regulates antigen processing, MHC-I is induced as 
a result of both IFNα/β and IFNγ expression however MHC-II expression is solely up regulated 
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by IFNγ signalling (Schroder et al. 2004) and similarly MHC class II transactivator (CIITA), a 
regulator of MHC-II expression (Muhlethaler-Mottet et al. 1998). Therefore it was expected that 
the absence of IFNγ would repeal protection. During other viral infections, removal of the 
IFNγR can even lead to exacerbated disease. Mice lacking the IFNγR are more susceptible to 
infection with vaccinia virus due to ameliorated antigen specific IgG2a responses (Cantin et al. 
1999) and herpes simplex virus in the trigeminal ganglia, where IFNγ usually acts to suppress 
reactivation from latency (Cantin et al. 1995). 
During the co-infection experiments the absence of IFNγ had a significant effect on MHV-68 
latency. Histological analysis showed that MHV-68 infected mice appear to maintain a 
persistent infection that caused severe pathology in the lung. Fibrosis was present as were 
macrophages containing crystal structures associated with chronic lung pathology, Figure 3.26. 
The protective phenotype observed in the absence of IFNγ suggests that either IFNγ is not 
required or there is a redundant pathway compensating for its absence. Similarly MHV-68 viral 
load was again significantly reduced in the lung but not the spleen, suggesting that the 
suppressive effect of influenza co-infection in the lung is still present in the absence of IFNγ. 
The overall viral loads were on average much higher in the spleen but maintain similar levels in 
the lung. This is surprising as the inflammatory response observed in the histology is much 
more severe in these mice than in the WT 129Sv/Ev mice. To account for this, the cytokine 
environment in the lung was measured for TNFα and IFNβ to determine if an absence of IFNγ 
altered the inflammatory pathways in the lung, IFNβ acts through a different receptor and is 
quite distinct from IFNγ however the two pathways have overlapping activation of other 
cytokines and immune responses. The level of IFNβ was increased in the co-infected mice at 
day 4, but not significantly and TNFα was only present at low levels in all groups at days 4 and 
7 post A/WSN/33 infection. The levels of type 2 and TH17 cytokines would be of interest. These 
cytokines show significant mediation by co-infection in the BALB/c mice and may provide a 
mechanism for protection still evident in the absence of IFNγ. 
Influenza virus replicates at tenfold lower levels in the 129Sv/Ev IFNγR
-/-
 mice than in the WT 
129Sv/Ev mice suggesting that IFNγ may even exacerbate the ability of A/WSN/33 to replicate 
in the lung. This is evident in both co-infected and singly A/WSN/33 infected mice which do 
not differ in viral titre.  
3.5.6 Latent MHV-68 infection  
MHV-68 preferentially establishes latent infection in B cells in the spleen (Flano, Husain et al. 
2000). Persistent infection has also been recorded at a high titre in lung epithelial cells (Stewart, 
Usherwood et al. 1998). The effect of MHV-68 latency on immune responses in the lung has 
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not been recorded, however, MHV-68 is known to cause an increase in serum levels of IFNγ 
and TNFα, even during the latent phase of infection (Barton, White et al. 2009). Due to this 
systemic change it was hypothesised that latent MHV-68 infection would alter the immune 
response in the lung to heterologous infection with the acute respiratory virus influenza A.  
Fatality following human influenza A infection is often associated with severe cytokine 
dysregulation and inflammation. To determine the potential impact of latent MHV-68 on 
inflammatory responses in the lung mice were culled 28 days post MHV-68 infection.  
ELISAs on lung homogenates (Figure 3.29A) demonstrated no significant changes in 
inflammatory cytokines IFNγ and TNFα. Similarly there was no increase in regulation by TGFβ 
and IL-10 suggesting that the systemic changes observed by Barton et al 2009 in the serum 
were not significantly altering the lung immune environment directly. Based on observations 
discussed in later experiments, it may be useful in a repeat experiment to measure the amounts 
of these cytokines in broncho-alveolar lavage samples instead of whole lung to see the direct 
influence of MHV-68 infection at the alveolar epithelial cell barrier; the site of influenza A 
infection.  
While day 28 is considered a latent stage of MHV-68 infection, persistent virus in the lung 
epithelial cells is still present and virus is easily detecable in the spleen by quantitative PCR 
(Figure 3.7A). Published data suggest that latency transcripts are detectable to some degree 
throughout infection while gene expression associated with all stages of lytic infection is 
detectable in the spleen (K3, M3, M8 and M9 genes) from 10-16 days post infection and in the 
mediastinal lymph node (K3, M3, M8, M9 and M11 genes) from 2-16 days post infection 
(Rochford, Lutzke et al. 2001). 
Lung draining lymph nodes (including the mediastinal) were taken 28 days post infection and 
examined by FACS to determine if CD4
+
 T cells were still proliferating in response to infection 
(Figure 3.29B and 3.29C). The percentage of CD4
+
 cells was not increased compared with 
uninfected litter mates and cytokine production by these cells was not significantly altered. 
Therefore at the point of influenza A/WSN/33 co-infection, 28 days after intranasal MHV-68 
infection, MHV-68 persists in the lung, (Stewart, Usherwood et al. 1998) is latent in the spleen 
and has no apparent immune response in the lung draining lymph nodes (Figure 3.18 and 
3.29C). Co-infection therefore occurs during latent MHV-68 infection when the immune 
response to lytic MHV-68 replication is cleared. 
Lavage samples from the lungs of MHV-68 infected mice and uninfected mice contain a high 
percentage of macrophages. By incubating lavage samples for 1 hour at 37ºC macrophages and 
other adherent cells can be isolated. These cells were lysed and the expression of markers 
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associated with M1 / M2 macrophage polarisation was measured by qPCR. None of the markers 
utilised were increased or decreased in this adherent population as a result of MHV-68 
infection. SOCS1 (suppressor of cytokine signalling 1) expression was however significantly 
increased in these cells. In influenza A infection, SOCS1 is induced and has been shown to 
regulate IFNβ expression and act as negative feedback regulators in early innate immunity to 
viral infection (Pothlichet, Chignard et al. 2008). Virus induced SOCS1 is produced in a 
cytokine independent manner and binds to STAT1 reducing IFNλ receptor signalling in vivo. 
SOCS-1 forms part of a negative feedback loop douwnstream of cytokine signalling and 
modulate IFNγ action (Alexander et al. 1999). IFNλ has anti-viral function in epithelial cells 
and many overlapping characteristics with the type 1 interferons during influenza infection 
(Mordstein, Kochs et al. 2008). However, reduction of STAT1 in turn induces NFκB expression 
and increases expression of IFNλ (Wei, Wang et al. 2014). This understanding may contribute 
to the protective effect observed following MHV-68 infection if SOCS1 is already at an 
increased level in macrophages and is therefore produced pre-emptive of influenza infection. 
This would also suggest a change to inflammatory signalling that is unrelated to IFNγ and TNFα 
production.  These cytokines were not detected at a higher level in the lung of latent MHV-68 
infected mice and therefore the protective effect observed in the co-infected mice might be a 
result of more subtle changes to the immune cells and epithelial barrier already present in the 




Gareth Hardisty Persistent Litomosoides sigmodontis and influenza A co-infection 129 
Chapter 4 -  Persistent Litomosoides sigmodontis and influenza A co-
infection 
4.1 Introduction 
Infections with persistent filarial helminths are widespread and as such present a common 
background in which co-infection can occur. Lymphatic filariasis poses a significant threat to 
human health. There are three human lymphatic filarial nematodes (roundworms) of the family 
filariodidea; Wuchereria bancrofti, Brugia malayi and Brugia timori.  These parasites can cause 
lymphedema and elephantiasis and are endemic in tropical and subtropical regions of Africa, 
Asia, Central and Southern Americas and many Pacific Isles (Taylor, Hoerauf et al. 2010). 
Filarial infection causes substantial morbidity and mortality through physical debilitation and 
damage to the lymphatic system, kidneys and immune system. Socio-economic problems often 
occur as a result of stigmatisation, loss of income and cost of medical bills contributing to an 
individual’s isolation and poverty (Ramaiah, Das et al. 2000; Babu and Nayak 2003). The 
severity of filariasis can be seen by its high disability adjusted life years (DALY) rating which 
determines the impact of disease on life expectancy and debilitation during the sufferer’s life 
time (Fenwick 2012). With 1.3 billion people at risk, ~120 million people across 83 countries 
already infected and around one third of that number disfigured or incapacitated by the resulting 
disease (WHO, 2014), understanding the immune responses to filarial nematode infection is 
critical to produce novel therapies and reduce morbidity due to infection or subsequent co-
infection. Incidence of infection is subject to increase above current estimations with better 
testing in endemic regions (Gyapong, Kyelem et al. 2002).  
 Filarial nematode life cycles 
Filarial nematodes are transmitted via blood feeding insects, specifically mosquitoes; Anopheles 
in Africa, Culex in the Americas and Aedes mosquitoes in human infections of Pacific and 
Asian regions (CDC, 2014). Microfilaria are ingested into the mosquito proventriculus and 
mesonteron from an infected individual during a blood meal. Upon losing their protective 
sheath they migrate to the thoracic muscles and develop to L3 stage larvae. This takes around 7-
12 days. Upon maturation, the L3 larvae migrate to the hemocoel of the probuscus, where they 
are subsequently transferred back into a susceptible human host as the mosquito takes another 
blood meal (Cross 1996). Transmission requires repeat exposure and risk of infection is 
therefore increased for those living in endemic areas. Transmission efficiency can also vary 
between vector species (de Souza, Koudou et al. 2012). Understanding the natural factors 
 
 
Gareth Hardisty Persistent Litomosoides sigmodontis and influenza A co-infection 130 
limiting transmission within the vector can be used to isolate strategies of treatment and predict 
epidemiology (Chandra 2008).  
- Human filarial nematode infections 
Brugia malayi is an example of a filarial nematode responsible for lymphatic filariasis in 
humans. The life cycle within the human host can be complex. After established infection it 
may still take years to develop symptoms of disease and some will remain entirely 
asymptomatic. L3 larvae migrate from the site of infection to the lymphatics where they 
undergo further developmental stages to adulthood and eventually produce sheathed microfilaria 
(L1) which enter the blood stream and peripheral tissues (CDC, 2014). Impact of infection upon 
the immune system likely differs between symptomatic and asymptomatic individuals and 
microfilaremic and amicrofilaremic infections. 
- Litomosoides sigmodontis  
Litomosoides sigmodontis provides a rodent model of filarial nematode infection. It is capable 
of infecting some inbred laboratory mouse strains to full patency (presence of L1 larvae). 
(Hoffmann, Pfaff et al. 2001) All stages of the L. sigmodontis life cycle may be acquired from 
infected jirds, (Meriones unguiculatus). L3 larvae acquired from infected jirds are 
subcutaneously injected into a murine host to mimic the vector transmission observed in human 
infection. In 3-4 days, migration through the lymphatics to the pleural cavity is observed. 
Within 8 days, L3 have moulted to L4 stage larvae. After 25 days, adult worms are found in the 
pleural cavity and by around 50 days, microfilaria are present in the blood of patently infected 
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mice. The infection model follows similar progression to an asymptomatic human infection. L. 
sigmodontis is also host to the endosymbiotic alpha protobacteria wolbachia (Rickettsiales). 
(Ferri, Bain et al. 2011)  
4.1.1 Strain and sex specificity 
Elimination of the infection varies between mouse strains. BALB/c females show greater 
susceptibility to infection than males of the same strain or C57BL/6 mice. There is greater 
survival of L3 larvae to L4 and adult stages of infection in BALB/c females while C57BL/6 
mice never develop circulating microfilaria and are therefore considered resistant (Graham, 
Taylor et al. 2005). Resistance in C57BL/6 is associated with increased production of CXCL-12 




 lymphocyte recruitment 
to the pleural cavity 30 days post infection (Babayan, Ungeheuer et al. 2003; Bouchery, Denece 
et al. 2012). Migration of worms to the pleural cavity by day 4 post infection, development to 
adulthood and production of IgG1 and IgG2a specific antibody responses are similar in both 
strains, however, 10-30 days post infection production of IL-5 and IL-6 by ex vivo stimulated 
lymphocytes from the draining lymph nodes is greater in C57BL/6 mice (Babayan, Ungeheuer 
et al. 2003). B10D2 and BALB/c mice share the same MHC haplotype H-2
d
 but differ in 
resistance. In resistant female B10D2 mice, worm burden in the initial month following 
infection is comparable with susceptible BALB/c females, however, L. sigmodontis life span is 
half that in BALB/c females and female worms recovered showed greatly decreased fecundity 
and size and were often covered with inflammatory cells including neutrophils and eosinophils 
(Marechal, Le Goff et al. 1996). Genetic variation between these strains may reflect disease and 
outcome of infection seen in human infections. While some individuals manage to mount an 
appropriate immune response and clear a filarial infection or remain asymptomatic, others 
succumb to disease with apparent signs of infection.  
4.2 Co-infection model 
Co-infections with Litomosoides sigmodontis and A/WSN/33 have not been performed before. 
The filarial nematode undergoes multiple stages of development inside the host which results in 
variations in the immune response. As such, 3 time points were chosen for co-infection 
experiments with 5x10
3
 PFU A/WSN/33. The dose of A/WSN/33 was chosen in order to cause 
moderate pathology within the 6 day co-infection time course. L. sigmodontis produces no 
clinical signs in a susceptible female BALB/c model. The following co-infection model was 
therefore produced:  
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A. L4 (immature) Litomosoides sigmodontis + A/WSN/33 co-infection 
 
 
Female 5-6 week old BALB/c mice were sub-cutaneously infected with 25 x L3 L. sigmodontis 
larvae. After 12 days, larvae have developed to L4 immature stage and have migrated via the 
lymphatics to the pleural cavity. Mice were then co-infected with 5x10
3
 A/WSN/33 for 6 days 
and compared with singly infected or uninfected controls.   
B. Adult (pre-patent) Litomosoides sigmodontis + A/WSN/33 co-infection 
 
 
Sub-cutaneously injected L. sigmodontis L3 larvae reach the adult stage of development at ~25 
days post infection in female BALB/c mice. At day 34 post infection mice were co-infected 
with 5x10
3
 A/WSN/33 and compared with singly infected and uninfected controls. 




L. sigmodontis larvae develop to patency at ~50-60 days post L3 infection. At day 68 BALB/c 
mice were infected with 5x10
3
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Upon A/WSN/33 infection, all mice were monitored for clinical signs and weight loss every 24 
hours. Mice were culled 6 days after A/WSN/33 infection. Groups of singly infected and 
uninfected mice were used as controls.  
4.3 Hypothesis 
Filarial nematode infection is associated with increased type 2 and regulatory immune 
responses. These infections are persistent and therefore have an on-going influence on the 
immune system. Mortality in human influenza infection is often associated with an 
overwhelming type 1 inflammatory immune response. It is therefore hypothesised that co-
infection during persistent filarial nematode infection will impact the outcome of acute 
influenza virus infection.  
- Persistent Litomosoides sigmodontis infection impairs the immune response to acute 
infection with influenza virus by suppressing appropriate inflammatory responses 
required to eliminate the infection.   
4.4 Results 
4.4.1 Pathology associated with Litomosoides sigmodontis infection at 
each developmental stage 
The effect of L. sigmodontis on lung pathology has not been reported. Current publications 
focus mainly on the cells recruited to the pleural cavity and those involved in granuloma 
formation on the pleural surface (Attout, Martin et al. 2008). Therefore, we determined the L. 
sigmodontis induced pathology at all 3 developmental stages of infection. 
Understanding the on-going pathological changes in the lung caused solely by L. sigmodontis 
infection allows us to determine how changes to lung integrity can moderate influenza induced 
pathology during co-infection. 
At the immature stage (L4) of infection, (Figure 4.1A-C) solid black arrows depict the 
infiltrating lymphocyte populations that were seen in the sub-pleural spaces. At this stage of 
infection, pathology from L. sigmodontis infection was subtle and focused in small areas around 
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Figure 4.1 Lung pathology caused by Litomosoides sigmodontis infection 
Immature (L4) - 18 days post infection 
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Patent (adult ± mf) – 74 days post infection 
 
Figure 4.1 Lungs from infected mice were fixed, cut and stained with hemoxylin and eosin 6 days post infection. 
Slides were assessed for a number of pathological features of L. sigmodontis infection at each time point of 
infection. (A-C) Immature L4 infection (D-K) Adult pre-patent infection (L-N) Patent adult ± mf infection. Results 
demonstrate typical signs of L. sigmodontis infection and cell types present in the infected lung and mesothelium. 
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At the (pre-patent) adult stage of infection, (Figure 4.1 D-K) L. sigmodontis infection was more 
evident. Lymphocyte infiltrations were more extensive in the mesothelium layer (see Figure  
4.1D and 4.1H).  Polymorphonuclear granulocytes were also identified within these infiltrations 
(the dashed arrows in Figure 4.1G and 4.1K). These mainly consisted of neutrophils but also 
eosinophils. L. sigmodontis at this time point had caused mechanical damage to the 
mesothelium cell layer, particularly around the hilus of the lung where many of the adult worms 
are recovered.  
In the patent (adult ± microfilaria) stage of infection there was similar pathology to that seen at 
earlier time points. In addition, this was now coupled with signs of chronic infection including 
hypertrophic and hyperplasic cells at the pleural surface which extended into exophytic frond-
like structures. These are identified by the hollow arrows in Figure 4.1J and 4.1M. Due to the 
chronic nature of L. sigmodontis infection later stages of infection lead to fibrosis within the 
hyperplasic mesothelium. (Dotted arrow, Figure 4.1M).  
In Figures 4.1J and 4.1L it is evident that the interstitial spaces of the lung were completely 
unaltered by the presence of L. sigmodontis worms. This was evident in all mice infected solely 
with L. sigmodontis and is an important observation for influenza co-infection, as damage from 
this pathogen largely impacts the alveolar epithelial cell surfaces surrounding the airways and 
blood vessels.  
The damage caused by the filarial nematode infection at each developmental stage is varied. 
Each stage is also considered during co-infection in Figures 4.3B, 4.7B and 4.14B.  
4.4.2 Co-infection with immature (L4) Litomosoides sigmodontis and 5x103 
A/WSN/33 
An early time point of L. sigmodontis infection (L4 stage of development) was chosen to 
determine the impact of co-infection before filarial nematode infection has skewed the host 
immune response towards a robust TH2 and regulatory phenotype.  
- Effect of immature (L4) Litomosoides sigmodontis on 5x103 A/WSN/33 co-infection 
Weight loss, clinical signs and influenza virus titre in the lung were measured to determine the 
effect of co-infection on the pathogenesis and outcome of influenza infection.  
Uninfected and L4 infected mice showed no change in weight during the experimental time 
course (Figure 4.2A). The final mean percentage weight changes were 103.32% and 103.03% 
respectively at day 6.  
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Figure 4.2 – Co-infection with immature (L4) Litomosoides sigmodontis has no effect on 
A/WSN/33 pathogenesis 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza lung titre – Day 6 
 
Figure 4.2 5-6 week old female BALB/c mice were infected S.C. with 25 x Litomosoides sigmodontis L3 larvae and 12 
days later infected I.N. with 5x10
3
 A/WSN/33 in 40 μl Dulbecco’s minimum essential medium or medium alone. A. 
Weight loss post A/WSN/33 infection.  Weight loss is calculated as percentage of weight at day 0 prior to infection. 
Mean weight loss is shown ± 1 standard deviation, N=6. B. Clinical severity was measured by 4 signs. Each was 
scored on a scale of 0-3 and the average sum reported ±1 standard deviation as clinical severity score, N=6. C. Left 
lung homogenate was measured by dilution series plaque assay on MDCK cells for levels of infectious virus. 
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The A/WSN/33 infected mice began to show clinical signs of infection at day 4 (Figure 4.2B). 
All mice in the singly infected group were scored 1 for decreased mobility. This increased to an 
average score of 2 by day 5 and was coupled with staring coat, increased respiratory effort and 
hunched stature all scored at an average close to 1. Multiple signs therefore meant that these 
mice were scored at a moderate severity with an average severity score of 5.17±1.42. This 
increased further at day 6 to 10.00±1.41 and all mice were scored between 2 and 3 for all signs 
of severity measured. This response was reflected in the weight loss. Weight loss in the 
A/WSN/33 singly infected mice was apparent by day 4 with a mean average decrease of 
5.95±4.19% (Figure 4.2A). The variation in this group was a result of a single outlying mouse 
(N=12) with 14.46% weight loss at this time point. At day 5 the mean weight loss was 
10.27±4.2% and this was increased to a final average of 16.34±3.90% by day 6.  
Co-infected mice showed moderately reduced clinical signs from A/WSN/33 infection. Clinical 
signs became apparent at day 5 with a mild decrease in mobility (average score of 1). On day 6 
clinical effects were increased. All mice in this group were scored at 2 for decreased mobility, 
increased respiratory effort, hunched stature and staring coat. Therefore, the final severity score 
was ‘moderate’ for this group at day 6. The mean severity score was 8.0±0.0.  Mean weight loss 
was slightly reduced in co-infected mice compared with singly A/WSN/33 infected mice. This 
was most notable at 5 days post infection. The mean weight of these mice was subtly decreased 
by an average of 2.73±2.56% on day 4 and this increased to 4.44±2.2% on day 5, (much lower 
than the 10.27% average decrease in the A/WSN/33 infected group). By day 6 however, weight 
loss increased more drastically to a mean average of 13.47±2.48% which is more consistent with 
the singly A/WSN/33 infected mice. The difference in weight loss between groups at day 5 was 
not significant (p>0.05) when measured by 2 way ANOVA.   
There was no effect of co-infection with L4 L. sigmodontis on the replication of A/WSN/33 
detected in the left lobe of the lung by plaque assay on MDCK cells (Figure 4.2C).  Viral load in 









singly A/WSN/33 infected animals. The standard deviation for each group was almost identical, 
±10,800 and ±11,700 PFU respectively.   
- Pathology in the lung 
As the outcome of the influenza infection and viral replication appear to be unaltered by co-
infection at this stage of L. sigmodontis co-infection, the underlying lung pathology was scored 
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As described in section 4.3, L. sigmodontis infection is associated with lung pathology at the 
mesothelium. Infection with immature L4 larvae has a subtle pathology on the lung. At this 
stage the L4 larvae are located in the pleural cavity. Mild infiltration of inflammatory cells, 
including lymphocytes, neutrophils and multi-nucleated giant cells (MNGC) are observed in the 
sub pleural layer of the lung (Figure 4.1A-C). Hyperplasia is also evident in the broncho-
alveolar associated lymphoid (BALT) tissues.   
To determine if influenza infection could alter L. sigmodontis induced pathology in the 
mesothelium, these pathologies were scored in each experimental group to determine the impact 
of co-infection.  
BALT hyperplasia was consistent between all groups with mean average scores of ~0.7-1 for all 
groups (Figure 4.3B). Infiltration of cells into the sub pleural space varied slightly between 
infections. Neutrophils were only present in the L. sigmodontis infected mice (mean score of 
0.17) and co-infected mice (mean score of 0.33), however, there was no significant difference 
between the two groups and not all mice in each group demonstrated neutrophil infiltrations in 
the sub pleural space.  
Lymphocyte infiltrations in these groups were also scored at a similar level, 0.5 and 0.5 mean 
averages for co-infected and L. sigmodontis groups respectively. A/WSN/33 infected mice had 
an average score of 0.4 whilst uninfected mice showed zero lymphocyte infiltration. This was 
the same for BALT hyperplasia which was present at minimal levels (~0.5) in all infected 
groups.  
Sub-pleural infiltration of MNGC was minimal at this time point and only present in a single 
A/WSN/33 infected mouse (see Figure 4.3B). A/WSN/33 therefore has no significant impact on 
the pathology caused by L. sigmodontis during the 6 day co-infection.  
Influenza infection causes distinct pathology 6 days post infection. This includes epithelial cell 
and interstitial necrosis, inflammation and infiltration of cells around airways and blood vessels. 
To determine the effect of presiding L.  sigmodontis infection on influenza induced pathology 
these effects were scored and compared between experimental groups. 
Interstitial pathology was scored at similar levels in co-infected and A/WSN/33 infected mice. 
A/WSN/33 singly infected animals had a mean score of 2.10 for interstitial inflammation and 
co-infected mice were scored at 2.17. Interstitial necrosis was scored at 1.5 and 1.4 on average 
in the A/WSN/33 infected and co-infected mice respectively. There were no signs of interstitial 
pathology in L. sigmodontis infected and uninfected mice (As discussed in section 4.3). 
Epithelial necrosis around the airways was also absent in the L. sigmodontis and uninfected  
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Figure 4.3 Co-infection with immature (L4) Litomosoides sigmodontis does not alter pathology 
caused by A/WSN/33
 
Figure 4.3 The left lobes of lungs from co-infected, singly infected and uninfected mice were harvested, fixed, cut 
into sections and stained by hematoxylin and eosin 6 days post infection with A/WSN/33.  A. The extent of lung 
damage was assessed as 0%, 25%, 50%, 75% or 100% per lung. B. Pathology and infiltration of immune cells was 
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scored on a scale from 0-3 for each lung. All results are presented as mean average for each group. N=6. Error bars 
are not displayed due to the ranked nature of the data. 
mice. In A/WSN/33 infected mice the mean score was 2.0 and co-infected mice showed similar 
pathology, scored at 1.8 on average (see Figure 4.3B).  
 Infiltration of cells around the airways and blood vessels were scored at 1.83 and 1.83 in the 
co-infected mice. This was very similar to the A/WSN/33 singly infected group, which averaged 
1.70 and 1.70 for these pathologies.  Scores for all influenza-associated pathologies were 
therefore generally very consistent within the A/WSN/33 infected and co-infected mice.  
The extent of pathology was also similar between co-infected and A/WSN/33 infected 
experimental groups with a mean average of 45-50% damage to the right lung of each mouse in 
both groups when histologically scored (see Figure 4.3A). 
- Cytokine environment 
While the pathology of influenza infection was unchanged by co-infection, L. sigmodontis was 
in the early stages of infection at the point of co-infection and therefore it was of interest to 
determine if the overall cytokine environment in the lung had already been altered by this stage 
of infection. It was also of importance to determine if such a change could impact the immune 
environment following influenza infection.  
The left lobe of each lung was homogenised and levels of inflammatory cytokines, TNFα and 
IFNγ along with regulatory cytokines, IL-10 and TGFβ were measured by ELISA (Figure 
4.4A).  Due to the high polarisation in cytokine levels between experimental groups, a standard 
curve of known concentration could not be used accurately at both low and high concentrations 
and therefore all cytokines were normalised to the levels found in the uninfected control group, 
and reported as fold change.   
TNFα and TGFβ levels were not significantly altered by either infection, when measured in the 
total lung homogenate. TNFα was detected at 0.81±0.17 and TGFβ was detected at 0.73±1.06 
fold differences (on average) in the A/WSN/33 infected group compared with the uninfected 
mice. Similarly, co-infected mice had 0.80±0.16 and 0.70±0.12 fold variations for these two 
cytokines. L. sigmodontis infection led to fold changes of 1.05±0.27 and 1.05±0.39 for TNFα 
and TGFβ respectively. 
The regulatory cytokine IL-10 was significantly increased in mice co-infected with L4 larvae 
and A/WSN/33, (p<0.001 general linear model). There was a 1.73 fold increase on average 
compared with the uninfected group.  Individual infections did not significantly increase the 
levels of IL-10. L. sigmodontis and A/WSN/33 infections had 0.94 and 0.97 times the amount of 
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IL-10 in uninfected mice respectively. Variation within these groups was also minimal (~0.2 in 
both cases), see Figure 4.4A.  
 
 
Figure 4.4 IL-10 level is increased in mice co-infected with immature (L4) Litomosoides 
sigmodontis and A/WSN/33 
A. Lung homogenate 
 
Figure 4.4 A. 6 days post A/WSN/33 infection, the left lung was homogenised in Dulbecco’s minimum essential 
medium. ELISA was used for detection of cytokines. Each group is represented as mean average fold change ± 1 
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IFNγ was increased in singly A/WSN/33 infected mice as expected however co-infected mice 
had on average a 1.16±0.11 fold IFNγ compared with the uninfected group. A/WSN/33 singly 
infected mice were 1.45±0.34 fold higher. This increase was not significant due to variation in 
the uninfected mice. L. sigmodontis infected mice were similar to the A/WSN/33 infected group 
with a surprising increase of 1.39±0.23 fold IFNγ.  
- T cell responses in the lung and lung draining lymph nodes  
The cytokine environment within the whole lung and pathology within the interstitial spaces and 
airways within the lung were predominantly modulated by the influenza infection. Pathology in 
the pleural cavity was solely due to L. sigmodontis infection. The immune response to L. 
sigmodontis and A/WSN/33 infections however will both require T cells to traffic to the lung 
and pleural cavity draining lymph nodes. As such it was hypothesised that changes to adaptive 
T cell responses to both infections may occur in the lymph nodes during co-infection.  
Six days after A/WSN/33 infection, cells from the thoracic and lung draining lymph nodes were 




 T cell 
counts were not significantly changed by either infection (Figures 4.5A and 4.5B). CD4
+
 T cells 
were detected at a higher overall level in all infected groups with mean averages of 
31.18±4.27% reported in the co-infected mice, 27.38±2.91% in the A/WSN/33 singly infected 
mice, 31.28±5.34% in the L. sigmodontis infected mice and 16.29±12.34% on average in the 
uninfected group. 




T cells to produce the inflammatory 
cytokine IFNγ at significantly higher levels than in uninfected and L. sigmodontis infected 
counterparts (p<0.001 calculated by general linear model).  
IFNγ was produced by 7.59±1.40% of CD8
+
 cells in the co-infected mice and 9.39±1.33% in the 
A/WSN/33 infected mice (Figure 4.5D). This was greater than the mean average amount of 
IFNγ produced in the uninfected (1.55±0.09%) and L. sigmodontis infected (2.47±0.75%) 
groups.  
IFNγ was produced by 2.32±0.31% of CD4
+
 cells in the co-infected mice and 3.04±0.88% in the 
A/WSN/33 infected mice (Figure 4.5C). This was greater than the mean average amount of 
IFNγ produced in uninfected (0.43±0.14%) and L. sigmodontis infected (0.55±0.06%) groups, 
however, was not significantly different between co-infected and A/WSN/33 infected mice, 
despite a subtle trend for a greater increase in the singly infected group.   





 (6.05±0.14%) cells, (Figures 4.5E and 4.5F). A/WSN/33 infected 
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Figure 4.5 Co-infection with immature (L4) Litmosoides sigmodontis has a subtle impact on T 




























































































































































Figure 4.5 Mice were culled 6 days post A/WSN/33 infection. Lung draining and thoracic lymph nodes were 
harvested. 1x10
7




 T cell markers. Samples were run on a BD LSR II Fortessa. 
Results are displayed as percentages (scatter plot) and mean per group ± 1 standard deviation (whisker plot). N=6, 
Uninfected N=3. Statistics calculated on 2 independent experiments, (*=p<0.05, **=p<0.01, ***=p<0.001 general 
linear model). A. CD4
+













































































Gareth Hardisty Persistent Litomosoides sigmodontis and influenza A co-infection 146 
mice had 6.21±2.15% CD4
+
 TNFα+ cells and 2.01±1.21% of CD8+ cells producing TNFα while 
L. sigmodontis had similar TNFα production of 5.68±0.88% and 1.85±0.37% in the CD4 and 
CD8 populations correspondingly. Co-infected mice produced the least TNFα in both cell types. 
Co-infected mice were 3.23±0.37% positive for TNFα in the CD4 population and 1.01±0.43% 
in the CD8 population. These results were unexpected. TNFα was not expected to increase in 
the uninfected mice. 
IL-4 and IL-5 cytokines were produced in very low numbers of CD4
+
 T cells in all groups, with 
no notable differences in expression. Uninfected mice however had unusually increased 
production of IL-4 and IL-5 (10.65±9.05% and 11.00±9.26% correspondingly).  
Although these results were highly variable, the absolute cell numbers recovered were high and 
therefore the results could not be discounted (Figures 4.5G and 4.5H). IL-4 and IL-5 production 
in other groups were more cohesive, with the L. sigmodontis infected group producing 
3.81±2.33% IL-4 and 2.54±2.18% IL-5, A/WSN/33 infected mice producing  2.97±2.77% and 
3.07±2.33% and co-infected mice producing 2.95±1.86% and 1.45±1.88% respectively. 
IL-10 production was minimal in all groups, with expression undetectable in some individuals. 
These results are therefore not presented. 
- Litomosoides sigmodontis L4 worm burden 
Pre-existing L4 stage L. sigmodontis infection did not appear to alter influenza pathogenesis or 
replication. To determine if influenza co-infection alters the course of L. sigmodontis infection, 
the number of worms that could be recovered from the pleural cavity was measured in the co-
infected and singly infected groups. The number of L4 worms recovered from the pleural cavity 
at the L4 developmental stage are recorded in Table 4.1 
The number of L4 worms recovered from the pleural cavity of mice infected with L. 
sigmodontis was not altered by the presence of a 6 day co-infection with 5x10
3
 A/WSN/33.  
At the L4 stage, the male to female ratio of L. sigmodontis larvae is undeterminable and 
therefore total numbers are reported (Table 4.1, end column). Singly L. sigmodontis infected 
mice had a mean worm burden 3.16 and ranged from 0-6. The single mouse with 0 recovered 
worms had no distinct characteristics compared with others within the group, perhaps 
suggesting recent clearance of the L. sigmodontis infection as opposed to an unsuccessful 
infection or early clearance at the site of infection in the skin.  Co-infected mice had a mean 
average of 5.16 and ranged from 1 and 9. There is therefore no significant difference between 
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4.4.3 Co-infection with pre-patent (adult) Litomosoides sigmodontis and 
5x103 A/WSN/33 
At this developmental stage of L. sigmodontis infection, the now adult larvae have a more 
significant impact on lung integrity (Figure 4.1D-K). The underlying infection also skews the 
local immune response towards a type 2 and regulatory phenotype. Co-infection at this time 
point was therefore used to determine the outcome of influenza infection in a host with an on-
going type 2 polarised immune response. 
- Effect of adult (pre-patent) Litomosoides sigmodontis infection on A/WSN/33 co-
infection.  
Weight loss, clinical scoring and influenza titre were once again used to determine the overall 
change in outcome of influenza infection caused by the underlying L. sigmodontis co-infection. 
A/WSN/33 induced weight loss was evident in singly infected mice at day 3 with a mean 
reduction in weight of 7.2±1.97% (Figure 4.6A). This increases to 8.8±2.5% by day 4 and 
further to 10.66±2.61% by day 5. Weight loss progressed to a mean average of 15.46±3.13% by 
day 6 post infection. This is identical to the weight loss seen in the younger mice infected at the 
earlier L. sigmodontis time point (see Figure 4.2A). All mice in the A/WSN/33 singly infected 
group displayed decreased mobility at day 3, with a mean score of 1.17 (Figure 4.6B). At day 4, 
decreased mobility was scored the same however mice in this group were also showing 
increased respiratory effort, mild staring coat and hunching (both scored at a mean of 1) 
resulting in a mean overall clinical score for this group of 3.5, placing them in the ‘moderate’ 
Mouse Day L.sigmodontis A/WSN/33 Male Female Total 
       3392 18 + + 
  
1 
3393 18 + + 
  
0 
3394 18 + + 
  
4 
3395 18 + + 
  
6 
3396 18 + + 
  
2 
3397 18 + + 
  
6 
       3398 18 + - 
  
1 
3399 18 + - 
  
8 
3400 18 + - 
  
9 
3401 18 + - 
  
2 
3402 18 + - 
  
7 
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Figure 4.6 Co-infection with pre-patent (Adult) Litomosoides sigmodontis has a protective effect 
against A/WSN/33 pathogenesis 
A. Weight loss 
 
B. Clinical severity score
 
C. Influenza lung titre – Day 6  
 
Figure 4.6 A. Weight loss post A/WSN/33 infection.  Results displayed as percentage of weight at day 0 prior to 
infection. Mean weight loss is shown ± 1 standard deviation, N=6, representative of 2 experiments. Significance 
determined by general linear model (*/† = p<0.05, **/†† = p<0.01 ***/††† = p<0.001). * denotes significance of 
A/WSN/33 vs. uninfected. † denotes significance between co-infected and A/WSN/33 infected groups. B. Clinical 
severity was measured by 4 signs, each was scored on a scale of 0-3 and the average sum reported ±1 standard 
deviation as clinical severity score, N=12, 2 experimental repeats. C. Left lung homogenate was measured by 
dilution series plaque assay on MDCK cells for levels of infectious virus. Individual values are plotted as PFU per ml 
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severity category. This moderate phenotype continued to day 5 and then increased in severity on 
day 6 when each mouse in the group was scored at ~2 in all categories, increasing the severity 
score to an overall average of 8.  
Co-infected mice show significantly less weight loss than singly infected mice (Figure 4.6A). A 
significant decrease in weight was only seen from day 5, when a mean decrease in weight of 
4.43±3.58% was recorded. At day 6 this mean value was increased rapidly to 12.75±2.55% 
mean average weight loss. When compared with A/WSN/33 mice, a significant difference was 
detected at days 3, 4 and 5 (p<0.05 by general linear model) post infection.  
This effect was also seen in the clinical severity of co-infected mice (Figure 4.6B).  Clinical 
signs of infection did not appear until day 4, a day later than A/WSN/33 infected controls. Half 
of the co-infected mice at day 4 were showing mild signs of increased respiratory effort (scored 
at 0.67) but this was not coupled with decreased mobility and hunching until day 5 when all 
mice began to show signs of infection. Mean overall severity score on day 5 was 3.17 which 
was a similar severity level to the A/WSN/33 infected group. Similarly at day 6 the severity 
score increased to 7.5 on average. All mice showed signs of increased respiratory effort, 
decreased mobility, hunching and staring coat, which were all scored individually at ~2.  
Uninfected and L. sigmodontis infected mice did not show clinical signs and did not undergo 
any weight loss. At day 6 post infection the uninfected mice were 103.88% of their original 
weight and L. sigmodontis infected mice were on average 101.78% of their original weight at 
the point of mock influenza infection.  
Influenza virus titre was measured in the lungs of infected mice at day 6 (Figure 4.6C). Co-
infected and singly A/WSN/33 infected mice had near identical viral loads in the lung. Co-









. Variation from the mean was also very similar within the two groups 
(10,700 PFU and 11,300 PFU respectively).   
 Pathology  
At this stage, co-infection can alter the outcome of influenza infection. To determine if co-
infection can also alleviate influenza induced pathology, the lungs were investigated for 
histological changes. 
Infection with adult worms showed similar pathology in the lung to the immature L4 infection 
(see Figure 4.1 D-K). The adult worms remain located in the pleural cavity, however are now 
much larger after undergoing a moulting stage (from L4 to adult). A/WSN/33 had no significant 
impact on the pathology caused by L. sigmodontis during the 6 day co-infection. 
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Figure 4.7 Co-infection with pre-patent (Adult) Litomosoides sigmodontis does not alter 
pathology caused by A/WSN/33
 
Figure 4.7 The left lobes of lungs from co-infected, singly infected and uninfected mice were harvested, fixed, cut 
into sections and stained by hematoxylin and eosin 6 days post infection with A/WSN/33.  A. The extent of lung 
damage was assessed as 0%, 25%, 50%, 75% or 100% per lung. B. Pathology and infiltration of immune cells was 
scored on a scale from 0-3 for each lung. All results are presented as mean average for each group. N=6. Error bars 
are not displayed due to the ranked nature of the data. 
















































B. Pathological scoring 
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Infiltration of inflammatory cells into the sub pleural layer was evident in all infected mice 
(Figure 4.7B). At this time point neutrophil infiltration was not evident in any group, however, 
lymphocytes were at similar levels (0.50, 0.40, 0.17 and 0.25 in the co-infected, L. sigmodontis 
infected, A/WSN/33 infected and uninfected).  Similarly hypertrophic mesothelium was not 
specific to L. sigmodontis infected groups with all groups averaging a score of 1 for this 
pathology.  
BALT hyperplasia was evident at a greater level in A/WSN/33 mice than any other group at this 
time point. A/WSN/33 infected mice were scored at 0.67 on average. Co-infected mice were 
scored at 0.25 but this pathology was not present in the uninfected and L. sigmodontis infected 
mice.  The most notable difference at this time point was the increased presence of exophytic 
frond-like structures extending into the pleural space in mice infected with L. sigmodontis. Co-
infection had little effect on this pathology with both L. sigmodontis groups scored at ~1.6 on 
average. These structures were seen in particular at the hilum of each lung in mice infected with 
the adult nematodes.   
Influenza pathology was also unaffected by co-infection (Figure 4.7B). Levels of influenza 
induced pathology were similar to that seen in the younger mice (see Figure 4.3B) for both 
A/WSN/33 infected groups. Interstitial necrosis was scored at 1.75 in the co-infected and 1.83 
on average in the A/WSN/33 singly infected mice. Similar levels of cell inflammation were also 
recorded, with both groups scoring a mean average of 2 (Figure 4.6B). Peri-bronchial and peri-
vascular inflammation were also recorded at similar levels in the singly A/WSN/33 infected and 
co-infected mice. Both groups scored an average of 1.83 for both peri-vascular and peri-
bronchial inflammation and the variation within each group was minimal (all mice were scored 
1.5 or 2 for this pathology). Both peri-bronchial (0.2) and peri-vascular inflammation (0.3) are 
now more evident in the L. sigmodontis infected group than was recorded at the previous time 
point. These pathologies are not present in the uninfected mice. Epithelial necrosis was similar 
between A/WSN/33 infected and co-infected mice with recorded scores of 1.75 and 1.83 
respectively. 
The extent of influenza induced pathology was also similar to the previous time point (see 
Figure 4.3A) with a mean average of 45-50% damage to the right lung of each mouse 
histologically scored (Figure 4.7A).  
 Lung cytokine environment  
While pathogenesis of influenza infection was less aggressive in co-infected mice, the 
pathology in the lung is compartmentalised and one infection does not appear impact the site of 
infection of the other pathogen. To determine if this is also true for the overall immune 
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responses to each infection, the inflammatory and regulatory cytokine environment was 
assayed.   
The inflammatory environment in the lung was measured by ELISA in two samples from each 
mouse at this time point. There were no cytokines in the lung homogenate found to show 
statistically significant differences between experimental groups (Figure 4.8A) when compared 
with the co-infected mice. IFNγ, a pro-inflammatory cytokine is increased by A/WSN/33 
infection (1.90±1.08 fold) and is increased to a lesser (but not significantly lower) degree in the 
homogenate of co-infected mice (1.34±0.67 fold). L. sigmodontis infected mice were measured 
at a 0.62±0.40 fold reduction in IFNγ level.  
TNFα, IL-10 and TGFβ were all unaltered by any infection (Figure 4.8A) in the lung 
homogenates. TNFα was present at 0.98±0.21, 0.96±0.33 and 1.22±0.51 fold concentrations in 
the co-infected, L. sigmodontis infected and A/WSN/33 infected groups respectively when 
compared with the uninfected mice. Levels of IL-10 were 1.23±0.37, 1.09±0.54 and 1.25±0.48 
times that of the uninfected mice and TGFβ levels were 0.93±0.25, 0.87±0.35 and 0.84±0.42 
that of the uninfected mice for the co-infected, L. sigmodontis infected and A/WSN/33 infected 
experimental groups.  
IFNγ was detectable at ~50 fold greater concentrations in all A/WSN/33 infected mice in the 
BALF samples compared with uninfected mice (Figure 4.8B). Co-infected mice had 41.9±11.6 
fold greater IFNγ and A/WSN/33 infected mice had 49.7±13.0 fold greater than the uninfected 
mice. These two groups are not significantly different from one another. L. sigmodontis 
infection did not elevate the levels of IFNγ.  
A coinciding increase in IL-10 (33.6±8.0 fold) was also evident in A/WSN/33 infected mice. 
Co-infection IL-10 levels were 26.3±12.4 fold higher than uninfected mice. Again L. 
sigmodontis infection did not appear to significantly increase the levels of IL-10 present, 
however, a single mouse within this group did show a 7 fold increase in IL-10; increasing the 
standard deviation. This data follows a bimodal distribution and cannot be normalised, therefore 
experimental groups were examined by Kruskal-Wallis non-parametric test for IFNγ and IL-10. 
Significance was identified at p<0.001 for both cytokines. Based on the average rank scores and 
z values for each experimental group, L. sigmodontis infected, uninfected, co-infected and 
A/WSN/33 infected groups were individually compared by Mann-Witney test to determine if 
co-infected differed from singly A/WSN/33 infected and whether L. sigmodontis has a 
significant effect on IFNγ or IL-10 compared with uninfected mice.  These tests showed there 
were no significant differences between the groups. The increase in IL-10 and IFNγ, however, 
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Figure 4.8 Cytokine environment is not significantly altered in mice co-infected with pre-patent 
(Adult) Litomosoides sigmodontis and A/WSN/33 
A. Lung homogenate 
 
B. Broncho-alveolar lavage fluid 
 
Figure 4.8 A. 6 days post A/WSN/33 infection, the left lung was homogenised in Dulbecco’s minimum essential 
medium and the homogenate used for ELISA detection of cytokines. Representative of 2 independent experiments. 
N=12. B. Lungs were lavaged with 2mls HBSS + 3mM EDTA, cells were removed and the broncho-alveolar lavage 
fluid (BALF) used to detect cytokines in the interstitial/alveolar environment. Single experiment, N=6.  Each group is 
represented as mean average fold change ± 1 standard deviation compared to the mean level of expression in the 
uninfected group. Statistics were performed by general linear model. Groups that do not share the same letter are 
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had a very strong positive Pearson’s correlation co-efficient of 0.884 (when all samples were 
aligned).  
TNFα and TGFβ were moderately increased in all infected experimental groups (Figure 4.8B). 
A/WSN/33 infected mice had a 5.7±2.7 mean fold increase in TNFα and 3.9±1.5 fold increase 
in TGFβ. Co-infected mice had a 4.8±2.2 fold increase in TNFα and 3.8±1.5 fold increase in 
TGFβ. L sigmodontis infected mice had a 4.0±0.8 fold increase in TNFα and 3.7±1.1 fold 
increase in TGFβ. TNFα and TGF-β were highly correlated in the BALF samples, (0.846 
Pearson correlation on all samples). These cytokines were significantly increased in all infected 
experimental groups compared with the uninfected mice.  
 CD8+ cell response in the lymph nodes  
The lymph nodes draining the lungs and pleural cavity are the site of antigen presentation 
during the adaptive immune response for both infections. As the pathology in the lung is not 
altered by co-infection, the change in outcome to influenza infection due to pre-existing L. 
sigmodontis co-infection may be a result of an altered adaptive response in the draining lymph 
nodes.  
Six days after A/WSN/33 infection, cells from the thoracic and lung draining lymph nodes were 
harvested and stained for CD8 and intracellular cytokines. The total CD8
+
 cell frequency 
(Figure 4.9A) was highest in the L. sigmodontis infected group (2.41%), however, this was not 
statistically significant when compared with all other groups. Overall the number of CD8
+ 
T 
cells in the draining lymph node was very low with a mean average of ~2% of total cells 
recorded in all groups.  
CD8
+
 cells from mice infected with A/WSN/33 produced higher levels of IFNγ (53.73±6.52%, 
p<0.001 general linear model) compared with uninfected (21.96±5.18%) and L. sigmodontis 
infected mice (16.04±6.04%). IFNγ levels were also significantly increased to a mean average 
of 29.52±13.52% (Figure 4.9B).  The co-infected mice produced significantly less IFNγ than 
their A/WSN/33 singly infected counterparts, (p<0.01) and showed much greater variation in 
IFNγ levels than the singly infected mice and uninfected controls.   
TNFα production by CD8+ cells was also increased in A/WSN/33 infected mice (Figure 4.9C) 
to a mean average of 9.08±2.89% (p<0.001) compared with uninfected mice 6.76±2.06%.  This 
did not vary significantly from the co-infected group (mean 4.44±1.67%) or L. sigmodontis 
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Figure 4.9 Pre-patent (Adult) Litomosoides sigmodontis co-infection alters the CD8+ T cell 




Figure 4.9 Mice were culled 6 days post A/WSN/33 infection and draining lymph nodes of the thoracic cavity and 
lung were harvested. 1x10
7 
cells from the lymph nodes were stained for a range of intracellular CD8
+
 T cell markers. 
The samples were run on a BD LSR II Fortessa. Results displayed as individual percentages (scatter plot) and mean 
per group ± 1 standard deviation (whisker plot). N=6 except for uninfected mice where N=2. All statistics are 
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These two inflammatory cytokines showed positive correlation in their expression in CD8
+
 cells 
(0.733 Pearson’s correlation co-efficient). IL-10 production by CD8
+
 cells was limited (~1%) 
and did not vary between experimental groups. Data is therefore not shown due to low numbers. 
 CD8+ response in the lung 
Six days after influenza infection, cells of the adaptive immune response are present in the 
lungs. To determine if the alterations to the immune environment in the CD4
+
 cells in the lymph 
nodes affects the responding CD8
+
 T cells in the lung, cells harvested by lavage were 
intracellular stained for inflammatory cytokine production. 
Six days post infection with A/WSN/33, the number of CD8
+
 cells in the broncho-alveolar 
lavage fluid (BALF) accounted on average for 37.03±5.16% of the lymphocytes recovered from 
co-infected mice (Figure 4.10A) and 23.20±2.00% in the A/WSN/33 infected mice.  Uninfected 
and L. sigmodontis infected mice had a significantly lower percentage (p<0.001, 2 way 
ANOVA) of CD8
+
 cells, (9.09 and 11.35% mean averages respectively). 
Co-infected mice have a greater proportion of CD8
+ 
cells than singly A/WSN/33 infected mice. 
The CD8
+
 cells in co-infected mice showed similar characteristics to those in A/WSN/33 
infected. IFNγ production (Figure 4.10B) in A/WSN/33 infected mice was present in 
30.68±4.01% of CD8+ cells. Similarly in co-infected mice 33.17±0.24% CD8+ cells were 
producing IFNγ. 4.18±2.66% of CD8+ cells in uninfected mice produce IFNγ and 8.76±6.29% 
of CD8
+
 cells in the L.sigmodontis infected mice produce IFNγ. TNFα production by these cells 
did not follow the same pattern (Figure 4.10C). CD8
+
 cells from uninfected, L. sigmodontis 
infected, A/WSN/33 infected and co-infected mice produced similar levels of TNFα (3.54, 4.14, 
5.37 and 6.34% respectively with 2-3% standard deviation in all groups). The absolute numbers 
of CD8
+
 cells producing IL-10 was minimal in all groups and is therefore not reported.  
 CD4+ T cell response in the lymph nodes 
Six days after A/WSN/33 infection, cells from the thoracic and lung draining lymph nodes were 
harvested and stained for CD4 and intracellular cytokines. Mice that were singly infected with 
A/WSN/33 showed a TH1 phenotype in the CD4
+
 T cell population. IFNγ was produced by 
8.80±0.95% of CD4+ cells (Figure 4.11A), which is significantly higher (p<0.001, general linear 
model) than in the co-infected (5.71±1.20%, p<0.001), L. sigmodontis infected (1.85±0.95% 
p<0.001) and uninfected control mice (1.98±1.47% p<0.001). While TNFα production by CD4
+
 
T cells was not significantly increased in A/WSN/33 infected mice (29.48±4.14%), compared 
with the uninfected animals (26.24±7.14%) there was a significant decrease (p<0.001) in TNFα 
production in the group infected solely with L. sigmodontis (14.48±1.16%) and in the co- 
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 Figure 4.10 Pre-patent (Adult) Litomosoides sigmodontis co-infection leads to an increased 





Figure 4.10 Mice were culled 6 days post A/WSN/33 infection and cells in the lung were harvested by broncho-
alveolar lavage (BAL). Maximum numbers of cells in the BAL fluid were stained for a range of intracellular CD8
+
 T cell 
markers. The samples were run on a BD LSR II Fortessa. Results are displayed as individual percentage (scatter plot) 
and mean fluorescence intensity per group ± 1 standard deviation (whisker plot). N=6 except for uninfected mice 
where N=3. All statistics are calculated on data from a single experiment, (**=p<0.01, ***=p<0.001 general linear 
model). A. Total CD8
+
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Figure 4.11 Pre-patent (Adult) Litomosoides sigmodontis co-infection alters the CD4+ T cell 
profile in the lung draining lymph nodes following A/WSN/33 infection 

























































































































































Figure 4.11  5-6 week old female BALB/c mice were infected with 25 x L3 Litomosoides sigmodontis larvae S.C. and 
34 days later with 5x10
3
 A/WSN/33 I.N. Mice were culled 6 days post A/WSN/33 infection and draining lymph nodes 
of the thoracic cavity and lung were harvested. 1x10
7 
cells from the lymph nodes were stained for a range of 
intracellular CD4
+
 T cell markers. The samples were run on a BD LSR II Fortessa. Results displayed as individual 
percentage positive (scatter plot) and mean per group ± 1 standard deviation (whisker plot). N=6 except for 
uninfected mice where N=3. These were compared with singly infected and uninfected controls. All statistics are 
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infected mice (19.88±4.33%). See Figure 4.11E. TNFα and IFNγ cytokines showed only a weak 
Pearson’s correlation co-efficient of 0.616.  
Infection with L. sigmodontis resulted in a TH2 phenotype in the CD4
+
 T cells. IL-4 and IL-5 
production (Figure 4.11B and 4.11C) was higher in this group (8.21±1.58% and 2.04±0.60% 
respectively) compared with A/WSN/33 infected mice, (0.37±0.62% and 0.01±0.02%), 
uninfected mice, (0.10±0.01% and 0.07±0.02%) and the co-infected group (5.65±1.61% and 
0.72±0.10%). IL-4 and IL-5 cytokines did not display normal distribution and could not be 
transformed and were therefore analysed by non-parametric tests. IL-4 and IL-5 both 
demonstrated significant differences between groups when evaluated by Kruskal-Wallis, 
(p=0.0048 for both). From the rank averages and z values, experimental groups were identified 
for comparison. 
 IL-4 and IL-5 were both significantly increased in the A/WSN/33 infected groups. The increase 
was significantly reduced by pre-existing co-infection with L. sigmodontis (p<0.001, Mann-
Whitney test). These cytokines were highly correlated in all groups, with a Pearson’s correlation 
coefficient of 0.893. 
The other cytokines, IL-10 (Figure 4.11D), IL-6 (Figure 4.11F) and IL-17a (Figure 4.11G) 
displayed some trends in mean differences between experimental groups but none were 
significantly changed by either infection.  IL-6 and IL-17a were also not normally distributed. 
IL-6 showed suggestion of significant differences between groups (p=0.022) however Mann-
Whitney analysis demonstrated no significant decrease in A/WSN/33 singly infected mice 
compared with the uninfected controls (p=0.09). IL-17a production was not assessed for 
significance.  
Co-infected mice produced lower levels of IFNγ than A/WSN/33 singly infected mice and had 
(surprisingly) an unaltered production of IL-10. Within the IFNγ producing CD4
+
 T cells 
however, there was a significant increase (p<0.01, general linear model) in the levels of IL-10 
co-expression (Figure 4.11H). CD4
+
 cells from co-infected mice were 4.58±1.07% IFNγ+ and 
IL-10
+
 whilst A/WSN/33 infected mice were 2.44±1.08% positive for this cell population due to 
an increased expression of IFNγ producing cells and reduced co-expression of IL-10. Although 
the number of cells in this population are low, the variation in the groups is evident in Figure 
4.11H. Uninfected and L. sigmodontis infected mice however had almost zero cells with this 
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Figure 4.12 Co-infection with A/WSN/33 reduces the number of CD4+ T cells in the lung during 
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Figure 4.12 Mice were culled 6 days post A/WSN/33 infection and cells in the lung were harvested by broncho-
alveolar lavage (BAL). Maximum numbers of cells in the BAL fluid were stained for a range of intracellular CD4
+
 T cell 
markers. The samples were run on a BD LSR II Fortessa. Results displayed as individual percentage (scatter plot) and 
mean per group ± 1 standard deviation (whisker plot). N=6, A/WSN/33 N=4 and uninfected N=3. All statistics are 
calculated on data from a single experiment, (*=p<0.05, **=p<0.01, ***=p<0.001 Kruskil Wallis and Mann-Whitney 
tests). A. Total CD4
+
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 CD4+ T cell responses in the lung 
To determine if the changes to lymph node CD4
+
 cells were also evident in the lung by day 6, 
cells were harvested by lavage.  
The number of CD4
+
 T cells in the lungs of L. sigmodontis infected mice (measured in BALF) 
was variable but averaged 41.4±13.71%.  The co-infected and A/WSN/33 groups showed 
significantly reduced (p<0.05) levels of CD4
+
 T cells. Lymphocytes from the A/WSN/33 
infected mice were 23.68±4.57% CD4
+ 
and lymphocytes from the co-infected mice were 
19.57±1.07% CD4
+ 
(Figure 4.12A). There was low recovery of CD4
+
 cells in the uninfected 
group and therefore the data are not shown.  
L. sigmodontis infected mice showed a TH2 phenotype, with increased but not significantly 
higher mean levels of IL-4 and IL-5 production (0.57% and 0.98% respectively) compared with 
almost absent expression in A/WSN/33 infected mice (0.00% and 0.02%) and co-infected mice, 
(0.00% and 0.07%) see Figures 4.12D and 4.12E.  
A similar relationship was observed in the proportions of IL-10 (Figure 4.12F) and IL-17a 
(Figure 4.12G) producing CD4
+
 cells. Careful assessment of the contribution of such cell 
populations was therefore an important consideration. L. sigmodontis infected mice produced 
significantly more IL-10 (p<0.0181, Mann-Whitney, following Kruskal Wallis analysis) and IL-
17a (p=0.0416) however these cytokines were in some cases not detected at all in A/WSN/33 
and co-infected animals and are therefore not discussed further. 
The pro-inflammatory IFNγ production by CD4
+
 cells was increased in A/WSN/33 infected 
(18.08±5.60%) and co-infected mice (17.24±3.47%) however not significantly (Figure 4.12B). 
TNFα did not follow the same expression pattern (Figure 4.12C) and on average was increased 
in the L. sigmodontis infected mice (14.57%) compared with the A/WSN/33 infected group 
(10.55%) and the co-infected mice (8.98%), however this difference was also not significant.  
 Litomosoides sigmodontis worm burden 
The number of adult worms recovered from the pleural cavity at each developmental stage are 
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Table 4.2 Litomosoides sigmodontis adult worm burden 
Mouse Day L.sigmodontis A/WSN/33 Male Female Total 
       
3414 40 + + 1 2 3 
3415 40 + + 3 1 4 
3416 40 + + 6 6 12 
3417 40 + + 4 4 8 
3418 40 + + 2 3 5 
3419 40 + + 2 3 5 
       
4574 40 + + 0 0 0 
4575 40 + + 9 8 17 
4576 40 + + 6 9 15 
4577 40 + + 0 1 1 
4578 40 + + 1 2 3 
4579 40 + + 8 6 14 
       3420 40 + - 2 4 6
3421 40 + - 4 2 6 
3422 40 + - 2 4 6 
3423 40 + - 2 3 5 
3424 40 + - 8 4 12 
       
4580 40 + - 2 3 5 
4581 40 + - 5 5 10 
4582 40 + - 5 11 16 
4583 40 + - 2 3 5 
4584 40 + - 3 2 5 
4585 40 + - 7 8 15 
 
The number of adult worms recovered from the pleural cavity of mice infected with L. 
sigmodontis was not altered by the presence of a 6 day co-infection with 5x10
3
 A/WSN/33. At 
the adult stage, male to female ratio of L. sigmodontis worms can be determined. As expected, 
co-infection did not alter the male to female ratio of adult worms which are reported alongside 
total numbers (see Table 4.2). Singly L. sigmodontis infected mice had a mean adult worm 
burden of 3.5 males and 3.75 females (7.25 total) and ranged from 0-17 worms. The mouse with 
0 worms recovered did not appear to act differently to the other mice in the group in terms of 
weight loss, clinical effects or cytokine production and is therefore included in the analysis. Co-
infected mice had a mean average of 3.8 males and 4.45 females (8.27 total) and ranged 
between 5 and 16. There is, therefore, no significant difference between the two groups.  
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4.4.4 Co-infection with patent (adult ± mf) Litomosoides sigmodontis on 
co-infection with 5x103 A/WSN/33. 
The outcome of the pre-patent co-infection was a temporarily reduced susceptibility to influenza 
infection. At the microfilaraemic stage of L. sigmodontis infection, L1 larvae are present in the 
tissues leading to a change in the immune response to a partially inflammatory phenotype from 
the established chronic type 2 and regulatory phenotype. Co-infection with influenza at this time 
point was therefore expected to produce a different outcome.  
 Effect of patent (adult ± mf) Litomosoides sigmodontis infection on A/WSN/33 co-
infection.  
Mice infected with A/WSN/33 were 13-14 weeks old due to the developmental stage of the 
nematode infection. As such, the adult mice were less susceptible to A/WSN/33 clinical signs 
and weight loss (see Figures 4.2A and 4.7A).  
Singly A/WSN/33 infected mice showed no weight loss until day 6 post infection (Figure 
4.13A) at which point this group had lost only a mean average of 6.64±3.3% in weight. A single 
mouse in this group even remained at 99.98% of its original weight. There are also limited 
clinical signs of infection (Figure 4.13B). At day 6, half of the mice in this group began to show 
mild signs of reduced mobility (scored at an average of 0.5) and respiratory effort (also scored 
at 0.5), giving a clinical score of ‘mild’ overall. 
 Co-infected mice at this time point however showed significantly increased weight loss 
(p<0.01) when compared with singly infected controls (Figure 4.13A). Weight loss became 
statistically significant at 5 days post-infection, with an overall mean loss of 8.88±4.0% at day 6 
this increased to 16.00±2.52% (p<0.001, general linear model). These mice also displayed 
heavily exacerbated clinical signs beginning at day 4 with mildly increased respiratory effort 
(observed in some but not all) but rapidly increasing in severity. At day 5 the increased 
respiratory effort (mean score of 0.92) was coupled with a staring coat (1.25), and a hunched 
stature (1.33) as well as reduced mobility (0.92) which meant that most of the mice were now 
scored as having moderate signs. A ‘severe’ score was recorded by day 6, consistent with the 
extensive weight loss (Figure 4.13B).  Respiratory effort was scored at 2.82 along with a 
hunched stature (2.82), a staring coat (2.86) and decreased mobility of 2.00. The overall severity 
score was therefore an average of 10 by the final time point and had increased rapidly over days 
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Figure 4.13 Co-infection with patent (Adult ± Mf) Litomosoides sigmodontis has a deleterious 
effect on A/WSN/33 pathogenesis 
A. Weight loss 
 
B. Clinical severity score 
 
C. Influenza lung titre – Day 6 
 
Figure 4.13 A. Mice were weighed every 24 hours post A/WSN/33 infection.  Weight loss is calculated as percentage 
of weight at day 0 prior to infection. Mean weight loss is shown ± 1 standard deviation, N=6, representative of 2 
experiments. Significance determined by general linear model (*/† = p<0.05, **/†† = p<0.01 ***/††† = p<0.001). * 
denotes significance of A/WSN/33 vs. uninfected. † denotes significance between co-infected and A/WSN/33 
infected groups. B. Clinical severity was measured by 4 signs scored on a scale of 0-3 and the sum is reported ±1 
standard deviation as clinical severity score, N=12, 2 experimental repeats. C. Left lung homogenate was measured 
by dilution series plaque assay on MDCK cells for levels of infectious virus. Individual values are plotted, N=12 from 
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Influenza titre in the lungs of co-infected animals was also significantly increased compared 
with A/WSN/33 infected mice, (p=0.027, 2-sample Student’s T test on log normalised data) at 











 in the lung homogenates.  
 Pathology 
The lungs were analysed for changes to pathology. This was of particular interest due to the 
increased resistance of the older mice to the influenza infection and the apparent deleterious 
effect of L. sigmodontis co-infection at this time point. 
The histopathology associated with influenza infection had a similar severity to mice infected 
with A/WSN/33 at the earlier time point (see Figures 4.1 L-N), despite the increased resistance 
to infection in these older mice. Evidence of epithelial necrosis was apparent at a similar score 
of 1.5. This was the same score in the co-infected mice despite their exacerbated weight loss. 
Similarly, interstitial necrosis, scored at 1.33 and interstitial inflammation, scored at 1.50 in 
A/WSN/33 infected mice was like that in co-infected mice (1.45 and 1.75 respectively). Peri-
bronchial and peri-vascular inflammation, were scored at an average of 1.50 and 1.58 in both 
A/WSN/33 infected mice and co-infected mice. The uninfected mice did not display any 
significant changes to lung integrity or signs of influenza-associated pathology. The L. 
sigmodontis group did show mild peri-vascular inflammation (0.42 mean average) and peri-
bronchial inflammation (0.42 mean average) as was the case in the previous co-infection time 
point.  
Pathology associated with the L. sigmodontis infection mirrored that of the pre-patent (adult) 
time point (Figure 4.14B). Evidence of chronic infection was now also identifiable, including 
fibrotic formations within the hypertrophic mesothelium extensions and some areas now 
exhibited extensive hyperplasia within the mesothelium and evidence of proliferation (see 
Figure 4.1L-M).  Hypertrophy in the mesothelium in the singly L. sigmodontis infected mice 
was scored at 1.92. In the co-infected group this was slightly reduced to an average of 1.42, 
while uninfected and A/WSN/33 infected mice were scored at 1.00. The presence of 
lymphocytes in the sub-pleural space was increased in the L. sigmodontis infected groups (Mean 
score of 1.2 in both groups) compared with A/WSN/33 infected (0.2) and uninfected mice (0.0). 
The presence of exophytic-frond like structures, a pathology associated with chronic mechanical 
damage to the mesothelium, was also scored at this time point. L. sigmodontis infected mice 
were scored at 1.17 and co-infected mice were scored at 1.00. A/WSN/33 infected and 
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Figure 4.14 Effect of patent Litomosoides sigmodontis co-infection on pathology caused by 
A/WSN/33. 
 
Figure 4.14 The left lobes of lungs from co-infected, singly infected and uninfected mice were harvested, fixed, cut 
into sections and stained by hematoxylin and eosin 6 days post infection with A/WSN/33.  A. The extent of lung 
damage was assessed as 0%, 25%, 50%, 75% or 100% per lung. B. Pathology and infiltration of immune cells was 
scored on a scale from 0-3 for each lung. All results are presented as mean average for each group. N=6. Error bars 
are not displayed due to the ranked nature of the data. Statistics performed by mann whitney test. *=p<0.05. 
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One significant difference at this time point was the extent of damage in the co-infected lungs 
(Figure 4.14A). While severity of each pathology was similar, A/WSN/33 infected mice had 
much less damage (~25% less) than at the previous time points, perhaps due to the increased 
age of the mice. Co-infected mice had around 50% of the lung affected by influenza associated 
pathology as was the case at the previous time point. This difference was significant (p=0.034) 
when the ranked data was analysed by Mann-Whitney test.   
- Lung cytokine environment 
Lung pathology was more widespread in the co-infected mice. To determine if this was due to a 
change in the inflammatory environment in the lung, cytokine responses were investigated.  
The inflammatory environment in the lung was measured by ELISA in two samples from each 
mouse at this time point. Cytokines were detected in homogenate from the left lobe of the lungs 
and in broncho-alveolar lavage fluid, collected prior to fixation of the right lobes of the lung.  
IFNγ levels were significantly increased in lung homogenate in all groups infected with 
A/WSN/33 (Figure 4.15A) compared with Litomosoides sigmodontis infected mice and 
uninfected controls. IFNγ was significantly higher in the singly A/WSN/33 infected (2.63 fold) 
than in the co-infected mice (1.67 fold, p<0.05 general linear model).  
IL-10 was also increased in these two groups compared with the uninfected mice. The 
A/WSN/33 infected mice had a 2.38 fold increase in IL-10 and co-infected mice had on average 
1.96 fold more IL-10 than uninfected mice. There was no significant difference between the two 
groups however.  
As with previous time points, TGFβ and TNFα were both unaffected by either infection when 
measured in the lung homogenates (Figure 4.15A). Co-infected mice, L. sigmodontis infected 
mice and A/WSN/33 infected mice produced 1.08, 1.19 and 1.17 fold increase in TNFα 
respectively and 0.86, 0.89 and 0.69 fold difference in TGFβ compared with uninfected mice. 
In the lavage samples (Figure 4.15B), IFNγ was significantly increased by 12.55 fold due to 
A/WSN/33 infection. This is much lower than at the previous time point. The co-infected group 
also showed a 6.75 fold increase in IFNγ while L.sigmodontis infected mice did not produce an 
increased amount of IFNγ in comparison with uninfected mice. There was no significant 
difference between singly A/WSN/33 and co-infected mice. 
 IL-10 levels showed only a moderate increase in the A/WSN/33 infected groups which is much 
lower than observed at the earlier time point. IL-10 was recorded at a mean fold increase of 1.89 
fold in the co-infected group and 1.27 fold in the A/WSN/33 singly infected mice.  
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Figure 4.15 Cytokine environment is not significantly altered in mice co-infected with patent 
(adult ± mf) Litomosoides sigmodontis and A/WSN/33 
A. Lung homogenate 
 
B. Broncho-alveolar lavage fluid  
 
Figure 4.15 A. 6 days post A/WSN/33 infection, the left lung was homogenised in Dulbecco’s minimum essential 
medium and the homogenate used for ELISA detection of cytokines. Representative of 2 independent experiments. 
N=12. B. Lungs were lavaged with 2ml HBSS + 3mM EDTA, cells were removed and the broncho-alveolar lavage fluid 
(BALF) used to detect cytokines in the interstitial environment. Single experiment, N=6.  Each group is represented 
as mean average fold change ± 1 standard deviation compared to the mean level of expression in the uninfected 
group.  Statistics were performed by general linear model. Groups that do not share the same letter are significantly 
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TGFβ and TNFα levels were not increased in any experimental group. In some instances these 
cytokines were undetectable. TNFα was present at 0.67, 1.27 and 1.47 fold differences in the 
co-infected, L.sigmodontis infected and A/WSN/33 infected mice when compared with the 
uninfected group. TGFβ was present at 0.93, 1.61 and 1.97 fold difference compared with the 
uninfected.  
To determine if changes in the T cell populations in the lymph nodes were again contributing to 




 cells were analysed by flow cytometry.  
- CD8+ T cell responses in the lymph node  
After 6 days A/WSN/33 infection, cells from the thoracic and lung draining lymph nodes were 
harvested and stained for CD8 and intracellular cytokines. Total CD8
+
 cell frequency was 
highest in both L. sigmodontis infected groups however this was not statistically significant. 
Overall the number of CD8
+
 T cells in the draining lymph node was very low (Figure 4.16A) 
with a mean of 2-4%. Lymphocytes from L. sigmodontis infected mice were 4.25±2.25% CD8+. 
Co-infected mice had 3.92±1.14%. The A/WSN/33 infected mice had 2.41±0.78% CD8+ 




 cells from L. sigmodontis infected mice were producing increased levels of IFNγ+ cells 
(33.26±11.00%) compared with the previous time point (Figure 4.16B). This coincides with the 
release of microfilaria by adult worms. IFNγ production by CD8+ cells was not significantly 
different from the A/WSN/33 singly infected group (44.14±5.30%) or co-infected mice 




 T cells from all infected groups were producing increased IFNγ compared with 
uninfected controls. Levels of TNFα and IL-10 production in CD8+ T cells were very low and 
so these results are not shown and were not analysed further.  
- CD8+ T cell responses in the lung 
CD8
+
 T cells in the lavage were at very low numbers in the uninfected group and are therefore 
absent from the analysis (Figure 4.17A). The numbers of CD8
+
 cells in the lung were increased 
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Figure 4.16 CD8+ T cells in the lymph node are producing IFNγ in all infected groups and 
therefore co-infection has no significant impact. 
         A.  Total CD8
+






Figure 4.16  5-6 week old female BALB/c mice were infected with 25 x L3 Litomosoides sigmodontis larvae S.C. and 
34 days later with 5x10
3
 A/WSN/33 I.N. These were compared with singly infected and uninfected controls. Mice 
were culled 6 days post A/WSN/33 infection and draining lymph nodes of the thoracic cavity and lung were 
harvested. 1x10
7 
cells from the lymph nodes were stained for a range of intracellular CD8
+
 T cell markers. The 
samples were run on a BD LSR II Fortessa. Results displayed as individual percentages per sample and mean per 
group ± 1 standard deviation. N=4-9. All statistics are calculated on data from 2 independent experiments, 
(*=p<0.05, **=p<0.01, ***=p<0.001 general linear model). A. CD8
+
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Figure 4.17 Patent (adult ± mf) Litomosoides sigmodontis co-infection leads to an increased 





Figure 4.17 5-6 week old female BALB/c mice were infected with 25 x L3 Litomosoides sigmodontis larvae S.C. and 
68 days later with 5x10
3
 A/WSN/33 I.N. These were compared with singly infected and uninfected controls. Mice 
were culled 6 days post A/WSN/33 infection and cells in the lung were harvested by broncho-alveolar lavage (BAL). 
Maximum numbers of cells in the BAL fluid were stained for a range of intracellular CD8
+
 T cell markers. The 
samples were run on a BD LSR II Fortessa. Results displayed as individual percentage (scatter plot) and mean per 
group ± 1 standard deviation (whisker plot). N=6 except for co-infected mice where N=9. Uninfected mice did not 
have sufficient numbers of cells to be included. All statistics are calculated on data from a single experiment, 
(***=p<0.001 Mann-Whitney test). A.Total CD8
+
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CD8
+
 IFNγ+ cells in L. sigmodontis infected mice were largely undetectable. A/WSN/33 
infected mice had 30.1±6.99% CD8+ cells producing IFNγ and co-infected mice were higher on 
average at 37.9±2.45% (Figure 4.17B). Unlike the previous time point TNFα production by 
CD8
+
 cells was elevated in A/WSN/33 to 19.28±2.81% (Figure 4.17C). This was significantly 
higher than in co-infected mice which had a similar level to the previous time point of 
7.43±4.30% (p=0.0075).  Once again uninfected mice and L. sigmodontis infected mice had low 
(close to undetectable) levels of CD8
+
 IL-10
+ cells in the BAL fluid.  
 CD4+ T cell responses in the lymph nodes 
After 6 days A/WSN/33 infection cells from the thoracic and lung draining lymph nodes were 
harvested and stained for CD4 and intracellular cytokines. At this time point, L. sigmodontis 
infected mice showed an increase in IFNγ production by CD4+ T cells (Figure. 4.18A). 
Therefore all infected groups had a significant (p<0.001, general linear model) increase in 
comparison to uninfected controls. IFNγ production by CD4+ cells was on average 7.51±1.91% 
in the co-infected group, 8.28±3.57% in the L. sigmodontis infected group and 9.76±2.16% in 
the A/WSN/33 infected mice. The uninfected group were 1.78±1.04% IFNγ positive.  
TNFα showed a significant decrease in production in both L. sigmodontis infected groups 
(Figure 4.18E). CD8
+
 cells in the co-infected mice were 18.21±2.05% TNFα positive and in the 
L. sigmodontis group, 15.063.01% of CD8
+
 cells were producing TNFα. This was in 
comparison to 33.0±24.19% in the A/WSN/33 infected mice and 31.0±9.01% in the uninfected 
mice, when non-specifically stimulated with PMA and ionomycin. There was therefore only a 
very weak inverse correlation between the inflammatory cytokines IFNγ and TNFα, (-0.462) at 
this time point.  
The IL-4 distribution was not normally distributed. Mann-Whitney analysis demonstrated a 
significant increase in IL-4 as a result of L. sigmodontis infection. 15.89±5.18% CD8+ cells 
from L. sigmodontis mice were producing IL-4 and 7.28±2.09% of CD8+ cells from co-infected 
mice were IL-4 positive (Figure 4.18B). The combined p value for the co-infected group 
compared with singly L. sigmodontis infected mice was 0.0713.  This shows a very strong trend 
(but not significance) for a smaller increase in IL-4 in co-infected mice than in the L. 
sigmodontis only group.  
IL-5 was significantly (p<0.001) raised in L. sigmodontis infected mice (4.52±2.11%) compared 
with all other experimental groups (1.37±0.45% in co-infected, 0.45±0.19% in A/WSN/33 
infected and 0.73±0.15% in the uninfected group). While levels were far lower in co-infected 
mice, IL-5 was increased significantly increased in these mice compared with uninfected and  
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Figure 4.18 Patent (Adult ± Mf) Litomosoides sigmodontis co-infection alters the CD4+ T cell 

























































































































































Figure 4.18  5-6 week old female BALB/c mice were infected with 25 x L3 Litomosoides sigmodontis larvae S.C. and 
68 days later with 5x10
3
 A/WSN/33 I.N. Mice were culled 6 days post A/WSN/33 infection and draining lymph nodes 
of the thoracic cavity and lung were harvested. 1x10
7 
cells from the lymph nodes were stained for a range of 
intracellular CD4
+
 T cell markers. These were compared to singly infected and uninfected mice. The samples were 
run on a BD LSR II Fortessa. Results are displayed as percentage of positive cells per sample (scatter plot) as well as 
mean per group ± 1 standard deviation (whisker plot). N=12 for L.sigmodontis infected groups, N=6 for A/WSN/33 
singly infected and N=4 for uninfected mice. All statistics are calculated on data from 2 independent experiments, 

































































































Gareth Hardisty Persistent Litomosoides sigmodontis and influenza A co-infection 177 
A/WSN/33 singly infected mice (Figure 4.18C). The TH2 cytokines, IL-4 and IL-5 strongly 
correlate in their production, (Pearson’s co-efficient 0.927). 
 IL-10 was produced at low levels in CD4
+
 cells and infection produced no significant 
modulation (figure 4.18D). IL-6 production by CD4
+
 T cells (Figure 4.18F) was significantly 
lower (p<0.01) in the uninfected group (0.17±0.08%) however there were no differences 
between the infection groups (1.32±0.04 in the co-infected, 1.43±0.70% in the L. sigmodontis 
infected and 1.80±0.55% in the A/WSN/33 infected mice). IL-17a was moderately raised in 
singly L. sigmodontis infected mice (at p<0.05 significance level) to 0.80% on average 
compared with an average of 0.30% in the co-infected group and 0.35% in the A/WSN/33 
infected however due to variation in the uninfected group the most significant difference was 
between L. sigmodontis and co-infected mice, (p<0.01 Figure 4.18G). 






 cells identified at the previous time point was less clearly 
defined at this time point. Expression of IFNγ in L. sigmodontis infected mice has increased on 
average but varies within the group (Figure 4.18H). Co-expression of IL-10 in these cells is 
much higher than at the previous time point which may contribute to the variation. Co-
expression of IL-10 and IFNγ in the co-infected mice and A/WSN/33 infected group are less 
easily distinguishable, as both groups appear to be producing IL-10 and IFNγ in equal measures 
in this cell population.  
 CD4+ T cell responses in the lung 
74 days post L. sigmodontis infection the proportion of CD4
+
 cells in the lung is increased in the 
L. sigmodontis infected group compared to the A/WSN/33 infected and co-infected groups 
(p=0.00054). L. sigmodontis infected mice had 29.9±10.4% CD4 positive cells whilst cells from 
co-infected mice were 16.8±2.3% positive for CD4 and 16.12±5.12% positive in the A/WSN/33 
infected mice (figure 4.19A). Uninfected mice had very low numbers of CD4
+
 lymphocytes in 
the lung and are therefore excluded from the analysis. 
The levels of IFNγ and TNFα production by lung CD4
+
 cells were increased in all infected 
groups. Co-infected mice were 27.41±7.11% and 11.04±4.15% positive for IFNγ and TNFα 
respectively, A/WSN/33 infected mice were 37.848.53% and 16.45.63% positive and L. 
sigmodontis infected mice were 27.86±9.65% and 13.49±2.69% positive on average for these 
two inflammatory cytokines (figure 4.19B and 4.19C). There were too few CD4
+
 cells in the 
lungs of uninfected mice to record accurately. The increase in expression of inflammatory 
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Figure 4.19  Patent (Adult ± Mf) infection with Litomosoides sigmodontis results in a mixed 


































































































































Figure 4.19 Mice were culled 6 days post A/WSN/33 infection and cells in the lung were harvested by broncho-
alveolar lavage (BAL). Maximum numbers of cells in the BAL fluid were stained for a range of intracellular CD4
+
 T cell 
markers. The samples were run on a BD LSR II Fortessa. Results displayed as individual percentage (scatter plots) 
and mean per group ± 1 standard deviation (whisker plots). N=9, A/WSN/33 N=5 and uninfected were at insufficient 
numbers and are not reported. All statistics are calculated on data from a single experiment, (*=p<0.05, **=p<0.01, 
***=p<0.001 Kruskil Wallis and Mann-Whitney tests). A. Total CD4
+
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analysed statistically. There was no difference in inflammatory cytokine production between 
infected groups.  
TH2 cytokines, IL-4 and IL-5 were significantly raised in L. sigmodontis infected mice (to 
24.20±7.98% and 14.89±4.11%, Mann-Whitney p=0.0009 and p=0.0006 respectively when 
compared with the co-infected mice). Co-infected mice have small increases in IL-4 and IL-5 to 
6.29±2.45% and 3.65±1.21% when compared with the influenza infected mice (Figure 4.19D 
and 4.19E). 
These two cytokines were once again very highly correlated in their production, IL-10 was 
significantly raised in the A/WSN/33 infected mice (p=0.0009) to 5.72±1.59% and in the co-
infected mice to 4.04±1.85% when compared with the uninfected mice but there was no 
difference between co-infected and singly A/WSN/33infected groups (Figure 4.19F).  
 Litomosoides sigmodontis worm burden 
Once the mice had been autopsied, both adult worms and microfilaria (L1 larvae) were 
enumerated. There was no significant differences between the number of adult males or 
females in either group infected with L. sigmodontis. There was also no significant difference in 
the number of mice to reach patent infection or the incidence of microfilaria in the blood. Co-
infection with influenza did not lead to an increase or decrease in the number of microfilaria in 
the blood or granuloma formation in the pleural cavity. Table 4.3 below shows the number of 
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Table 4.3 Litomosoides sigmodontis adult and microfilaria worm burden 









          3437 74 + + 1 0 1 19  1 
3438 74 + + 3 2  X  5 
3439 74 + + 1 1 2 2  2 
3440 74 + + 2 2  57  4 
3441 74 + + 2 1  6  3 
3442 74 + + 0 2 1 0  2 
3444 74 + + 1 2 * 22  3 
3445 74 + + 1 0 2 5  1 
3446 74 + + 1 4  2  5 
3447 74 + + 4 3  134  7 
          
4593 74 + + 1 1 1 0 2 2 
4597 74 + + 2 0 0 17 0 2 
4598 74 + + 0 2 2 15 12 2 
4599 74 + + 4 3 0 2 217 7 
4600 74 + + 1 3 0 3 0 4 
4601 74 + + 2 1 1 14 150 3 
          3448 74 + - 2 3 1 101  5 
3449 74 + - 0 1 2 0  1 
3450 74 + - 2 0 1 116  2 
3451 74 + - 2 1  553  3 
3452 74 + - 2 2  501  4 
3453 74 + - 3 2  323  5 
3454 74 + - 3 4 1 23  7 
3456 74 + - 8 6  2  14 
3457 74 + - 3 2  51  5 
3458 74 + - 1 2  13  3 
3459 74 + - 2 6  0  8 
          
4602 74 + - 5 1 1 5 4 6 
4603 74 + - 2 1 1 2 0 3 
4604 74 + - 1 1 1 0 0 2 
4605 74 + - 4 2 0 355 269 6 
4606 74 + - 3 0 1 31 25 3 
4607 74 + - 3 5 1 5 2 8 
          
* = partial worm in granuloma  x = undetermined / clotted sample 
Mf 68 = number of L1 larvae (microfilaria / mf) measured on day 68 post infection. 
Mf 74 = number of L1 larvae (microfilaria / mf) measured on day 74 post infection. 
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4.5 Discussion 
4.5.1 Co-infection with immature (L4) Litomosoides sigmodontis had no 
significant impact on A/WSN/33 pathogenesis 
The early stage of Litomosoides sigmodontis infection in BALB/c mice does not skew host 
immunity towards a strong TH2 or TREG phenotype. Mouse strains resistant to infection display 
an expansion and infiltration of leukocytes in the pleural cavity and excessive production of 
both type 1 and 2 cytokines; subsequently leading to the destruction of adult worms within 10-
30 days post infection (Babayan, Ungeheuer et al. 2003). This response is not evident in 
susceptible strains. Infection with L4 stage L. sigmodontis of susceptible BALB/c strain 
produces a subtle TH2 influence on host immunity which subsequently does not alter A/WSN/33 
infection. At a dose of 5x10
3
 A/WSN/33 (delivered intranasally), mice develop clinical signs of 
reduced mobility and increased respiratory effort within 4 days of infection. While a reduction 
in onset of such signs can be observed in the co-infected group, the anorexia associated weight 
loss consistent with influenza infection is not altered significantly by pre-existing L4 L. 
sigmodontis nematode infection, suggesting unaltered viral pathogenesis. Upon repeat of this 
experiment, the slight modification was less defined and again not significant. This result is 
mirrored in the levels of viral replication. Virus titres recovered from lung homogenates 6 days 
post infection were almost identical in co-infected and A/WSN/33 singly infected mice, 
confirming that viral replication was not impacted by pre-existing infection. While disease 
progression is influenced by successful viral replication, a number of studies have concluded 
that outcome of influenza infection is not exclusively tied to levels of replicating virus 
(Taubenberger and Morens 2008). Instead, severe clinical signs and fatality in influenza 
infection in humans and mice are correlated to the excessive production of cytokines and 
chemokines, termed ‘cytokine storm’. A phenomenon most commonly observed in the highly 
pathogenic sub-strains of the virus (Clark 2007). As the A/WSN/33 singly infected mice were 
recorded at high severity 6 days post infection the cytokine environment in the lung was 
monitored. Inflammatory cytokines IFNγ and TNFα were not increased to significant levels 
compared with uninfected mice. These results were measured by ELISA on lung homogenates 
and therefore a significant increase in such cytokines is required for detection, an issue that is 




 cells was raised significantly 
in response to A/WSN/33 infection however the increase was at similar levels in lymphocytes 
from the lung draining lymph nodes in both singly and co-infected mice suggesting activation of 
inflammatory T cells by the viral infection was also not altered. The ability to produce normal 
polarisation of naïve CD4
+
 T cells to a TH1 phenotype is therefore intact in mice with pre-
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 cell populations was not 
increased by infection either. The regulatory cytokine IL-10 increased in incidence in the lung 
homogenates from co-infected mice. The immunosuppressive qualities of this cytokine, 
commonly produced by infiltrating CD8
+
 T cells  are known to limit pathology during viral 





 lymphocytes, however, did not show any increase in the co-infected group in 
comparison to singly infected mice and therefore support the theory that L. sigmodontis 
infection at this early time point is not able to skew a subsequent immune response. 
Furthermore CD4
+
 T cells from the draining lymph nodes of L. sigmodontis infected mice did 
not display increased polarising IL-4 and IL-5 production associated with skewing towards a 
TH2 phenotype. This response is observed upon chronic infection with L. sigmodontis, with a 
significant increase in strong TH2 responses reported previously in BALB/c mice at around day 
58 post infection (Marechal, Le Goff et al. 1997). Therefore to determine the extent of 
inflammatory damage between groups and potential influence of the increased IL-10, lungs 
were fixed, sectioned and stained by hemoxylin and eosin. Pathology was scored on a scale of 
0-3 for a number of signs of influenza infection (Taubenberger and Morens 2008). Interstitial 
and epithelial necrosis and measures of immune cell infiltration around airways and blood 
vessels, common signs of influenza infection were not noticeably different between A/WSN/33 
and co-infected mice. The extent of the lung damage was consistent with previous experiments 





 T cells in the lymph nodes were not significantly increased, these results 
demonstrate that pre-existing co-infection with immature L4 Litomsoides sigmodontis larvae is 
not sufficient to modulate the immune response to acute influenza infection. This is reinforced 
by a lack of significant change to the lung pathology caused by the L. sigmodontis infection 
alone.   
4.5.2 Co-infection with pre-patent (adult) Litomosoides sigmodontis 
delays the pathogenesis of A/WSN/33 infection 
At this pre-patent stage of Litomosoides sigmodontis infection, co-infection with A/WSN/33 
results in an attenuated phenotype. Weight loss in A/WSN/33 singly infected mice is the same 
as in the younger mice from the previous time point; reaching a maximum weight loss of around 
15% 6 days post infection. Weight loss is coupled with the onset of clinical signs as before, 
however, by day 6 all A/WSN/33 infected mice do not exceed the moderate severity scoring for 
combined respiratory effort, reduced mobility, staring coat and hunching stature. The mice at 
this time point are 10-11 weeks old before infection, which likely explains the slower 
progression in disease severity. Age is a significant factor contributing to the immune response 
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to influenza in mice models (Bender, Taylor et al. 1995; Bender, Cottey et al. 1996). Significant 
differences between A/WSN/33 singly infected mice and co-infected mice occur at the initial 
stages of clinical presentation. At the onset of influenza clinical signs, (day 3 and 4) 4 out of 6 
co-infected mice show only mild signs of infection whilst all A/WSN/33 infected mice already 
have moderate signs of infection. This correlates with weight loss, which in the A/WSN/33 
infected group is significantly increased compared with uninfected and L. sigmodontis infected 
controls from 3 days post infection whilst co-infected mice do not show a statistically 
significant decrease in weight until 5 days post infection. There is also much greater variation 
within the co-infected group than others at this time point. Weight loss in co-infected mice is 
less severe between days 3 and 5, however, as with clinical signs, co-infected mice reach similar 
weight loss by day 6 suggesting that L.sigmodontis affords a delay or initial reduction in 
response rather than significant protection from viral infection.  
The total CD8
+
 T cell response in the draining lymph nodes during A/WSN/33 is not altered by 
pre-existing L. sigmodontis infection however the production of the inflammatory cytokine 
IFNγ is mediated by the presence of co-infection. IFNγ production by CD8
+
 T cells is, as 
expected, significantly raised in A/WSN/33 infected mice, however, this is to a lesser extent in 
those with prior L. sigmodontis infection. L. sigmodontis infection alone did not produce CD8
+ 
T cells capable of IFNγ production. IFNγ production by CD8
+
 T cells is required to recruit other 
immune cells to the site of infection and mediate the inflammatory environment in the lung 
(Wiley, Cerwenka et al. 2001). It was therefore of interest to investigate if this cell population 
was also at decreased concentration in the alveolar spaces of the lung. Interestingly the 
percentage of total CD8
+
 cells was highly increased in the lungs of co-infected mice in 
comparison to all other experimental groups. A similar percentage of such CD8
+
 cells are 
capable of IFNγ production when compared to levels produced by singly A/WSN/33 infected 
mice.  
Pre-existing infection with Trichinella spiralis, a parasitic roundworm, is capable of modulating 




 as well as 
neutrophils (Furze, Hussell et al. 2006). Similarly in Plasmodium yoelii / Litomosoides 
sigmodontis co-infection studies, production of IFNγ and TNFα by TH1 cells is suppressed 
reducing the inflammatory environment and pathological lesions. (Karadjian, Berrebi et al. 
2014).  It was therefore expected that L. sigmodontis infection would provide protection from 
influenza pathogenesis by similar interactions or induction of hypo responsiveness in T cells, as 
is also seen in inhibition of allergic sensitization (Dittrich, Erbacher et al. 2008).  An increase in 
CD8
+
 T cells was therefore unexpected. It is therefore important to consider that CD8a may also 
be expressed on a number of other cell types, which might explain the increase in percentage of 
CD8
+ 
cells but lack of increase in the percentage of cells producing IFNγ and subsequent 
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alterations to pathology. The increase is solely seen in the lung lavage and not in the draining 
lymph nodes. This population in part, may be composed of CD8
+ 
dendritic cells. Mouse CD8
+
 
DCs have been previously described as non-migratory resident cells which are continuously 
seeded exclusively to lymph nodes from a bone marrow monocyte precursor (Belz, Smith et al. 




 dendritic cells in the lung 
have been shown to increase in response to influenza or parainfluenza infection, although these 
cells display differential kinetics to CD8- DCs; they migrate less efficiently to lymph nodes and 
are weaker in regards to T cell activation (Beauchamp, Yammani et al. 2012). However it is not 





 cell markers the contribution of non T cell CD8
+
 cells to the increased 
population observed in co-infected mice is purely speculative.  
The phenotype of CD4
+
 T cell subsets is also different between groups. A/WSN/33 infection 
leads to canonical activation of TH1 cells in the draining lymph node by MHC-II presentation of 
antigen by antigen presenting cells (Fonteneau, Gilliet et al. 2003). As a result TH1 cells produce 
IFNγ leading to an inflammatory immune environment. Alternatively L. sigmodontis infection 
results in production of TH2 cells governed by production of IL-4 and IL-5 (Allen and Maizels 
2011). In the lymph nodes of adult L. sigmodontis infected mice there is a robust TH2 response 
with significantly increased levels of IL-4 and IL-5 and very low levels of inflammatory 
cytokines IFNγ and TNFα. A/WSN/33 infected mice however show large increases in 
production of IFNγ and minimal levels of IL-4 and IL-5. Co-infected mice produce both TH1 
and TH2 cells, however, all cytokines are produced at intermediary levels compared with the 
singly infected mice. IL-4 and IL-5 levels are increased significantly less than in solely L. 
sigmodontis infected mice and IFNγ and TNFα levels are similarly moderated compared with 
singly A/WSN/33 infected mice. However in the case of TNFα, levels of production in the co-
infected mice are much more aligned with the L. sigmodontis infected mice. These results show 
that while site of infection for the two pathogens is not the same the resulting production of an 
adaptive immune response during the co-infection is altered at the site of the draining 
lymphatics. IL-10, a regulatory cytokine associated with suppression of adaptive immune 
responses did not appear to be up regulated in any of the infected mice, however within the 
IFNγ generating CD4
+
 T cells identified in the co-infected mice, IL-10 was co-expressed to a 






 Tr1 cells with suppressive function 
have been identified before in chronic infections (Chen and Liu 2009). Alternatively, these cells 
may represent a population of TH1 cells that intrinsically negatively regulate IFNγ by production 
of IL-10 to mediate excessive inflammation in response to other suppressive stimuli, a response 
usually seen toward the end of the TH1 cell life cycle. (Cope, Le Friec et al. 2011) While this 
cell population is only a very small population of the total CD4
+
 cells it may be an indication of 
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how co-infection with a filarial nematode, can mediate subsequent heterologous responses in the 
draining lymph node.  
The lung environment, however, does not follow the same pattern. Production of IL-4 and IL-5 
cytokines is slightly increased in L. sigmodontis infected mice as expected although at very low 
levels. These TH2 cytokines are not found in the co-infected group. Instead the CD4
+
 cells from 
the lung lavage show an identical TH1 phenotype to the CD4
+
 T cells in the singly infected 
A/WSN/33. Both groups produce similarly increased levels of IFNγ exclusively. The migration 
of inflammatory CD4
+
 T cells from the lymph node to the site of A/WSN/33 infection in the 
lung is therefore specific for TH1 cells despite the mixed TH1/TH2 phenotype observed in the 
lymph nodes of co-infected mice.  Alternatively, all cells may migrate into the lung however 
only upon recognition of influenza antigen in the lung do primed CD4
+
 T cells proliferate and 
therefore produce IFNγ, as shown previously with the use of an OVA-transgenic influenza virus 
(Chapman, Castrucci et al. 2005). This would suggest that even if the influenza specific CD4
+
 T 
cell phenotype is altered in the lymph nodes of co-infected mice, sufficient influenza specific 
TH1 CD4
+
 T cells migrate and proliferate in the lungs of co-infected mice by day 6 as in 
A/WSN/33 singly infected mice. Previous studies have also demonstrated that antigen bearing 
dendritic cells migrating from the lung have imprinting capacity on the T cells they activate in 
the lymph node and therefore during influenza infection lung DC-primed CD4
+
 T cells have 
greater capacity to return to the lung (Mikhak, Strassner et al. 2013). Correspondingly, CD4
+
 T 
cells migrate predominantly to the pleural cavity during L. sigmodontis infection (Taylor, Harris 
et al. 2007). At day 6 post infection the kinetics of these responding CD4
+
 cells in the lung are 
identical between co-infected and A/WSN/33 infected mice. This is supported in the 
pathological scoring of the lung. Interstitial, peribronchial and perivascular inflammation is 
equivalent in the two groups, as is the extent of lung damage, proposing similar cellular 
infiltrates and proliferation in both groups. A subtle difference in overall IFNγ production is 
observed by ELISA of lung homogenates. Whilst not significant when measured at a 95% 
confidence level, IFNγ is increased to a greater degree in singly A/WSN/33 infected mice 
compared with co-infected mice which could not be statistically distinguished from the 
uninfected and solely L. sigmodontis infected mice in regards to IFNγ levels. TNFα, IL-10 and 
TGFβ levels were unaltered. Despite spiked sample testing prior to use with lung homogenates, 
the ELISAs appear to require large increases for detection of differences between groups. To 
look specifically at the epithelial alveolar environment, broncho-alveolar lavage fluid was 
collected and examined for the same cytokine levels.  In these results IFNγ and IL-10 were both 
significantly increased in A/WSN/33 infected groups, however, the ability to distinguish 
between co-infected and singly infected mice was no longer apparent. All of these observations 
are measured 6 days post infection and therefore represent the time point at which the delay in 
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pathogenesis of A/WSN/33 infection in the co-infected group was no longer significant. 
Identifying differences in the lung environment between day 3 and 5 may be useful to determine 
the mechanism of the delay observed in weight loss and clinical signs.  
4.5.3 Co-infection with patent (adult ± mf) Litomosoides sigmodontis 
exacerbates the pathogenesis of A/WSN/33 infection 
As the mice were infected with L3 stage larvae, which progress though a number of 
developmental stages before reaching patency, equivalent 15-16 week old age matched adult 
mice were used in all experimental groups. In the A/WSN/33 singly infected group this led to 
markedly reduced pathology and weight loss from the same 5x10
3
 infective dose. Mice at this 
age showed only mild clinical signs that did not become apparent until day 6 post infection. 
Similarly significant weight loss occurred from day 6 compared with day 3 in earlier time points 
and clinical signs were not apparent in the majority of mice in this group. Some individuals 
showed very mild increase in respiratory effort. Co-infected mice at this time point however had 
severe clinical signs and weight loss over the time course with strong resemblance to previous 
time points. Increased respiratory effort and decreased mobility was apparent in all mice from 
day 4, progressing to severe presentation of infection by day 6. Co-infected mice were therefore 
significantly worse than A/WSN/33 infected mice in presentation from day 4 onwards and from 
day 5 in weight loss measurements. This time point is also the only point at which influenza 
titre in the lung has shown significant difference. Co-infected mice have a statistically 
significant increase in infectious virus however the difference between groups is unlikely to be 
biologically significant. To determine the effect of this, an experimental repeat would need to be 
undertaken until day 8 or 9 to determine changes to viral clearance. Pathology caused by 
infection is not significantly altered in the lungs of A/WSN/33 and co-infected groups. 
Inflammatory cell infiltration surrounding both the airways and blood vessels can be seen in 
both groups, along with epithelial and interstitial necrosis, all to similar levels as the previous 
time point. A significant difference occurs in the extent of pathology. Previous time points have 
shown ~50% of the lung to be affected at this dose of viral infection irrespective of pre-existing 
L. sigmodontis infection, however, consistent with the decreased signs and weight loss,  
influenza infection alone in older mice affects only ~25% of the lung. Co-infection however 
seems to exacerbate the area of pathology back to ~50%. This response is not validated by the 
cytokine environment in the lung homogenates. Once again IFNγ is increased in the A/WSN/33 
singly infected mice compared with co-infected mice. Both groups also show an increase in IL-
10 although variation in the uninfected group means this is not a significant increase. In the 
BAL fluid IFNγ is increased in both A/WSN/33 groups, although IL-10 is now no longer 
increased to the same degree. Both cytokines are at much lower levels than in the previous time 
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point. These cytokines are therefore likely part of the adaptive immune response to A/WSN/33 
which is less aggressive in these adult mice. There also seems to be limited evidence to suggest 
that IFNγ levels detected in the lung homogenate and BAL fluid directly at day 6 are indicative 
of clinical signs or weight loss associated with influenza infection in these experiments. 
CD8
+
 T cell levels in the lymph nodes are again unaltered between experimental groups 
however L. sigmodontis infected mice now show an increase in production of IFNγ. As has been 
previously described by antigenic stimulation of lymphocytes with microfilaria antigen, 
(Taubert and Zahner 2001) patent infection leads to a switch in immune phenotype and L. 
sigmodontis infected mice produce type 1 and type 2 cytokines synergistically. This is a 
response mirrored in the CD4
+
 T cells subsets in the lymph node, where L. sigmodontis infected 
mice now produce elevated IFNγ levels indistinguishable to those that of A/WSN/33 infected 
and co-infected mice. CD4
+
 T cells in these mice however maintain high production of IL-4 and 
IL-5, at levels significantly higher than all other experimental groups. Synergistic TH1 / TH2 
responses in L. sigmodontis infected mice are required for production of neutrophil responses 
against adult worms (Saeftel, Arndt et al. 2003). Co-infected mice also show an increase in 
these TH2 cytokines however to a once again intermediary phenotype. TNFα is also still 
produced in co-infected and L. sigmodontis infected mice at significantly lower levels than the 
A/WSN/33 singly infected group. IL-10 production is not different in CD4
+
 T cells in the lymph 






 are identifiable to similar levels in co-
infected and A/WSN/33 infected mice.  
CD4
+
 T cells identified in the lavage were again IL-4 and IL-5 positive in L. sigmodontis 
infected and to a lesser degree in the co-infected mice but all experimental groups were now 
capable of IFNγ production. The increase in IFNγ in L. sigmodontis infection was coupled with 
a decrease in IL-10 production that was elevated at the earlier time point. IL-10 may therefore 
be responsible for inhibiting IFNγ production by CD4
+
 T cells in L. sigmodontis infected mice 
at earlier stages of development. Total numbers of CD8
+
 T cells in the lavage samples were 
again raised in the co-infected animals. It is therefore uncertain that this population was directly 
involved in the delayed phenotype at the pre-patent co-infection. IFNγ production by these cells 
was equivalent to the earlier time point however CD8
+
 T cells in the lungs of A/WSN/33 singly 
infected mice are now producing high levels of TNFα. During viral infection with 
lymphochoriomeningitis virus (LCMV) or vesicular stomatis virus (VSV), production of TNFα 
by CD8
+
 T cells is associated with a virus specific effector population. The spleen contained 
high proportions of these CD8
+
 TNFα producing cells (Kristensen, Madsen et al. 2004). An 
increase in effector function by CD8
+
 T cells in response to influenza infection may explain the 
increasing resistance in mice with age to A/WSN/33. Limited expression of such a population in 
the co-infected mice may therefore explain why the co-infected mice have similar pathology to 
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earlier time points. Intrinsic production of TNFα by CD8
+
 T cells is integral for clearance of 
virus and resolution of pathology during influenza infection (Wortzman, Lin et al. 2013). 
A similar pattern of inflammation dependent on the developmental stage of L. sigmodontis is 
observed in mice injected with sub lethal doses of LPS at pre-patent and microfilaraemic stages 
of L. sigmodontis infection. Adult female worm infected mice suppressed cytokine production 
to subsequent LPS injection compared with sham infected, LPS treated mice. However at patent 
stage of infection presence of microfilaria induced increased levels of inflammatory cytokines in 
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Chapter 5 -  Discussion 
5.1 Hypotheses 
The aim of this project was to test the theory that pre-existing infection with a chronic or 
persistent pathogen would skew the immune response to a secondary infection with influenza A. 
It was hypothesised that latent gammaherpesvirus infection would decrease susceptibility to 
influenza infection by increasing the ‘anti-viral’ type 1 immune responses in the lung. This 
hypothesis was also tested in the absence of the inflammatory cytokine IFNγ. A second 
hypothesis was tested with a persistent filarial nematode infection that was hypothesised to 
skew the immune response towards a type 2 and suppressive immune response, impairing the 
ability to produce optimal anti-viral immunity to influenza and increasing susceptibility.  
5.2 Context 
The importance of understanding co-infections and their potential to adjust immune responses 
or homeostasis of the host is a relatively new concept. In the context of single infections, much 
has been gained by studying a single pathogen in a model animal that is completely naïve to 
other infections. Immune responses may synchronise with, inhibit or have an additive effect on 
subsequent infection. This means that further understanding can be gained from a model of co-
infection. This system of modelling attempts to be more reflective of human infections, where 
sub-clinical infections with multiple persistent and on-going pathogens are common place. 
Influenza infection is more highly likely to occur in an individual who is already mounting an 
immune response to a pre-existing pathogen.  
In the preceding chapters two models of co-infection have been investigated. Latent 
gammaherpesvirus infection appears to provide a protective effect against acute respiratory 
infection with influenza A in a dose dependent manner, with protection less effective during 
severe infection. Co-infection led to a reduction in inflammatory cytokines and chemokines 
resulting in reduced pathology and clinical signs without impacting influenza viral replication. 




 cells in the lung may be responsible in part for the 
attenuation. The effect was not negated by removal of the inflammatory and in some 
circumstances regulatory, cytokine IFNγ. Chronic infection with L. sigmodontis, a model of 
filarial nematode infection, modulated influenza A infection with differing outcomes depending 
on the developmental stage of the parasite. Early stage (L4) infection had no significant impact. 
Pre-patent adult stage of infection delayed the pathogenesis of influenza infection for 1-2 days. 
Patent, late stage infection resulted in exacerbated disease. At all time points, pathology and 
 
 





 T cell responses were compartmentalised to the site of each infection whilst 
some interaction was observed in the draining lymph nodes. 
5.3 Interaction between divergent immune responses 
The project considered that immune responses from unrelated pathogens could interact and alter 
the outcome of each infection. Immune responses to different pathogens and in particular those 
that cause polarised immune responses are thought to interact in a number of ways.  
5.3.1 Competing responses 
CD4
+
 T cells are pivotal in polarising the adaptive immune response. Development of TH1 and 
TH2 cells requires a degree of competition between IL-12, IL-18 and IL-4, IL-13 to influence 
antigen responsive cells and develop appropriate T helper lineages (Glimcher and Murphy 
2000). This is of particular importance for CD4
+
 T cells returning to the epithelial barrier 
surfaces in the lung and gut where overexpression of GATA-3 and resulting suppression of T-
bet can induce asthma and cause chronic inflammation and other immunopathology (Neurath, 
Finotto et al. 2002). In the context of a chronic infection, a heightened ‘anti-inflammatory’ 
immune response restricting the chronic infection could lead to modulation of responses to 
another type 1 co-infecting pathogen. This can be seen in  infection with Schistosoma mansoni 
where chronic infection of mice skews the CD4
+
 immune response to a number of unrelated 
antigens (Kullberg, Pearce et al. 1992) and Brugia malayi infection, which alters cytokine 
production by PPD (Mycobacterium tuberculosis antigen) specific T cells due to IL-4 
production.  
This effect can be seen in the L. sigmodontis and A/WSN/33 co-infection experiments when 




 cells in the co-infected 
mice consistently showed reduced production of both type 1 and 2 cytokines compared with 
single infected controls (Figure 4.11A-C).  The draining lymph node is an important site of 
attenuation in the production of appropriately polarised adaptive responses during co-infection. 
Antigen specific activation of T cells from the lymph nodes would be a logical next step in 
order to determine if this change in phenotype is due to competition between the IL-4 and IL-12 
governed arms of the immune system.  
In chronic MHV-68 infected mice (28 days post infection), CD4
+
 T cells in the mediastinal and 
tracheobronchial lymph nodes were not increased in number or in the amount of inflammatory 
(IFNγ and TNFα) or regulatory (IL-10) cytokines produced when stimulated non-specifically 
with ionomycin and PMA (in comparison with uninfected mice). The acute phase of the 
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gammaherpesvirus infection, which requires expansion of CD4
+
 T cells in the lung draining 
lymph nodes, is therefore resolved by this time point and the virus has achieved latency. The 
inflammatory cytokine environment in the lung is also unaltered when detected by ELISA 
(Figure 3.29A). It is therefore unlikely that ongoing inflammatory immune responses in the 
lymph node as a result of chronic gammaherpesvirus infection are changing the outcome of 
A/WSN/33 co-infection. 
L. sigmodontis and A/WSN/33 co-infection does alter the cytokines produced (at day 6) by 
CD4
+
 cells in the lymph nodes. However during co-infection, CD4
+
 cells in the lung at the same 
time point have similar cytokine production to mice infected with A/WSN/33 alone. Changes to 
CD4
+
 T cells in the lymph nodes are therefore not apparent in the lungs of co-infected mice. 
Likewise, pathology at the mesothelium layer also appears unaltered in the co-infected mice 
compared with the solely L. sigmodontis infected mice. The mechanism of delay in severity and 
weight loss during the adult, pre-patent (day 34-40) L. sigmodontis and A/WSN/33 co-infection 
is therefore unknown.  
Counter-inhibitory type 1 cytokines (IFNγ and TNFα) and type 2 cytokines (IL-4 and IL-5) are 




 cells during co-infection in 
the lymph nodes, but this effect is not mirrored at the site of influenza infection. This suggests 
changes to another cell population as a result of pre-existing infection may be responsible for 
the delay in severity of clinical signs caused by influenza.  
The delay in response to A/WSN/33 during co-infection with pre-patent L. sigmodontis  is 
consistent with another L. sigmodontis co-infection experiment in the literature, where the 
immune responses to L. sigmodontis and co-infecting Leishmania major were successfully 
compartmentalised by the immune system and did not interact, however there was a delay in 
pathogenesis of L. major (Lamb, Graham et al. 2005).  
The second touch hypothesis states that activation, polarisation and expansion of adaptive 
immunity occurs in the lymph nodes and requires antigen presentation and specific cytokine 
production but effector function at the site of infection is activated by a second antigen specific 
signal at the point of inflammation where the antigen is derived (Ley 2014). Within the lymph 
nodes TH1 and TH2 prototypical cytokines appear to interact leading to the induction of 
sufficiently polarised antigen specific responses. Appropriate expression of chemokines by 
macrophages, innate lymphoid cells, damaged infected cells and dendritic cells at the site of 
infection (Lebre, Burwell et al. 2005) recruit suitable cell populations back into the peripheral 
tissues to exert effector function. The interaction between responses in the lymph node may 
explain the delay in the co-infected mice which take longer to produce an appropriate response 
on account of the other cytokine responses present. At day 6 appropriate responses are present 
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in the lungs and there is no difference between L. sigmodontis and A/WSN/33 co-infected and 
singly A/WSN/33 infected mice.  
Another reason for the delay may be changes at an earlier time point. Poor antigen presentation, 
changes to phagocytic capacity of macrophages at the site of infection, inefficient production of 
cytokines by innate lymphoid cells or impaired NK cell activation could contribute. It would 
therefore be of interest to compare the lung resident immune cells 6-48 hours after influenza 
infection in the co-infected mice with those from singly infected mice.   
5.3.2 Regulatory responses 
As an alternative to competition between TH1/TH2 and other polarised responses of the host 
immune response (TH17, TH9 etc), the interactions between concurrent immune responses may 
be explained by regulatory mechanisms. L. sigmodontis produces a regulatory T cell response 
from early time points during infection that is capable of suppressing an allergic asthmatic 






 T cells are 
induced during infection to prevent a neutralising TH2 response in resistant strains of mice 
(Taylor, Harris et al. 2007). Regulation of cytokine production in the lymph node may explain 
why reduced type 1 and 2 cytokines were seen in the mice co-infected with L. sigmodontis and 
A/WSN/33 however this is not supported by an increased production of IL-10 by CD4
+
 T cells, 






 cells was increased in co-infected mice (Figure 
4.11H) suggesting that the effector function of these cells may have been altered despite their 
ability to produce IFNγ.  
In latent MHV-68 infected mice, macrophages from lung lavage had an increased level of 
SOCS-1, a suppressor of cytokine production. Down regulation of macrophage cytokine 
production is found in other herpesvirus infections for example HHV-6 can suppress the 
activation of macrophages by GM-CSF and IL-3 and similarly KSHV encodes a protein mimic 
of CD200 to down-regulate macrophage activation (Foster-Cuevas, Wright et al. 2004). Many 
persistent viruses encode immunosuppressive proteins in order to evade the acute immune 
response and establish latency. Therefore the requirement to suppress on-going responses to 
long-lived pathogens to avoid excessive collateral damage may provide an explanation for 
assuaging the response to A/WSN/33 in infected mice.  
5.3.3 Synergistic responses 
In reality it is likely that a combination of the previously described factors alter immune 
responses during co-infection. It is also apparent that polarisation of the immune response is not 
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simple and sufficient immunity to all pathogens requires interactions between all (TH1, TH2, 
TH17 etc) branches of the immune response to act synergistically or to varying degrees.  
In L .sigmodontis infection, IL-5 and IFNγ act synergistically following the establishment of 
patency to eliminate the parasite (Saeftel, Arndt et al. 2003), evidenced in the increased 
production of IFNγ by CD4
+
 T cells in the solely L. sigmodontis infected group in the last 
developmental stage experiment (Figure 4.18A). Influenza responses combine neutrophil 
recruiting IL-17a responses, with TH1 inflammatory responses. IL-17RA
-/-
 mice have reduced 
pathology. Therefore activation of different branches (E.g. TH1/TH2 etc) of the immune system 
must be balanced. Increased expression of TH17 responses may contribute to hypercytokinemia 
induced fatality (Bermejo-Martin, Ortiz de Lejarazu et al. 2009) and therefore understanding 
how MHV-68 infection manages to reduce the production of all cytokines and chemokines 
measured in the cytokine array (Figure 3.17) could contribute to development of therapeutics 
against self-propagating inflammatory responses. 
 It is likely that this synergistic balance in responses is important in influenza infection, where 
increases in IL-4 and IL-5 expression were seen alongside the expected inflammatory cytokines 
(Figure 3.17C). Counter-regulation and suppression of these systems is required for resolution 
of pulmonary damage and therefore, as evidenced in the co-infection experiments, imbalance of 
this response can greatly alter the outcome of infection without altering influenza replication.  
5.4 Mouse strain  
Mouse strain specific differences observed in the MHV-68 and A/WSN/33 co-infection 
experiments in BALB/c and 129Sv/Ev mice provide evidence of host genetic factors 
contributing to susceptibility to infection. In humans this can be seen in the identification of 
IFITM3 alleles that make individuals more likely to succumb to influenza infection (Everitt, 
Clare et al. 2012). In mice this is seen in the presence or absence of Mx proteins (Staeheli, Grob 
et al. 1988) and both L. sigmodontis and MHV-68 infections have been shown to produce 
differing immune responses in BALB/c and C57BL/6 mice (Hoffmann, Petit et al. 2000; 
Weinberg, Lutzke et al. 2004). It is consequently unsurprising that different mouse strains may 
respond differently to the same co-infection, especially considering additional differences such 
as murine MHC haplotype. Some mice are more adept at producing particular responses than 
others, which can be seen most clearly in their ability to instigate TH1/TH2/TH17 etc. responses. 
Results of the MHV-68 and A/WSN/33 co-infection in the 129Sv/Ev model had a drawback in 
the unintended alteration to the diurnal light cycle and this experiment therefore needs repeating 
before conclusions can be drawn. Understanding genetic differences and their influence on 
susceptibility during infection may however demonstrate target cell populations that control 
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immunity during co-infection. This is evidence of the highly complicated network of immune 
responses that are constantly evolving and interacting to meet the needs of the host and regulate 
homeostasis.  
5.5 Antigen specificity  
Evidence of direct cross-reacting immune responses or ‘heterologous immunity’ driven by 
chronic herpesvirus infection has been observed in some co-infections. EBV antigen-specific 
CD8
+
 T cells were observed to respond to hepatitis B infection in a human cohort with similar 
kinetics to that of the total CD8
+
 T cell population (Sandalova, Laccabue et al. 2010). Later 
individual cross-reactive epitopes were identified between EBV and antigens from influenza A, 
explaining the reactivity of herpes-specific memory responses during heterologous infection 
(Clute, Naumov et al. 2010). This could also be a mechanism by which protection against 




 T cells in the 
lung would determine if direct cross-reactivity occurs in the mouse model of MHV-68 and 
A/WSN/33 co-infection. In this case protective secondary immunity could be compromised as 
discussed in 3.6.2. 
5.6 The role of IFNγ 
IFNγ was hypothesised to contribute to the protective effect seen in the MHV-68 co-infection. 
Co-infected animals displayed a decrease in mean IFNγ levels in lung homogenates measured 
by ELISA compared with singly A/WSN/33 infected mice. MHV-68 infection, however, had a 
similar protective effect in IFNγRA
-/-
 mice. IFNγ is integral to recall responses (Bot, Bot et al. 
1998) and cytolytic activity in CD4
+ 
T cells (Brown, Lee et al. 2012). IFNγ is expressed by TFH 
following influenza infection (Luthje, Kallies et al. 2012) and regulates macrophage function 
(Sun and Metzger 2008). It has been shown to have enough overlap and redundancy with other 
signalling cascades in the immune system that expression of IFNγ is not essential to mount 
successful immunity to influenza A (Graham, Dalton et al. 1993). Augmentation of IFNγ 
responses, however, still showed potential to influence the outcome of influenza infection, as 
seen in previous co-infection experiments (Metzger 2014). While IFNγ was reported to increase 
as a result of MHV-68 infection in the serum (Barton, White et al. 2009), the increase reported 
in the lung by qPCR in other studies (Saito, Ito et al. 2013) was not observed by ELISA during 
these experiments. The rise in IFNγ in the lung due to latent MHV-68 infection may therefore 
not be the crucial change caused by gammaherpesvirus infection that alleviates the expansion of 
other inflammatory cytokines and adaptive cellular immunity at later stages of infection.  
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MHV-68 infection produces a more evident persistent response in the lung, coupled with 
infiltration of immune cells in the absence of IFNγRA, (Figure 3.26) and causes multiple organ 
fibrosis, alternative activation of macrophages and a significant impact on leukocyte trafficking 
(Ebrahimi, Dutia et al. 2001; Gangadharan, Hoeve et al. 2008). It is therefore difficult to 
compare this significantly altered phenotype in the context of the co-infection as lymph nodes 
cannot be collected due to fibrosis.  
Both single infections are changed and normal immune function is compromised by the absence 
of IFNγ receptor (and subsequent signalling). Targeted depletion of IFNγ with monoclonal 
antibodies may be more useful to understand its influence at specific time points during 
infection. This method would also allow for comparison of competent MHV-68 infection prior 
to co-infection when IFNγ could be depleted for a more direct comparison however this could 
reactivate MHV-68 as a result. 
 In the absence of IFNγ signalling, MHV-68 infection in the spleen resulted in increased M2 
markers Ym/1 and Fizz1 and transcription of type 2 cytokines IL-21, IL-5 and IL-13 was up-
regulated suggesting a highly type 2 polarised response (Gangadharan, Hoeve et al. 2008). This 
environment may share similarity with that seen in the persistent helminthic infection 
experiments and would suggest that type 2 responses alone are more capable of controlling 
influenza infection in the complete absence of IFNγ driven type 1 immunity.  
MHV-68 and A/WSN/33 co-infection in BALB/c mice had a large reduction in all cytokines 
and chemokines (Figure 3.17) 6 days post infection. 129Sv/Ev mice produce a more 
inflammatory response to influenza and are more resistant to weight loss (Figure 3.21A). A 
significant reduction in inflammatory cytokines does not explain the increased resistance seen in 
the co-infected BALB/c mice. Therefore the role of IFNγ is contentious.  
Ultimately it is likely another mechanism of action that causes protection in the MHV-68 co-
infection and further investigation of the early stages of response and in the solely MHV-68 
infected mice is required. 
5.7 Future directions 
5.7.1 Lung homeostasis and early innate responses 
In the MHV-68 and A/WSN/33 co-infection no alterations occur in the lymph nodes but subtle 
changes in the responding populations are evident in the lung. These changes may reflect the 
alterations to lung homeostasis during latent infection with MHV-68. Macrophages in latently 
infected mice showed increased SOCS-1 expression while CD4
+
 T cells and cytokines in the 
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lung were unaltered.  The ELISA method of cytokine detection, however, may not be sensitive 
enough to determine subtle increases in IFNγ required levels to suppress virus replication, as 
discussed previously. The results of the cytokine array in the MHV-68 and 5x10
3 
A/WSN/33 co-
infection suggest that all cytokines and chemokines were reduced in co-infected mice by day 6 
post A/WSN/33 infection. The ability of MHV-68 to suppress inflammatory responses in the 
lung must therefore be an on-going effect of latent infection on the immune system. 
Currently we do not understand the mechanism underlying the alteration to influenza virus 
infection by latent MHV-68 infection but early signalling pathways and changes to receptors 
and anti-viral surveillance molecules may be the source of this transformation. If the production 
of inflammatory cytokines such as IFNγ is required to control gammaherpesvirus latency, then 
expression of IFNγ inducible genes or anti-viral receptors such as RIG-I, MDA-5, NOD 
receptors, type 1 and 3 interferon production and even MHC expression may be altered. The 
importance of such receptors can be seen in their inhibition, which increases susceptibility to 
influenza virus infection (Wu, Patel et al. 2011).  
In the absence of the IFNγ receptor, the protective effect is still observed and A/WSN/33 
replication is not significantly altered by co-infection. This weakens the hypothesis that 
expression of  inhibitors of viral replication would be increased. Instead the effect of MHV-68 
infection may be attributed to changes in lung integrity, phenotype of residing immune cells 
such as macrophages and even the epithelial barrier and its interaction with professional antigen 
presenting cells.  
The regulation and suppression of inflammation at the site of infection lead to reduced 
infiltration of immune cells. This is observed in the lung pathology (Figure 3.9I and 3.9L). 
Therefore it would be important to investigate the early time points of influenza infection during 
co-infection with latent MHV-68. This would require further investigation in order to identify 
subtle changes in the immune environment caused by the underlying latent MHV-68 infection 
that subsequently provide protection against influenza A infection. 
While the lung environment during latent infection is not known, changes to lung homeostasis 
may be identifiable in innate recognition molecules such as CD200 expressed on airway 
epithelium. CD200 is capable of suppressing macrophage responses to influenza infection 
(Snelgrove, Goulding et al. 2008). Similarly in a steady state the lung environment is governed 
by IL-10 production by dendritic cells and TREG induction against innocuous antigens. 
Correspondingly, epithelial cells secrete GM-CSF and NO and TGF-β that alter the responses of 
dendritic cells to harmless inhaled antigens (Snelgrove, Godlee et al. 2011). If chronic infection 
can adjust this balance it is likely a source of the protection during co-infection.  
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The increase in production of type 2 cytokines in response to mechanical damage caused by 
filarial nematode infection may offer insight into changes in the lung environment that provide 
the changes in pathogenesis seen in the L. sigmodontis and A/WSN/33 co-infection at different 
developmental stages. Helminth infection induces a range of cytokines and alarmins (TSLP, IL-
25, IL-33) and release of DAMPs such as uric acid and extracellular ATP from apoptotic cells 
that are usually absent in the uninfected lung. It is also apparent in the later developmental stage 
that L. sigmodontis causes a degree of fibrosis in the lung mesothelium. The phenotype of 
macrophages in the lungs of these mice would also be interesting to delineate, as helminthic 
infection often induces alternative activation and increased production of MHC-II (Reece, 
Siracusa et al. 2006).  
Key cytokines required to initiate responses in the lung released by epithelial cells such as IL-33 
may also be of key consideration in future work to determine how airway homeostasis and 
remodelling is altered by pre-existing infection. Administration of IL-33 during influenza A 
infection increases TH17 and TH2 cytokine production and as IL-33 is induced upon helminth 
infection it could be a source of regulation in the early response to co-infection (Yagami, 
Orihara et al. 2010). Such changes at epithelial barriers could also determine the alleviation of 
inflammation observed in MHV-68 and A/WSN/33 co-infection. Although production of IL-33 
during latent infection is unlikely, changes to IL-33 cause alterations in effector function by 
CD8
+
 T cells (Ngoi, St Rose et al. 2012) which is seen in the MHV-68 and A/WSN/33 co-
infection in the lung.  
An unexpected outcome of co-infection with MHV-68 and A/WSN/33 was a reduction in 
MHV-68 viral load in the lungs of co-infected mice. This is hypothesised to be a result of 
increased presence of inflammatory cytokines including IFNγ which is responsible for 
maintaining latency in gammaherpesvirus infection and a reduction in IL-4 which has been 
shown in helminthic co-infection to reactivate MHV-68 (Steed, Barton et al. 2006; Reese, 
Wakeman et al. 2014). Dysregulation of early innate responses is a key contribution to the 
outcome of infection (Vogel, Harris et al. 2014). Therefore understanding of the effect of MHV-
68 and L. sigmodontis infections on the lung is predicted to determine why these infections can 
confer a level of protection or exacerbate disease and pathogenesis of influenza A. 
5.7.2 Secondary infection and memory responses 
While better understanding of the early innate responses could be integral to determining the 
changes in outcome caused by co-infection, the protective effect and dampened immune 
responses may come at a cost to memory responses (Beaumier, Mathew et al. 2008; Min-Oo 
and Lanier 2014). Correspondingly there may also be an impact on antibody responses and class 
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switching if inflammatory cytokines and signalling is reduced by co-infection. Measuring the 
outcome of A/WSN/33 pathogenesis and long term immune responses may therefore also be of 
interest in the context of co-infection. Identifying influenza specific IgG1 vs. IgG2a balance 
following L. sigmodontis and A/WSN/33 co-infection was an aim of the project that 
unfortunately could not be completed. 
5.7.3 Impact 
The outcome of the two co-infection experiments suggests that immunity to influenza infection 
is greatly altered by co-infection. Latent gammaherpesvirus infection which is common among 
human populations, appears to offer protection from inflammatory responses to influenza A in 
this model. Filarial nematode infection, which is highly prevalent in the tropics also impacted 
influenza virus pathogenesis and varied due to developmental stage of the worm. These 
observations could have important implications during the treatment of severe influenza. While 
many studies have addressed the effect of co-infecting respiratory pathogens during infection 
and identified the impact of influenza A virus on lung integrity in the promotion of bacterial 
infection, it has only recently been understood that pre-existing unrelated pathogens, infecting 
sites away from the lungs can have a significant impact on the outcome of influenza infection. 
This knowledge could be an integral factor contributing to the wide variations in responses 
recorded during highly pathogenic influenza infections. Similarly if chronic infection is capable 
of skewing immune responses to unrelated infection, understanding the mechanism may provide 
better vaccination strategies or highlight potential targets within the host’s immune system for 
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Chapter 6 -  Appendix  
Figure 6.1 Comparison of A/WSN/33 infection between mouse strains 
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Figure 6.2 FACS Analysis Protocol 
Representative plots of FACS analysis and gating strategy to identify lymphocyte populations 
1. Sample before analysis 
 
Figure 6.2.1 Whole samples run on SSC-A and FSC-A 
2. Removing dead cells 
 
Figure 6.2.2 Live cells are gated based on stain with Zombie cyan live/dead stain (Biolegend). Cells are 
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3. Removing doublets  
 
Figure 6.2.3 Live single cells were identified by analysis of live cells on a FSC-height vs FSC-area plot. 
Single cells were identified as those with tightly correlated height and area detection. 
4. Identifying lymphocyte population 
 















 lymphocytes were identified with population specific antibodies 





 A. Experimental sample     B. Isotype negative control 
 
 
Figure 6.2.6 Intracellular staining was performed on fixed cells to determine production of cytokines 
after 4 hour stimulation with PMA and Ionomycin. Relevant isotype controls were used to identify 
nonspecific binding. This value was subtracted from positive samples. 
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